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Epigenetics refers to heritable changes in phenotype without alterations to the 
genotype. Epigenetic changes involve two main mechanisms: DNA methylation and 
histone modification. Methylation of DNA at cytosine bases is the best-studied 
epigenetic process to date. CpG methylation states are thought to be maintained 
throughout cell divisions. However, loss of DNA methylation or DNA demethylation 
has been observed in specific stages of mammalian development. Such prominent 
examples of developmental DNA demethylation processes occur in developing 
primordial germ cells and in preimplantation embryos. However, little is known 
about DNA methylation changes of other tissues in mammalian development. 
Therefore, the first aim of this PhD study was to investigate changing nuclear 
distributions and levels of DNA methylation during development in order to discover 
dynamic variations amongst developing mouse tissues. In addition, a transgenic 
MBD-GFP mouse was employed to visualise DNA methylation in tissues. 
 
Several hypothetical mechanisms for the enzymatic removal of 5mC have been 
proposed. One of the proposed candidates is Tet-mediated successive oxidation of 
5mC to generate 5hmC, 5fC and 5caC. 5hmC has therefore been considered as a 
transient intermediate in an active cytosine demethylation pathway. Nevertheless, 
some studies suggest that 5hmC may also function as an epigenetic modification in 
its own right. Thus, the second aim of this study was to address the research question 
of how and where 5hmC originates during development. 
 
In order to be able to identify tissues undergoing dynamic nuclear changes in DNA 
methylation and hydroxymethylation states during early mouse development, new 
working protocols for immunodetection of 5mC and 5hmC on tissue cryosections 
were required. The protocol optimisation for 5mC immunodetection is discussed in 
greater detail in Chapter 3. It was found that DNA methylation immunostaining of 
cryosections required heat-mediated DNA denaturation, which was partly compatible 




Next, Chapter 4 focuses on identifying tissues undergoing dynamic changes in 5mC 
and 5hmC patterns during development from E9.5 to E14.5 mouse embryonic stages, 
using optimised immunohistochemistry protocols. These protocols revealed 
interesting dynamic observations of 5mC and 5hmC in the developing cerebral 
neocortex, surface ectoderm, liver, red blood cells, diaphragm and heart. These 
findings suggested that dynamic changes of 5mC and 5hmC during neocortical and 
compact myocardial development were in good agreement with a model where the 
formation of 5hmC may correlate with the loss of old 5mC, but the observations 
were also consistent with an involvement of de novo methylation in the generation of 
5hmC. In other developing tissues, including surface ectoderm, liver, red blood cells, 
diaphragm and cardiac trabeculae, dynamic changes in 5mC and 5hmC levels were 
in line with a model where the 5hmC may act as a new epigenetic mark that 
functions independently. The optimised protocol also confirmed DNA demethylation 
of the germ cells at E12.5. The presence of three Tet family enzymes (Tet1, Tet2, 
Tet3) and de novo methyltransferase DNMT3A in mouse E12.5 tissues is reported in 
the second part of Chapter 4. It was found that Tet1, Tet2, Tet3 and Dnmt3a were 
present at detectable levels in neocortex, liver, diaphragm and heart. Contrastingly, 
no apparent signals for Tet1, Tet2, Tet3 and Dnmt3a were observed in red blood 
cells. This result was expected due to the very low levels of 5hmC staining in E12.5 
red blood cells. 
 
The third aim of the present study was to investigate the existence of crosstalk 
between various epigenetic mechanisms. Thus, Chapter 5 focuses on exploring the 
relationship between 5mC and repressive histone marks, H3K9me3 and H3K27me3. 
Histone methylation dynamics at H3K9 and H3K27 were observed during mouse 
fetal development in neocortex and heart. The overall distribution patterns of 
H3K9me3 and H3K27me3 demonstrated strong association with developmental 
changes in 5mC, suggesting that these three repressive epigenetic marks work in 





Chapter 6, on the other hand, focuses on visualising DNA methylation in tissues 
using mouse transgenic tools. It was found that brain, liver, heart and neural tube 
expressed high levels of GFP. But no apparent developmental dynamics of GFP was 
observed. 
 
In conclusion, this study will contribute scientific understanding of dynamic DNA 
methylation and nuclear heterochromatin organisation during mammalian 
development, and its role in the specification and maintenance of cell lineages 
forming tissues and organs. This knowledge will provide insight into current barriers 



























Well known examples of epigenetic DNA demethylation processes occur in early 
mammalian development; nonetheless, little is known about the DNA methylation 
dynamics of other developing tissues. It is important to discover DNA methylation 
changes in other mammalian tissues and investigate whether the role of 5hmC is as 
an intermediate product of cytosine demethylation or as a stable epigenetic 
modification that functions independently. Furthermore, recent studies reported that 
DNA methylation and histone modifications appear to be associated with one 
another. It was therefore important to investigate the relationship between DNA 
methylation and histone modifications. 
 
Optimised immunohistochemistry protocols revealed new observations of DNA 
methylation dynamics at 5mC and 5hmC during mouse embryo development in brain 
neocortex, surface ectoderm, liver, red blood cells, diaphragm and heart. Moreover, 
the results suggested that the generation of 5hmC may correlate with the loss of old 
5mC, but the observations were also consistent with an involvement of de novo 
methylation in the formation of 5hmC. Some results were in agreement with the 
model where 5hmC may possess independent functions. Furthermore, this study also 
discovered a strong correlation between 5mC and histone methylation at H3K9 and 
H3K27. 
 
Together, this study provides advanced scientific understanding of the nuclear 
epigenetic dynamics during development, which is of relevance to cell 
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Chapter 1 - Introduction 
 
1.1 What is epigenetics? 
Transcription, translation and subsequent protein modification are processes by 
which the information coded in a strand of deoxyribonucleic acid (DNA) is 
expressed into a new molecule of messenger ribonucleic acid (mRNA) for 
production of protein. Although all cells in an organism have identical genetic 
instructions, cell types and functions vary due to qualitative and quantitative 
differences in their gene expression, and control of gene expression is therefore 
important for differentiation and development (Meehan et al., 2005). During 
development, the patterns of gene expression that characterise differentiated cells are 
established and maintained as the cells divide by mitosis. Thus, in addition to 
inheriting genetic information, cells inherit and propagate functionally relevant  
expression instructions to the genome that do not involve a change in the nucleotide 
sequence, and this has been termed epigenetic information (Gilbert, 2012; 
Waddington, 1942). Epigenetics is now considered a vital mechanism for controlling 
gene expression in a potentially heritable way (Portela and Esteller, 2010).  
 
The Greek prefix ‘epi-’ in epigenetics means ‘on top of’ or ‘in addition to’ genetics. 
So, the term ‘Epigenetics’ refers to an additional layer of information coded ‘on top 
of’ the organism’s underlying DNA sequence (Nightingale, 2015). The term 
epigenetics was coined by the British developmental biologist Conrad H. 
Waddington in 1942. He defined epigenetics as “the branch of biology that studies 
the causal interactions between genes and their products which bring the phenotype 
into being” (Deans and Maggert, 2015; Waddington, 1942). In 1957, Waddington 
developed the idea of epigenetic landscape (Figure 1.1) to illustrate cellular 
decision-making through the processes of development (Noble, 2015; Waddington, 
1957). Today, epigenetics is widely known as “the study of changes in gene function 
that are mitotically and/or meiotically heritable and that do not entail a change in 




process that alters gene expression without affecting the original base sequence 
(Bonasio et al., 2010). 
 
 
Figure 1.1: Waddington’s epigenetic landscape. The landscape of dividing 
valleys and the cell (represented by a ball) at the top of the hill are from his initial 
drawing. The images of the cell rolling down the epigenetic landscape have been 
added to explain that the cell makes different choices by taking only one of several 





To understand the phenomenon of epigenetics requires an understanding of the 
chromatin structure and organisation as is foundations. Chromatin is the 
conformational state in which DNA is packed tightly inside the nucleus of every cell 
(Margueron and Reinberg, 2010). Chromatin is the complex of DNA, protein, and 
RNA that constitutes chromosomes, and is organised into small repeat units known 
as nucleosomes (Flaus and Owen-Hughes, 2017; Westhorpe and Straight, 2015). In a 
nucleosome, 147 base pairs (bp) of DNA are wrapped around an octamer of histone 
proteins which is composed of two copies of each of the four core histone proteins 
H2A, H2B, H3, and H4 (Pastore, 2017; Tessarz and Kouzarides, 2014). Each of the 
core histones, in addition to their globular C-terminal domain, also contain an 
unstructured, flexible, highly conserved N-terminal domain which is described as the 
histone ‘tail’. A distinct feature of the core histones, especially their protruding N-
terminal tails, is the large number and type of covalently modified residues they can 





In addition to the four core histones, there is another type of histone called linker 
histone, also known as histone H1 (Hergeth and Schneider, 2015). The linker histone 
H1 plays pivotal roles in various cellular functions, including condensation of 
chromatin, regulation of transcription, nucleosome spacing and chromosome spacing 
(Kalashnikova et al., 2016). Furthermore, histone H1 can interact with linker DNA 
between nucleosomes and promotes compaction of chromatin by coiling 
nucleosomes from the smaller “beads-on-a-string” fibres of approximately 10-11 nm 
into higher-order chromatin structures known as the 30 nm chromatin fibres (Gross 
et al., 2015; Harshman et al., 2013).  
 
The dynamics of 30 nm higher-order chromatin fibres are key regulators of 
transcription as well as other biological processes involving DNA (Li and Reinberg, 
2011). Altering higher-order chromatin structures through the control of DNA-
binding proteins and/or complexes is essential in order to gain access to the DNA for 
transcription, DNA repair, and DNA replication (Bell et al., 2011). A number of 
factors, including DNA methylation, histone modifications, histone variants and 
architectural proteins have now been well recognised for their important function in 
the modulation of higher-order chromatin structure that carries epigenetically 
inherited information (Kaufman and Rando, 2010; Li and Reinberg, 2011).  
 
As the chromatin structure may be transmissible from mother to daughter cells 
through mitotic division, chromatin modifications can serve as major carriers of 
epigenetic information that influence the expression of the underlying genes (Bintu et 
al., 2016; Budhavarapu et al., 2013). The epigenetic marking of chromatin is required 
to define each cell's identity during development, in which cells develop different 
identities despite the fact that they are genetically similar (Cantone and Fisher, 
2013). The unique property of DNA and histones, specifically their ability to recruit 
epigenetic modifications, allows chromatin to assimilate cellular ‘memory’ (D’Urso 
and Brickner, 2014) and cellular plasticity (Duncan et al., 2014; Liu et al., 2016b; 
Rajagopal and Stanger, 2016). Epigenetic regulation involving covalent modification 
of DNA and histone proteins, may add a further layer of regulatory complexity to the 




1.1.2 Epigenetic mechanisms 
Epigenetic mechanisms including DNA methylation, histone modifications as well as 
regulation of gene expression by non-coding RNAs play essential roles in numerous 
fundamental biological processes (Feinberg AP and Fallin M, 2015; Yao et al., 
2016). Together, they work in concert to organise DNA into chromatin and 
contribute to shaping the gene expression profile that defines the exact phenotype of 
a cell (Boland et al., 2014). Epigenetic mechanisms are necessary for proper 
development and maintenance of tissue-specific gene expression programs through 
mitotic cell division in mammals (Fedoriw et al., 2012; Handy et al., 2011). 
Epigenetic changes can be influenced by numerous factors, including aging, disease 
development, and environmental exposure (Cacabelos, 2016). Furthermore, 
epigenetic changes have been found to be involved in a variety of disease conditions, 
including various monogenic and multifactorial disorders (Maarel, 2008). However, 
epigenetic changes are potentially reversible and thus can be promising targets for 
pharmacological interventions (Cacabelos and Torrellas, 2015). 
 
The two most extensively studied and well-characterised epigenetic modifications 
are DNA methylation and histone modifications (Figure 1.2) (Putiri and Robertson, 
2010), while the role of non-coding RNAs in epigenetic regulation had been 
relatively less studied but is gaining interest (Roundtree and He, 2016). DNA 
methylation and histone modification can impact chromatin accessibility through 
controlling the chromatin structure, and thereby regulate gene expression patterns 
(Rothbart and Strahl, 2014). In mammals, DNA and histone methylation marks can 
be inherited (Chen and Dent, 2014). These epigenetic marks can be transmitted 
through mitotic cell divisions (Probst et al., 2009) and, in some cases, the marks 
could be potentially passed on to the subsequent generations through meiosis, a 
phenomenon known as transgenerational epigenetic inheritance (Daxinger and 






Figure 1.2: Schematic representation of two major mechanisms of epigenetic 
gene regulation. DNA methylation refers to the addition of methyl groups to 
cytosine (C) residues in DNA (shown in light blue) and thereby repress gene 
expression. Histone modifications, on the other hand, refer to the addition of various 
functional groups for instance methyl or acetyl to specific amino acid residues on the 
tails (shown in dark blue) of histone proteins (shown in pink) and thereby either 







Faithful transmission of these epigenetic marks during each cellular division as well 
as across generations is critical in order for cells to retain their non-DNA sequence 
information (Alabert and Groth, 2012; He et al., 2014). Both epigenetic marks must 
avoid being erased in the process called epigenetic reprogramming in order for 
epigenetic inheritance to occur (Whitelaw, 2015). Epigenetic inheritance is critically 
important in numerous fundamental biological processes, including expression of 
genes during early embryogenesis, genomic imprinting and transposon silencing 
(Migicovsky and Kovalchuk, 2011; Triantaphyllopoulos et al., 2016). Improper 
maintenance of heritable epigenetic marks can lead to developmental abnormalities 
and common diseases such as cancer (Lorthongpanich et al., 2013; Peters, 2014; 
Tomizawa and Sasaki, 2012). In addition, poor maternal nutrition can lead to 
epigenetic changes increases the risk of certain diseases, including obesity and 
diabetes. These changes are proposed to be passed on to the subsequent generation 
via transgenerational epigenetic inheritance, indicating that parental eating disorders 
may raise the risk of diabetes and obesity in offspring (Huypens et al., 2016).  
 
1.1.3 Epigenetic mechanisms determine chromatin state 
From the functional point of view, chromatin can be classified into two major types 
of material, euchromatin and heterochromatin (Figure 1.3), depending on the degree 
of compaction and gene activity profile (Wang et al., 2014). The concepts of 
euchromatin and heterochromatin were first described in the late 1920s by Emil 
Heitz (Heitz, 1928). The initial classification of chromatin was based on its 
appearance, where euchromatin described the regions of chromatin that were 
decondensed and were no longer visible during interphase, while, on the other hand, 
heterochromatin described the regions that remained visibly condensed throughout 






Figure 1.3: Electron micrograph of euchromatin and heterochromatin in an 
interphase nucleus. Regions of chromatin that are less condensed and lightly 
stained in interphase are known as euchromatin. The rest of the chromatin, which 
appears highly condensed, darkly stained, scattered throughout the nucleus but 
concentrated close to the nuclear envelope, is called heterochromatin. The DNA in 
loosely packed euchromatin is accessible for transcription, whereas the DNA in 





The less condensed euchromatin contains high concentrations of genes that 
participate in the active transcription. On the contrary, the condensed 
heterochromatin contains very few genes that are mostly transcriptionally silent 
(Allis and Jenuwein, 2016). In addition, heterochromatic state can be further divided 
into two main subtypes according to their distinct molecular signatures: constitutive 
heterochromatin and facultative heterochromatin (Grewal and Jia, 2007). 
Constitutive heterochromatin refers to the chromosomal regions that are permanently 
condensed and transcriptionally silent throughout the cell cycle. The majority of 
constitutive heterochromatin is located at the pericentromeric regions and telomeres, 




(Saksouk et al., 2015). In contrast, facultative heterochromatin refers to the 
chromosomal region that are not permanently kept in the condensed state, instead, 
they can be unwound to form euchromatin in response to cellular signals that 
regulate activity of specific genes (Trojer and Reinberg, 2007). A classic example of 
the formation of facultative heterochromatin is the silent X chromosome in female 
mammals (Chow et al., 2010; Vallot et al., 2016).  
 
The partition of the genome into active euchromatin and inactive heterochromatin 
regions is largely determined by epigenetic modifications (Tamaru, 2010). 
Epigenetic mechanisms are capable of organising chromatin into “open” 
(euchromatin) or “closed” (heterochromatin) states, and thereby control the “on” and 
“off” status of the target genes (Hahn et al., 2010; Williamson et al., 2012; Wright 
and Saul, 2013). Open chromatin structure may allow access of the transcriptional 
machinery, thereby resulting in transcriptional activation, on the other hand, in the 
closed chromatin structure, the accessibility of genes to the transcriptional machinery 
could be restricted leading to transcriptional repression (Allan, 2015). Therefore, the 
patterns of epigenetic modifications may serve as markers to represent transcriptional 
activity and gene expression as well as chromatin state for a genomic region (Baker, 
2011; Bernstein et al., 2007; Li and Zhang, 2012). In addition, chromatin remodeling 
alone, without affecting transcription, is sufficient to drive nuclear reorganisation 
during differentiation (Therizols et al., 2014). 
 
1.2 DNA methylation 
DNA methylation is one of the best studied epigenetic modifications and the most 
mechanistically understood (Smith and Meissner, 2013). It is found in most 
mammalians and many other organisms, as well as in plants (Meyer, 2015; Moffat et 
al., 2012). Chemically, it refers to the covalent transfer of a methyl group (CH3) from 
S-adenosyl-L-methionine (SAM) to the fifth position of the pyrimidine ring of 
cytosine, mostly within cytosine-phosphate-guanine (CpG) dinucleotides to produce 
5-methylcytosine (5mC), often referred as the ‘fifth base’ of DNA (Figure 1.4) 
(Moore et al., 2013). DNA methylation is typically associated with transcriptional 




various forms of stable silencing mechanism, including genomic imprinting, X-
chromosome inactivation and silencing of repetitive DNA (Schübeler, 2015).  
 
 
Figure 1.4: Schematic representation of DNA methylation. DNMT enzymes 
catalyse the transfer of a methyl group (CH3) from the methyl donor SAM to the 
carbon 5 position of the pyrimidine ring of cytosine. SAM donates the methyl group 
and is transformed into S-adenosyl-L-homocysteine (SAH). Figure redrawn from 
Maresca et al. (2015). 
 
 
1.2.1 DNA methylation machinery 
Methylation of mammalian genomic DNA is regulated by a family of enzymes called 
DNA methyltransferases (DNMTs), which are recognised as key factors in 
epigenetic silencing of transcription. The DNMT family has four known members, 
including DNMT1, DNMT3A, DNMT3B as well as DNMT3L. Three catalytically 
active enzymes, DNMT1, DNMT3A and DNMT3B, are vital for establishment and 
maintenance of DNA methylation patterns during development of an embryo. 
DNMT1 preferentially methylates hemimethylated CpG dinucleotides that are 
produced upon replication and thus acts as a maintenance methyltransferase. On the 
other hand, DNMT3A and DNMT3B have preference for unmethylated CpG 
dinucleotides and thus are known as de novo methyltransferases. Unlike the other 
DNMTs, DNMT3L has no catalytic activity because it lacks some regions that are 
required for methyltransferase activity, but it modulates the DNA methylation 
activity of DNMT3A and DNMT3B by directly binding to these enzymes (Figure 





Figure 1.5: A schematic representation of de novo and maintenance 
methylation in mammals. DNMT3A and DNMT3B act as de novo 
methyltransferases that methylate unmethylated cytosines at CpG sites, whereas 
DNMT1 acts as a maintenance methyltransferase that preferentially methylates 
hemimethylated cytosines at CpG sites, thus maintaining DNA methylation patterns 






Early reports invoked direct interference of the methyl group at gene promoters, 
which is known to affect the binding sites of specific transcription factors (Deaton et 
al., 2011; Domcke et al., 2015; Maurano et al., 2015). A more general mechanism is 
provided by proteins specifically binding to the methyl groups. Once CpG sites are 
methylated, they can be specifically recognised and read by the methyl-CpG binding 
proteins (MBPs), which then recruit chromatin remodelling corepressor complexes to 
methylated DNA sequences to suppress the expression of gene and/or to form a 
higher order compacted chromatin structure called heterochromatin, thereby 
establishing a transcriptionally inactive chromatin state (Li and Zhang, 2014). MPBs 
are grouped into three different families according to their structural similarity: MBD 
(methyl-CpG binding domain), Kaiso and SRA domain proteins (Gibney and Nolan, 
2010). The MBD protein family comprises seven members, namely MBD1, MBD2, 
MBD3, MBD4, MBD5, MBD6, and MeCP2. MBD1, MBD2, MBD4 and MeCP2 
have a conserved methyl CpG binding domain that enables them to bind to 
methylated DNA. However, unlike the other family members, MBD3, MBD5, and 
MBD6 fail to bind to methylated DNA due to the lack of numerous essential amino 
acids in the MBD domain that are crucial for the DNA binding activity (Menafra et 
al., 2014).  
 
1.2.2 CpG islands 
In mammalian genomes, DNA methylation occurs most often at CpG sites, where a 
cytosine is directly followed by a guanine in the sequence of the DNA (Klose and 
Bird, 2006). While methylated CpGs are distributed globally throughout the genome, 
those that seem to be protected from the methylation exhibit dramatic clustering. 
These clusters of unmethylated CpG dinucleotides tend to reside in regions known as 
CpG islands (CGIs) and frequently located at the 5' ends of genes (Bird, 1986, 1987; 
Gardiner-Garden and Frommer, 1987; Reddington et al., 2013a). CGIs are stretches 
of DNA approximately 1000 bp in length that have an elevated G + C content, little 
CpG depletion, and normally free from DNA methylation (Blackledge and Klose, 





Up to 70% of human genes are associated with CGIs (Saxonov et al., 2006). It has 
been predicted that the human genome contains roughly 29,000 CGIs (Lander et al., 
2001), most of which are associated with the 5’ ends of genes, including the 
promoters of housekeeping genes which are often embedded in CGIs as well as a 
proportion of tissue-restricted genes and developmental regulator genes (Harraghy et 
al., 2015; Chatterjee and Vinson, 2012; Zhu et al., 2008). Based on their location in 
the promoters, it has been hypothesized that CGIs may play key roles in gene 
regulation (Beck et al., 2014), most likely by the recruitment of the CXXC finger 
protein 1 (Cfp1) and possibly other CpG-binding proteins (Clouaire et al., 2012; 
Thomson et al., 2010).  
 
CGIs, however, avoid the phenomenon of CpG dinucleotide suppression and 
preserve their CpGs. A mechanism involved in protecting these DNA regions against 
de novo methylation is under intense investigation (Sormani et al., 2016). Some 
results suggest that the protection mechanisms of promoter-associated CGIs from de 
novo methylation are DNA-encoded and evolutionarily conserved, regardless of host 
species (Long et al., 2016). Moreover, CGIs may escape DNA methylation 
machinery through a conserved property of unmethylated CGI promoters known as 
GC skew by forming R-loop structures upon transcription (Hartono et al., 2015; 
Ginno et al., 2012). Even more, by hosting DNA-binding proteins, particularly 
transcription factors, CGIs could make them resistant to the DNMTs (Saadeh and 
Schulz, 2014). Alternatively, CGIs are targeted by a DNA demethylation mechanism 
through direct removal of a methyl moiety from the cytosine residue, thus making 
CGIs remain free of methylation (Jin et al., 2014). However, while most CGIs 
remain unmethylated, promoter CGIs located on the inactive X chromosome in 
females readily acquire DNA methylation (Gendrel et al., 2013). 
 
The CGI promoter methylation can impair transcription factor binding and results in 
stable silencing of gene expression (Deaton et al., 2011). The phenomenon of 
aberrant promoter CGI hypermethylation has been well recognised as a hallmark of 
cancer involved in transcriptional inactivation of tumour suppressor genes and 




promoter CGIs can completely block the transcription of tumour suppressor genes, 
causing uncontrolled growth of abnormal cells, which subsequently leads to 
cancerous tumour formation (Rodríguez-Paredes and Esteller, 2011). Furthermore, a 
reduction in Tet1 activity at CGIs may induce hypermethylation events in many 
cancers (Thomson et al., 2016). 
 
1.2.3 DNA demethylation 
DNA methylation has long been thought to be a relatively stable epigenetic 
modification. However, recent evidence demonstrated that this modification may be 
more dynamic and complex than previously thought. In theory, loss of DNA 
methylation, or DNA demethylation can occur through passive or active processes. 
Passive DNA demethylation is caused by the failure of maintenance methylation 
during several cycles of DNA replication. By contrast, active DNA demethylation 
occurs via direct enzymatic removal of the methyl group from 5mC (Figure 1.6). 
Passive DNA demethylation is well understood and accepted, however the 
mechanism of active DNA demethylation has been a controversial subject in recent 
decades (Wu and Zhang, 2014). 
 
DNA methylation marks are comprehensively reprogrammed across the genome via 
DNA demethylation in a process known to occur at two major points in mammalian 
development. DNA methylation reprogramming occurs firstly following fertilization 
in the zygote and secondly occurs in PGCs (primordial germ cells) which are the 
embryonic progenitors of sperm or oocytes. In both cases, a unique set of 
mechanisms regulates the global DNA demethylation followed by extensive 
remethylation (Seisenberger et al., 2013a). This reprogramming is necessary for 
resetting parental imprints, erasing acquired epimutations, returning the genome to a 
pluripotent or totipotent state and potentially for the activation of transposable 









Figure 1.6: Passive and active mechanisms of DNA demethylation. Loss of 
5mC can occur through passive or active mechanisms. Passive demethylation 
refers to the loss of 5mC due to poor of maintenance methylation during several 
rounds of replication. On the contrary, active demethylation refers to the enzymatic 















1.3 DNA hydroxymethylation 
Several molecular mechanisms for the enzymatic removal of the methyl group from 
5mC have been proposed to play a role in reprogramming. One potential active 
demethylation mechanism involves enzymatic oxidation of 5mC to generate 5-
hydroxymethylcytosine (5hmC) (Figure 1.7A) (Hill et al., 2014). Current evidence 
suggests that 5hmC may play an intermediate role in the process of oxidative 
demethylation (Pfeifer et al., 2013).  
 
The existence of 5hmC was initially discovered in the DNA of T-even bacteriophage 
(Wyatt and Cohen, 1952). Later on, in the early 1970s, 5hmC was further reported in 
mammalian genomes (Penn et al., 1972). However, this finding did not draw much 
attention as it could not be reproduced in subsequent studies (Kothari and Shankar, 
1976), therefore 5hmC was simply thought to be a by-product of oxidative damage 
of DNA in mammalian genomes, rather than serving as a functional epigenetic mark. 
For that reason, 5hmC was largely ignored and it took almost 40 years to confirm the 
presence of 5hmC and gain insights into its molecular function (Kriukienė et al., 
2012).  
 
1.3.1 Tet-mediated 5mC oxidation 
Progress was made in 2009 when 5hmC was independently re-discovered by the 
groups of Nathaniel Heintz at Rockefeller University and Anjana Rao at Harvard 
Medical School. Heintz’ and Rao’s groups confirmed the presence of 5hmC in 
mouse brain cells (Kriaucionis and Heintz, 2009) and mouse embryonic stem (ES) 
cells (Tahiliani et al., 2009). By using thin layer chromatography (TLC), high 
pressure liquid chromatography (HPLC) and mass spectrometry (MS), Kriaucionis 
and Heintz detected the presence of 5hmC in Purkinje cells and granule cells 
comprising approximately 0.6% and 0.2% of total nucleotides, respectively 
(Kriaucionis and Heintz, 2009). Coinciding with this observation, Rao and co-
workers discovered the key player responsible for active DNA demethylation, the 
Ten-eleven translocation (Tet) gene; Tet1. They found that Tet1 can catalyse the 
conversion of 5mC to 5hmC in a 2-oxoglutarate (2OG)- and Fe(ll)-dependent manner 




Soon after, two other Tet family members, Tet2 and Tet3, were also identified as 
being able to catalyse a similar reaction (Ito et al., 2010). Tet family proteins share a 
conserved C-terminal catalytic domain (Cys-rich and DSBH regions) that belongs to 
the dioxygenase superfamily (Gao et al., 2016). The Zhang group discovered that all 
three Tet proteins can further oxidize 5hmC to 5-formylcytosine (5fC) and 5-
carboxylcytosine (5caC) in an enzymatic activity-dependent manner (Figure 1.7B 
and 1.7C) (Ito et al., 2011). Their potential redundancy adds a degree of complexity 
to revealing the role of Tet proteins and 5hmC in epigenetic regulation during 
development (Tan and Shi, 2012). 
 
 
Figure 1.7: Oxidative reactions catalysed by Tet enzymes. (A) All three 
mammalian Tet proteins, Tet1, Tet2 and Tet3, catalyse the oxidation of 5mC to 
generate 5hmC. This chemical reaction requires 2OG, ferrous ion (Fe2+), oxygen 
(O2) and adenosine triphosphate (ATP) and yields succinate and carbon dioxide 
(CO2). (B,C) Similar reactions oxidise 5hmC further to generate 5fC and 5caC. 




1.3.2 Tet-mediated DNA demethylation 
Tet proteins play vital roles in the active DNA demethylation through iterative 
oxidation of 5mC followed by the conversion of 5caC to cytosine (Wu and Zhang, 
2015). Restoration of 5mC back to unmodified cytosine cannot happen 
spontaneously. It is likely that there are a number of chemically plausible pathways 
responsible for the reversal of DNA methylation, and that Tet proteins are involved 
in several of these (Pastor et al., 2013). 
 
Several proposed DNA replication-independent active DNA demethylation pathways 
involving Tet-mediated oxidation for the conversion of 5mC to unmodified cytosine 
are outlined in (Figure 1.8). Such pathways were mostly inferred from in vitro 
studies. One possibility is that Tet-catalysed 5hmC conversion into 5fC and 5caC can 
be efficiently excised from DNA by the DNA repair enzyme thymine-DNA 
glycosylase (TDG) and subsequently repaired via base excision repair (BER). 
Subsequent repair of the resulting abasic site via BER can generate an unmodified 
cytosine residue, thus completing the process of DNA demethylation (Weber et al., 
2016). It has been revealed that TDG possesses robust excision activity towards 5fC- 
and 5caC-containing DNA, but not 5hmC- and 5mC-containing DNA (He et al., 
2011b; Maiti and Drohat, 2011). 
 
Another possibility is that 5fC and 5caC can be directly deformylated or 
decarboxylated by a putative DNA deformylase or DNA decarboxylase enzyme, 
which eventually leads to the restoration of unmodified cytosine (Branco et al., 
2012). Intriguingly, 5caC decarboxylase activity has been detected in mouse 
embryonic stem cell (mESC) lysates, but no putative decarboxylase has yet been 
identified (Schiesser et al., 2012). First in vitro evidence for direct decarboxylation of 
5caC to unmodified cytosine by an enzyme was found by Xu et al. (2013), which 
demonstrated that IDCases (isoorotate decarboxylases) possess decarboxylase 
function albeit with weak activity. Another study found that C5-MTases (cytosine-5-
S-Adenosylmethionine-dependent DNA methyltransferases) can convert 5caC 
directly to unmodified cytosine in vitro but are lacking the ability toward 5fC 




5caC DNA decarboxylase remains uncertain and has yet to be identified (Shukla et 
al., 2015). 
 
Alternatively, 5mC or 5hmC can be deaminated by cytidine deaminases, leading to 
replacement of the residue with an unmodified cytosine residue and resulting in 
active DNA demethylation. The activation-induced cytidine deaminase 
(AID)/apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 
(APOBEC) family of cytidine deaminases are well characterised for their ability to 
deaminate 5mC or 5hmC to generate thymidine (T) or 5-hydroxymethyluracil 
(5hmU), respectively. As these are present in mismatched T:G and 5hmU:G 
basepairs, they have been suggested to be excised by TDG or single-strand-selective 
monofunctional uracil DNA glycosylase 1 (SMUG1), another DNA glycosylase, 
leaving intact abasic sites in DNA. The resulting abasic sites are repaired by BER to 
restore unmodified cytosines (Nabel et al., 2012). 
 
On the other hand, a recent study presented in vitro evidence that the mammalian de 
novo DNA methyltransferases DNMT-3A and -3B, in addition to their well-known 
methyltransferase activity, could also function as reduction-oxidation (redox) state-
dependent DNA dehydroxymethylases that can convert 5hmC directly to unmodified 
cytosine, although the exact pathways are yet to be better defined (Chen et al., 2012). 
Interestingly, the direct conversion of 5mC to unmodified cytosine might be 
catalysed by DNMT-3A and -3B in the context of SAM deficiency, although the 







Figure 1.8: Mechanisms of Tet protein-mediated DNA demethylation. A number 
of potential mechanisms for active DNA demethylation, in which 5mC is converted 
back to a naked cytosine, have been proposed. Tet family proteins consecutively 
oxidise 5mC to 5hmC, 5fC and 5caC. The oxidation products 5fC and 5caC are 




further repaired by the BER mechanism to reinstate unmodified cytosines. Other 
less well-characterised mechanisms include deformylation of 5fC and 
decarboxylation of 5caC by as yet unidentified deformylases and decarboxylases, 
respectively. These enzymes could directly remove the formyl and carboxyl groups 
from fC and caC, respectively, leading to the restoration of unmodified cytosines. 
Alternatively, 5mC and 5hmC may be deaminated by AID or APOBEC, producing 
T:G and 5hmU:G mismatches, respectively, which can subsequently be removed by 
DNA glycosylases and then repaired by BER. Another possibility is that DNMT-3A 
and -3B could directly remove the hydroxymethyl group of 5hmC to generate 
unmodified cytosine. Figure redrawn from Branco et al. (2012). 
 
 
1.3.3 5hmC in brain 
The relative abundance of cytosine modifications tends to vary in the order of 
5mC>5hmC>5fC>5caC in tissues (Delatte et al., 2014). The overall levels of 5hmC 
are substantially lower than 5mC in the mammalian genome, which have been 
reported to be approximately 10% of 5mC and 0.4% of all cytosines (Branco et al., 
2012; Malan-Müller et al., 2014). However, initial studies of 5hmC in 2009 
uncovered that 5hmC occurs at relatively high levels in the brain and neural tissues, 
suggesting a unique role for 5hmC in neuronal function through epigenetic control of 
gene expression (Kriaucionis and Heintz, 2009). Indeed, in a study published by 
Khare et al. (2012), the enrichment of 5hmC was detected in the vicinity of genes 
with synapse-related functions. 
 
Unlike 5mC, which is detected at similar levels in numerous cell types, the global 
levels of 5hmC vary markedly between different tissues and cell types (Nestor et al., 
2012). Interestingly, research into the 5hmC distribution across different tissues 
discovered that brain tissue has the highest abundance of 5hmC compared to other 
tissues (Li and Liu, 2011), in agreement with the previous study reported on 5hmC 
(Kriaucionis and Heintz, 2009). A more detailed survey of various brain tissues 
revealed that the 5hmC was particularly prominent in cerebral cortex and 
hippocampus, which are the areas of the brain that involved in higher cognitive 
functions (Münzel et al., 2010). 
 
Another interesting observation is the discovery that the 5hmC content in mouse 




hippocampus tissue of 90 day old mice was significantly increased by approximately 
75% from one day old mice (Münzel et al., 2010). Soon after, a study by Song et al. 
(2011) also observed the developmental stage-dependent increase of 5hmC in mouse 
cerebellum. A similar correlation was later shown in human brain tissues, which 
suggest that the amount of 5hmC in the brain is age dependent (Kraus et al., 2014; 
Wagner et al., 2015), consistent with the overall observations of prior studies in mice 
(Münzel et al., 2010; Song et al., 2011). Together, these discoveries suggest that 
5hmC might play a crucial role in brain maturation and neuronal development 
(Münzel et al., 2010; Zheng et al., 2015).  
 
The presence of high levels of 5hmC in the brain suggests that 5hmC is necessary for 
proper neurodevelopment, thus dysregulation of 5hmC may lead to severe 
neurological and neurodegenerative diseases (Cheng et al., 2015). Mounting 
evidence has recently demonstrated that 5hmC is involved in the pathology of 
numerous neurological diseases, among them ischemic brain injury (Miao et al., 
2015), fragile X-associated tremor/ataxia syndrome (Yao et al., 2014), Alzheimer's 
disease (Chouliaras et al., 2013), and Huntington's disease (Wang et al., 2013), 
suggesting that 5hmC may play a vital role in the mechanisms underlying 
neurological diseases (Sun et al., 2014). 
 
5hmC is now widely recognised as an important epigenetic mark that is linked to 
both normal neurodevelopment and neurological diseases and has become the subject 
of many new studies (Cheng et al., 2015). It is not fully known yet what the functions 
are of 5hmC, but evidence suggests that 5hmC could also perform as a stable 
epigenetic marker exerting a specific regulatory role during brain development and 
ageing, in addition to being an intermediate in demethylation (Kraus et al., 2015). 
However, further studies on biochemical and molecular interactions between 5hmC 
and neural tissue are necessary to more deeply understand the critical function of 
5hmC in the brain where it may play an important role in neural development, as 






1.3.4 Potential roles of 5hmC 
Although 5hmC has been well characterized as a transient intermediate in an active 
DNA demethylation pathway, increasing data are suggesting that 5hmC may also be 
a stable epigenetic mark in its own right that possesses unique regulatory functions 
(Hahn et al., 2014). 5hmC is enriched in euchromatic regions of the genome, 
suggesting that it is associated with increased gene expression (Ficz et al., 2011). 
5hmC might prime specific genes for rapid activation, either by triggering active 
DNA demethylation or perhaps through recruitment of a specific set of 
transcriptional regulators that recognise 5hmC (Pastor et al., 2011).  
 
The conversion of 5mC to 5hmC by Tet proteins may be required to protect the 
genome from any unwanted DNA methylation by preventing DNA methyltransferase 
activity (Jeong et al., 2014). 5hmC is recognised poorly by DNMT1 during DNA 
replication, therefore the oxidation of 5mC to 5hmC may aid passive DNA 
methylation dilution in proliferating cells by impairing methylation maintenance 
machinery (Giehr et al., 2016). Thus, Tet protein-mediated oxidation of 5mC may 
contribute to dynamic changes in global or locus-specific 5mC and/or 5hmC levels 
by facilitating both active DNA demethylation and passive DNA methylation 
dilution, thereby modulating gene transcription (Li et al., 2015a). 5hmC could also 
be involved in fine-tuning of the regulation of gene expression (Ehrlich and Ehrlich, 
2014).  
 
According to a number of reports 5hmC levels are remarkably depleted in numerous 
types of cancer cells (Jin et al., 2011; Thomson et al., 2016; Yang et al., 2013), which 
indicates that a lack of 5hmC could be developed into a beneficial molecular 
biomarker for cancer detection and diagnosis (Munari et al., 2016). For this reason, 
the detection of 5hmC has gradually become a major focus of epigenomic research 







1.4 Post-translational modifications (PTMs) of histone 
proteins 
Post-translational modifications (PTMs) of histone proteins in conjunction with DNA 
methylation play an important role in determining the state of chromatin structure 
(Winter and Fischle, 2010). Importantly, most of the epigenetic marks on the 
chromatin platform do not function alone, but rather crosstalk with one another 
(Fischle, 2008), and this regulatory crosstalk can be mediated by the interaction of 
numerous epigenetic modifier proteins (Cedar and Bergman, 2009). Interestingly, 
accumulating evidence suggests that extensive crosstalk exists between different 
epigenetic pathways in mammals (Wang and Zhu, 2015). 
 
Alongside histone modifications on the amino-terminal tails of histones, the 
nucleosome structure itself can also play a decisive role in the regulation of gene 
expression. In the last two decades, it has become clear that the function of 
nucleosomes is much broader than just facilitating the packaging of large amounts of 
DNA into the small volume of a cell nucleus. Nucleosomes may participate in the 
regulation of gene expression by modulating access of transcription factors and 
transcription machinery to DNA (Bai and Morozov, 2010; Wight et al., 2016). 
Emerging data have revealed that nucleosome positioning works in tight concert with 
histone modifications as well as DNA methylation to determine the epigenetic 
regulation of the genome (Pennings et al., 2005; Portela and Esteller, 2010; Rhie et 
al., 2014). It has been suggested that nucleosome positioning and histone 
modification are able to switch on or off, temporally and spatially, specific genes in 
order to establish cellular identity at different stages of development or 
differentiation (Teif et al., 2012, 2014). 
 
The histone core of a nucleosome contains two copies of each of the four core 
histone proteins H2A, H2B, H3 and H4 (Luger et al., 2012). The four core histones 
can undergo a wide variety of post-translational modifications, including acetylation 
of lysines, methylation of lysines and arginines, phosphorylation of serines and 
threonines, ubiquitylation and sumoylation of lysines, as well as glycosylation, 




modifications are carried out by an equally large number of histone modifying 
enzyme complexes specialised in adding or removing the covalent modifications at 
particular sites on the histone proteins (Lalonde et al., 2014).  
 
Additionally, these various histone modifications are further separable into different 
degrees of chemical modification, for instance, a single lysine residue can accept up 
to three methyl groups, thus forming four different methylation states; unmethylated 
(me0), monomethylated (me1), dimethylated (me2), and trimethylated (me3) (Zhou 
et al., 2011). Multiple lines of evidence indicate that different methylation states on 
the same protein are often associated with distinct biological functions (Fuchs et al., 
2012; Schwämmle et al., 2016). 
 
The histone tails of the nucleosome are the most common regions of extensive post-
translational modification (DesJarlais and Tummino, 2016). Histone tails, which 
refer to the disordered N-termini, extend beyond the surface of the nucleosome core 
particle, making them more accessible. The N-terminal histone tails are required for 
stabilizing higher order chromatin structures (Allan et al., 1982; Pepenella et al., 
2014). Firstly, histone tail modifications appear to modulate the interactions between 
histones and DNA, thereby altering nucleosome stability (Iwasaki et al., 2013). In 
addition, these histone tail modifications may also contribute to defining the 
condensed state of the chromatin fibre by controlling interactions between 
nucleosomes to form higher order structures, which also require linker histone H1 
(Allan et al., 1981; Bowman and Poirier, 2015). By weakening histone-DNA and 
nucleosome-nucleosome interactions, post-translational modifications of histone tails 
modulate access of DNA-binding proteins that regulate biological processes (Biswas 
et al., 2011). In this way, histone tail modifications are crucial for the fundamental 
cellular processes of transcription, replication, recombination, and DNA repair 
(Iwasaki et al., 2013; Simon et al., 2011).  
 
Histone modification patterns are established through a highly regulated interplay 
between histone modification enzymes, which have been categorised as histone 




acetyltransferases (HATs), histone methyltransferases (HMTs), protein arginine 
methyltransferases (PRMTs) and kinases are the histone modifying enzymes that add 
covalent post-translational modifications to the histone tails. Histone erasers such as 
histone deacetylases (HDACs), lysine demethylases (KDMs) and phosphatases are 
the enzymes that can remove post-translational marks from histone substrates. On the 
other hand, histone readers such as proteins containing bromodomains, 
chromodomains and Tudor domains are the proteins that recognise and bind to post-
translational marks on histones (Falkenberg and Johnstone, 2014; Gillette and Hill, 
2015). Disruption of histone writers, erasers, and readers can lead to malfunction 
including cancer (Chi et al., 2010; Højfeldt et al., 2013; Liu et al., 2016a).  
 
1.4.1 Histone code 
The total number of possible combinations of histone modifications within a single 
nucleosome runs into many thousands, creating an abundance of regulatory potential 
(Schwämmle et al., 2014). Interestingly, multiple post-translational modifications of 
core histones appear to work synergistically to fine tune a precise chromatin state, 
forming a so-called ‘histone code’ that can be read and interpreted by specialised 
proteins to bring about distinct downstream events (Fischle et al., 2015; Tian et al., 
2012). In general, histone code is the term that often used to describe how different 
combinations of histone modifications affect gene expression at a transcriptional 
level (Strahl and Allis, 2000; Turner, 2000). Specifically, certain combinations of 
histone modifications are capable of driving gene expression up, while others are 
capable of driving it down (Dong and Weng, 2013).  
 
According to the histone code hypothesis initially proposed by Strahl and Allis 
(2000) and Turner (2000), distinct combinations of covalent post-translational 
modifications of histones can have a dramatic impact on chromatin structure and 
function, leading to varied transcriptional outputs (Strahl and Allis, 2000). Jenuwein 
and Allis (2001) further generalized the concept to the idea that numerous 
combinations of histone modifications are linked to specific chromatin-related 




strongly associated with apoptosis-induced chromatin changes, providing cumulative 
evidence for a potential ‘apoptotic histone code’ (Füllgrabe et al., 2010). 
 
1.4.2 Histone acetylation and histone methylation 
The most widely studied and best understood post-translational modifications of 
histones constituting a putative histone code are histone acetylation and histone 
methylation, which occur predominantly at lysine (K) residues (Figure 1.9) (Sun et 
al., 2013). The presence of histone acetylation was first observed by Allfrey et al. 
(1964) in 1964. In this pioneering study, it was demonstrated that histones were 
hyperacetylated at the promoters of actively transcribed genes, whereas at silenced 
genes histones were hypoacetylated (Allfrey et al., 1964). Since then, it has been 
revealed that the acetylation of lysine residues is highly dynamic and dependent on 




Figure 1.9: Acetylation and methylation of lysine (K) residues in histones. The 
nucleosome core histones (H2A, H2B, H3 and H4) are subjected to a variety of 




nucleosome. Two major modifications, histone acetylation and histone methylation, 




The HATs utilise acetyl-coenzyme A as the acetyl group donor and catalyse the 
transfer of an acetyl group to the ε-amino group of a target lysine side-chain within a 
histone. This is associated with a relaxed chromatin structure that allows binding of 
transcription factors and thus constitutes an activating gene transcription mark 
(Marmorstein and Zhou, 2014; Taylor et al., 2013). Acetylated histones regulate 
transcription via interaction with proteins that contain a motif called a bromodomain, 
which consists of approximately 110 amino acid residues predominantly found in a 
variety of transcription factors as well as in some chromatin remodeling complexes 
(Filippakopoulos and Knapp, 2014). HAT activity can be counteracted by HDACs 
through the removal of the acetyl groups (deacetylation) from the histone tails, 
leading to hypoacetylation. This is associated with compaction of the chromatin 
structure, and consequently shutting down transcription (Seto and Yoshida, 2014).  
 
Unlike histone acetylation, where only one acetyl group can be added to a lysine 
residue within a histone tail, histone methylation can lead to the addition of either 
one, two or three methyl groups per lysine residue (Rivera et al., 2014). Histone 
methylation can occur at different amino acid residues, including lysine, arginine and 
histidine. Amongst these, methylation of lysines has been extensively studied and is 
considered one of the most versatile covalent histone modifications (Musselman et 
al., 2014). This is because lysine residues can exist in monomethylated, 
dimethylated, or trimethylated states and depending on the site and methylation state, 
can be associated with either an active or a silent state of gene expression (Zhang et 
al., 2012b).  
 
The attachment of methyl groups occurs predominantly, but not exclusively, on 
lysine residues of histones H3 and H4 and is carried out by specific histone lysine 
methyltransferases (KMTs) (Black et al., 2012). KMTs mediate the transfer of one to 




on histones (Mohan et al., 2012). All KMTs, with the exception of DOT1-like 
protein (DOT1L; also known as KMT4), contain a conserved suppressor of 
variegation, enhancer of zeste and trithorax (SET) domain, which is crucial for the 
binding of SAM and the interaction with the targeted lysine to mediate the transfer of 
the methyl group (Mozzetta et al., 2015). SET domain KMTs catalyse the 
methylation of lysine residue in a site- and state-specific manner (Izzo and 
Schneider, 2010; Wagner et al., 2014).  
 
Initially, histone methylation was considered to be stable and irreversible. Its 
dynamic nature was not confirmed until 2004 when Shi and co-workers broke new 
ground with their discovery of the first lysine-specific histone demethylase (LSD1; 
also known as KDM1A) (Shi et al., 2004b). Soon afterward, a second and larger 
family of histone demethylases consisting of the Jumonji C (JmjC)-domain 
containing proteins was discovered, another module that possesses enzymatic 
activity to remove the methyl groups from lysine residues (Tsukada et al., 2006). 
Two evolutionarily conserved families of histone demethylases with distinct cofactor 
requirements and reaction mechanisms have thus far been identified (McAllister et 
al., 2016). First is the FAD (flavin adenine dinucleotide)-dependent amine oxidase 
LSD1 family, and the second is the Fe(II) and alpha-KG (alpha-ketoglutarate)-
dependent dioxygenase JHDM family (JmjC domain-containing histone 
demethylase) (Dimitrova et al., 2015; Nowak et al., 2016). LSD1 can theoretically 
catalyse only demethylation of monomethylated and dimethylated lysine residues, 
whereas JHDM enzymes can demethylate all three lysine methylation states (Suzuki 
and Miyata, 2011).  
 
The transcriptional consequences of histone methylation depend on the specific 
amino acid residues in the histone tails that are modified, and can also depend on the 
degree of methylation. While methylation of certain lysine residues is associated 
with active transcription, methylation of other lysines is associated with the opposite 
effect on gene activity (Bannister and Kouzarides, 2011). For instance, trimethylation 
of lysine 27 at histone H3 (H3K27me3) by polycomb repressive complex 2 (PRC2) 




lysine 4 at histone H3 (H3K4me3) through trithorax group (trxG) proteins 
counteracts PRC2-mediated repressive activity and activates gene expression 
(Geisler and Paro, 2015; Schuettengruber et al., 2011). For other lysine residues in 
histones, the degree of methylation determines the effect on gene expression. For 
example, in mammalian chromatin, monomethylation of lysine 9 at histone H3 
(H3K9me1) is associated with gene activation (Barski et al., 2007), whereas 
dimethylation and trimethylation of the same lysine residue, H3K9me2 and 
H3K9me3, respectively, are associated with gene silencing (Boros et al., 2014).  
 
To date, the most widely investigated histone lysine methylation sites include H3K4, 
H3K9, H3K27, H3K36, H3K79, and H4K20, although numerous methylations of 
lysine residues have also been found in histones H1, H2A, H2B, and in further 
positions within H3 and H4 (Morera et al., 2016). Multiple lines of evidence suggest 
that aberrant histone methylation, which is often caused by a gene mutation, 
translocation, or dysregulated expression is likely to play a critical role in the 
development and progression of cancer. In addition, altered expression and mutations 
of genes that encode histone methyl modifiers and readers correlate with increased 
incidence of many different types of cancers. (Albert and Helin, 2010; Greer and Shi, 
2012; Song et al., 2016; Thinnes et al., 2014). Furthermore, a genetic change, such as 
an insertion of a transposable element has been suggested for causing aberrant 
expression or function of histone modifying enzymes, which may subsequently lead 
to aberrant histone methylation (Ezponda and Licht, 2014; Grégoire et al., 2016). 
 
1.4.3 Histone lysine methylation and linking with DNA methylation 
Among the different histone lysine methylation states, H3K9 and H3K27 
methylation appear to be the best candidates for epigenetic histone modifications that 
can be propagated through cell division, not only because they are critical for classic 
epigenetic phenomena such as position effect variegation, Polycomb silencing, and X 
chromosome inactivation, but also because these two modified histones have been 
shown to possess certain characteristics of a prototype-guided information 
duplication system (Huang et al., 2013). It has recently become apparent that the 




dependent on one another to play a part in establishing patterns of gene repression 
during development (Reddington et al., 2013b; Rose and Klose, 2014). It seems that 
the DNA methylation and histone lysine methylation reciprocally influence each 
other in the deposition: histone lysine methylation state of chromatin may help to 
direct DNA methylation patterns, while DNA methylation may serve as a template 
for the establishment of certain methylation states on accompanying histones in 
chromatin after DNA replication (Cedar and Bergman, 2009). 
 
At the molecular level, the interplay between DNA methylation and histone 
methylation during gene silencing can be mediated through direct interactions 
between DNA methyltransferases and SET domain histone methyltransferases 
(Vaissière et al., 2008). Furthermore, the presence of methylated CpGs attracts 
methyl-CpG-binding domain proteins, which in turn recruit repressor complexes that 
induce repressive histone modifications, resulting in a compact chromatin structure 
with repressed gene transcription (Du et al., 2015b).  
 
MBD1, for instance, which specifically binds to methylated DNA, can induce 
transcriptional repression by recruiting the H3K9 methyltransferase SET domain, 
bifurcated 1 (SETDB1), an enzyme that responsible for the deposition of H3K9me3. 
Additionally, during S-phase, MBD1 recruits SETDB1 through its TRD domain to 
the large chromatin assembly factor (CAF)-1 subunit to form an S-phase specific 
complex to establish new repressive H3K9 methyl marks within pericentric 
heterochromatin during replication-coupled chromatin assembly (Sarraf and 
Stancheva, 2004). The S-phase specific complex mediates methylation of H3K9 with 
the help of heterochromatin protein 1 (HP1), which is a reader of H3K9me3, and 
promotes the formation of heterochromatic structure (Hiragami-Hamada et al., 
2016). The involvement of MBD1 in the formation of condensed heterochromatin 
suggests that this protein can act as a histone modulator and a chromatin assembler 
(Li et al., 2015b). A recent study suggested that this complex may also play a crucial 
role in the maintenance of the silent state of the X chromosome inactivation in 





The crosstalk between DNA methylation and PRC2-dependent modification of 
histone H3K27me3 has been revealed in several organisms (Bogdanovic et al., 2011; 
Brinkman et al., 2012; van Heeringen et al., 2014; Irimia et al., 2012; Landan et al., 
2012; Nakamura et al., 2014; Potok et al., 2013), and both marks are important for 
normal cell function (de la Calle Mustienes et al., 2015). The first connection 
between DNA methylation and H3K27 methylation was made when it was observed 
that Polycomb group protein enhancer of zeste homolog 2 (EZH2) can interact 
directly with all three DNMTs in vitro,  implicating a role for PRC2 in directing 
DNA methylation (Viré et al., 2006). However, subsequent studies in cancer cells 
discovered that tumor-suppressor gene silencing by EZH2-mediated H3K27me3 is 
independent of promoter DNA methylation, a finding that seems to contradict with 
previous studies (Kondo et al., 2008). In addition, Meehan and co-workers have 
uncovered an unappreciated plausible role for the DNA methylome in ensuring the 
correct PRC2-targeting and hence the H3K27me3 deposition on chromatin 
(Reddington et al., 2013b). Therefore, aberrant DNA methylation patterns could 
possibly affect the affinity of PRC2 binding, leading to Polycomb mis-targeting, and 
consequently drive carcinogenesis and disease progression (Reddington et al., 2014). 
 
1.5 Epigenetic reprogramming 
During mammalian development, epigenetic states of early embryos and PGCs are 
extensively reprogrammed on a genome-wide scale (Saitou et al., 2012). The 
genome-wide demethylation of DNA appears to be part of a comprehensive 
epigenetic reprogramming, together with global changes of histones and their 
modifications (Feng et al., 2010). This epigenetic reprogramming involves the 
erasure of previously established epigenetic states followed by the initiation of new 
epigenetic marks for the totipotency programme (Hill et al., 2014). The 
reprogramming process plays a pivotal role in the re-establishment of the correct 
epigenetic marks in early embryogenesis and germ cell development, resetting the 
patterns associated with somatic differentiation thus preventing incorrect epigenetic 
information being passed down from one generation to the next (Bunkar et al., 2016; 
Rose et al., 2013). Moreover, the reprogramming process in the germline may also be 




order to protect the offspring from epigenetic errors (Barlow and Bartolomei, 2014; 
Hajkova, 2011; Stringer et al., 2013). 
 
Two recent studies have shown the distribution and dynamics of 5mC and 5hmC 
during mouse germ cell development. These results demonstrate a temporal 
increment of 5hmC in PGCs between E9.5-E10.5, accompanied by decreased levels 
of 5mC followed by a significant depletion of 5hmC levels between E11.2-E12.5 
(Hackett et al., 2013; Yamaguchi et al., 2013). Meanwhile, other studies revealed the 
distribution patterns of histone modifications in the developing mouse germ line. 
These immunofluorescence studies show that H3K9me3 and H3K27me3 were 
maintained at relatively high levels in PGCs between E10.5 to E12.5 (Kagiwada et 
al., 2013; Prokopuk et al., 2017; Tang et al., 2016). On the other hand, in mouse 
embryonic brain, a recent study has found that the levels of 5hmC were elevated 
during neurogenesis, whereas no significant changes in 5mC levels were detected. 
Moreover, the formation of 5hmC was often accompanied by the loss of H3K27me3 
(Hahn et al., 2013). 
 
Extensive erasure of epigenetic modifications can occur both naturally at two points 
in the life cycle of mammals, but also artificially using various cell fate 
reprogramming strategies (Cantone and Fisher, 2013). This artificial reprogramming 
system in which differentiated somatic cells are converted into a pluripotent state 
holds great promise for the emerging field of regenerative medicine (Hochberg et al., 
2011; Takahashi and Yamanaka, 2013). Artificially reprogrammed cells were called 
induced pluripotent stem cells (iPSCs) and were first generated by Shinya 
Yamanaka’s research group in 2006 (Takahashi and Yamanaka, 2006).  
 
Yamanaka’s group discovered that the generation of iPSCs from differentiated 
somatic cells can be obtained through ectopic expression of four embryonic 
transcription factors, octamer-binding transcription factor 3/4 (Oct3/4), SRY (sex 
determining region Y)-box 2 (Sox2), c-myc proto-oncogene (c-Myc), and Kruppel-
like factor 4 (Klf4), under the culture conditions for ES cells (Takahashi and 




known as the “Yamanaka factors” (Cyranoski, 2014). In addition to regenerative 
medicine, iPSCs technology may open up new opportunities for disease modeling 
and drug discovery (Avior et al., 2016; Grskovic et al., 2011). 
 
In addition to iPSCs derivation, there are a number of strategies proven to facilitate 
the reprogramming of somatic cells to pluripotent cells, including somatic cell 
nuclear transfer, cell fusion, reprogramming through cell extracts and direct 
reprogramming (Patel and Yang, 2010). The iPSCs derivation technique has been 
broadly investigated for the mechanisms underlying direct cell reprogramming, 
which are not fully understood (Hirschi et al., 2014). However, research into direct 
reprogramming, in which fully differentiated somatic cells are directly 
reprogrammed into another differentiated cell type while bypassing the intermediate 
pluripotent stage, is at a more preliminary stage than work on iPSCs but may 
eventually provide a safer, quicker method for regenerative medicine (Eisenstein, 
2016; Kelaini et al., 2014). 
 
1.6 Aims of the thesis 
This PhD study aims to advance scientific understanding of the nuclear epigenetic 
dynamics during mammalian development. Dynamic developmental DNA 
methylation changes have been observed in zygotes and germ cells. Nevertheless, 
DNA methylation dynamics of other tissues in mammalian development have been 
less studied. Therefore, this study investigated changing nuclear distributions and 
levels of DNA methylation during development to discover dynamic variations 
amongst developing mouse tissues. These changes were characterised to report on 











Therefore, the objectives of this study were: 
 
1. To discover dynamic nuclear changes in DNA methylation and 
hydroxymethylation in the developing mouse embryonic tissues. 
 
2. To investigate the origin of 5hmC, either as a demethylation intermediate or an 
independent epigenetic mark. 
 
3. To explore the relationship between DNA methylation (5mC) and histone 
lysine methylation. 
 
4. To visualise DNA methylation in transgenic MBD-GFP mouse and further 






Chapter 2 – Materials and methods 
 
2.1 Animals 
Wild type CD-1 outbred mouse line and transgenic methyl binding domain-green 
fluorescent protein (MBD-GFP) mice in the same CD-1 background used in this 
study were generated and maintained in the animal facility at the MRC Human 
Genetics Unit (HGU), Institute of Genetics and Molecular Medicine, The University 
of Edinburgh, Edinburgh, United Kingdom. Heterozygous transgenic MBD-GFP 
embryos and wild-type (non-GFP) siblings were obtained from crosses between 
heterozygous transgenic MBD-GFP males and CD-1 females of matching wild type 
background. Female mice that had reached sexual maturity at about 6 weeks of age 
were used to generate embryos at specific developmental stages. To establish natural 
matings, male and female mice were housed together overnight and the females were 
checked the following morning for the presence of vaginal plugs.  
 
2.1.1 Staging of mouse embryos 
The presence of a vaginal plug the next morning was referred to as embryonic day 
E0.5 (in the literature also described as 0.5 days post-conception or DPC). However, 
this system is not a reliable indicator of the anatomical stage, thus unable to stage 
mouse embryos comprehensively. Furthermore, there is considerable uncertainty 
about the precise time of conception, which can result in inter-litter variation in 
embryo development as a consequence of variable implantation time and 
disproportionate supply of nutrients. Nevertheless, mouse embryos can be accurately 
staged by observing morphological landmarks including eye development, limb and 
tail formation through a dissecting microscope (Wong et al., 2015).  
 
In the present study, natural matings were used to obtain embryos at E9.5, E10.5, 






Figure 2.1: Early-stage mouse embryos. Embryos at day 9.5, 10.5, 11.5, 12.5, 
13.5, 14.5 (E9.5, E10.5, E11.5, E12.5, E13.5, E14.5) stages of embryonic 




2.1.2 Mouse tissue dissection 
Plug-positive females were considered as pregnant. Pregnant mice were sacrificed at 
specific stages by cervical dislocation. A midline laparotomy was then performed to 
expose the pregnant uterus. The paired uterine horns were dissected out and flushed 
with Dulbecco's phosphate-buffered saline (DPBS) (Life Technologies). The uterine 
horns were placed in sterile 15 ml centrifuge tubes (Corning) containing 10 ml DPBS 
and immediately transported on ice to the laboratory within 0.5 hours. 
 
All mouse work, including mating setup and laparotomy, was performed by David 







2.1.3 Embryo collection  
Individual embryos were dissected under a Leica MZ7.5 dissecting microscope 
(Leica, Bensheim, Germany) from the uterine horns while in DPBS. With a pair of 
surgical scissors, each embryo was first separated by cutting between implantation 
sites along uterine horns. Following separation, the embryos were then dissected out 
of the uterus with the placenta and yolk sac attached and intact. Using fine forceps, 
conceptuses with embryos within their yolk and amniotic sacs were opened and 
Reichert's membranes surrounding the yolk sacs were subsequently removed. After 
that, the umbilical vessels were cut with fine scissors to separate the embryos from 
the placentas with the yolk sacs intact. Finally, the yolk sacs were cut and the thin 
amniotic sacs surrounding the embryos were removed to release the embryos. The 
embryos were placed in an individual well of a 24-well plate containing DPBS for 
microscopic observation. A fluorescent microscope with a eGFP Bandpass Emission 
filter set (Chroma 41017) was used to examine GFP positive and GFP negative 
embryos. 
 
The protocol described above is representative of that used for dissecting embryos 
from E9.5 to E14.5. Typically, 11-17 embryos were collected per pair of uterine 
horns. 
 
2.2 Tissue embedding for cryopreservation 
A simple freezing technique for the cryopreservation of mouse whole embryos was 
used in this study based on comparative method testing in the lab (Aguilar-Sanchez, 
2016). After dissection, individual embryos were embedded in optimal cutting 
temperature (OCT) (Tissue-Tek) compound and snap frozen on dry ice. Embedding 
in OCT followed by snap freezing not only preserves cellular morphology and 
retains the antigenicity of the target molecules of epigenetic markers, but also allows 
for easier sectioning of the frozen tissue.  
 
To prepare the frozen tissues for cryosectioning, a few drops of OCT were first 
placed onto the centre of the bottom of a cryomold [Simport base mould 15 x 15 x 




dissected embryos with tissue paper until all surface liquid was absorbed. Excess 
liquid on the surface of the tissue can form ice crystals, which can be responsible for 
tissue cracks during the sectioning procedure. Using forceps, the surface dry embryos 
were then transferred to the OCT-filled cryomolds and gently submerged into the 
media. The embryos were carefully oriented in the cryomolds near the bottom to 
ensure maximum exposure for cutting. More OCT was added to fully cover the 
exposed embryos. It was crucial to avoid formation of air bubbles when adding the 
OCT as this may cause problems when cutting cryosections. Moreover, it was also 
important to ensure that the top surface of the OCT compound was completely level 
and covering the embryos. The embryos were allowed to sit in OCT for a few 
minutes to promote adhesion of the OCT to the embryos during sectioning. 
 
Cryomolds were immediately placed on dry ice for a few minutes until the OCT 
turned into a solid white colour, indicating that the embryos were sufficiently frozen. 
After hardening of the OCT compound, the frozen blocks were then stored in an air-
tight container at -70ºC until ready to proceed with cryosectioning. 
 
2.3 Cryosectioning 
All sectioning steps described in this procedure were performed using a Bright 
cryostat (Bright Instruments, Huntingdon, UK). Before cryosectioning, the cryostat 
chuck was first covered with a thin layer of OCT embedding compound. Then, the 
frozen tissue block was immediately placed on the OCT-coated chuck in the 
appropriate orientation. The tissue/OCT/chuck complex was allowed to freeze solid 
(10 to 15 minutes at -20°C) inside the cryostat. The positioning of the frozen block 
was adjusted to align the block with the knife blade. The tissue block was trimmed to 
expose the tissue surface to a level where a representative section could be cut. 
Trimming was normally performed at a thickness of 10 to 20 µm. 
 
After trimming, the cryostat was set to cut sections at a thickness of 5 µm. Several 
serial 5 µm sections were then cut. A paint brush was used to help guide the 
emerging sections over the microtome blade knife (MX35 Premier microtome blade, 




microscope slide (Superfrost Plus, ThermoFisher) by touching the slides to the 
sections. This step was accomplished within 1 minute of cutting the sections to avoid 
freeze-drying of the tissues. A maximum of two sections was collected on each slide. 
To maximize the adherence, the sections were allowed to air-dry at room temperature 
until the sections firmly adhered to the slides. After drying at room temperature, the 
slides were ready for fixation.  
 
2.4 Immunofluorescence staining 
Indirect immunofluorescence studies were performed on cryostat sections on the day 
of cutting. Immunofluorescent staining of epigenetic modifications allowed for the 
nuclear presence and distribution of these epigenetic marks to be examined. Mouse 
embryonic tissues from stages E9.5 to E14.5 were used in this study as 5 µm 
cryosections of whole embryos adhered on microscope slides. In addition, MBD-
GFP mouse embryonic tissues from stages E10.5 to E14.5 were also used as 5 µm 
cryosections of whole embryos adhered on microscope slides to visualise DNA 
methylation in tissues and subsequently characterise the transgenic model. 
 
Standard immunofluorescence staining procedures were used. The standard protocols 
were tested on both mouse embryonic fibroblasts and cryosections to ensure that the 
protocols were working reliably. The protocol for 5mC detection on cryosections, 
however, required methodology changes and optimisation. The protocol optimisation 
for 5mC immunodetection is discussed in greater detail in Chapter 3. 
 
Standard immunofluorescence staining protocols for detecting histone modifications 
and DNA methylation on mouse embryonic fibroblasts and cryosections are 
described below. An optimised 5mC immunodetection protocol is also presented. 
 
2.4.1 Histone immunostaining in mouse embryonic fibroblasts 
Mouse E13.5 fibroblasts used in this study were grown on 13 mm No. 1.5 round 
coverslips (VWR) inside a 24-well plate (Greiner). The cells were washed with PBS 
containing 1 mM CaCl2 (calcium chloride 2-hydrate, BDH) twice for 5 minutes each. 




10 minutes at room temperature. PFA solution was removed and cells were washed 
with 200 µl of PBS (phosphate buffered saline, Bioline) twice for 5 minutes each. 
The cells were permeabilised with 200 µl of 0.4% of Triton X-100 (VWR) for 15 
minutes. Triton X-100 was removed and cells were washed with PBS twice for 10 
minutes each. The cells were blocked with 200 µl of 2% of BSA in PBS (bovine 
serum albumin, Sigma Aldrich) for 1 hour. The blocking solution was removed and 
the cells were incubated with 200 µl of anti-H3K9me3 primary antibody (rabbit 
polyclonal antibody, Millipore) at 1:1000 dilution in blocking solution overnight at 
4oC. The antibody was removed and cells were washed with 200 µl of PBST 
(containing 0.05% of Tween 20, BDH) three times for 15 minutes each. The cells 
were incubated with 200 µl of Alexa Fluor 488 donkey anti-rabbit secondary 
antibody (Invitrogen Molecular Probes) at 1:200 dilution in blocking solution for 1 
hour. The antibody was removed and cells were washed with PBST for 15 minutes. 
The cells were incubated with 200 µl of 0.3 µM of DAPI (4′,6-Diamidino-2-
phenylindole dihydrochloride, Sigma Aldrich) for 15 minutes. DAPI solution was 
removed and cells were washed with PBST twice for 15 minutes each. The 
coverslips carrying the cells were mounted onto slides with mounting medium 
(Prolong Gold, Invitrogen Molecular Probes). The cells were left to cure overnight in 
the dark at room temperature and stored at 4C.  
 
2.4.2 Histone immunostaining in mouse embryonic tissues 
The following staining procedure was performed at room temperature in a dark 
humidity chamber unless indicated otherwise. PAP pen liquid blocker (a water-
repellent marking pen; Sigma) was used to help retain reagents during incubation. 
The cryosectioned tissues were fixed in 200 µl of 4% of PFA for 50 minutes at room 
temperature within a PAP pen traced area of the slide. The PFA solution was 
removed from the slide by gently tapping the side onto paper tissue and tissues were 
washed with 200 µl of PBS twice for 5 minutes each. The tissues were permeabilised 
with 200 µl of 0.4% of Triton X-100 for 30 minutes. Triton X-100 was removed and 
tissues were washed with PBS twice for 10 minutes each. The tissues were blocked 
with 200 µl of 2% of BSA for 1 hour. Blocking solution was removed and tissues 




1:1000 dilution in blocking solution or 200 µl of anti-H3K27me3 primary antibody 
(Millipore) at 1:500 dilution overnight at 4oC. The antibody was removed and tissues 
were washed with 200 µl of 0.05% of PBST three times for 15 minutes each. The 
tissues were incubated with 200 µl of Alexa Fluor 488 donkey anti-rabbit (see 
Chapter 3) or 200 µl of Alexa Fluor 568 donkey anti-rabbit (Invitrogen Molecular 
Probes) (see Chapter 5) secondary antibodies at 1:200 dilution in blocking solution 
for 1 hour. The antibody was removed and tissues were washed with PBST for 15 
minutes. The tissues were incubated with 200 µl of 0.3 µM of DAPI for 15 minutes. 
DAPI solution was removed and tissues were washed with PBST twice for 15 
minutes each. The tissues were mounted using Prolong Gold antifade reagent 
(Molecular Probes, Life technologies) and covered with a coverslip. The tissues were 
left to cure overnight in the dark at room temperature and stored at 4C. 
 
2.4.3 DNA methylation immunostaining in mouse embryonic 
fibroblasts 
Mouse embryonic fibroblasts were grown on 13 mm round coverslips and handled as 
stated in section 2.4.1. The cells were washed with PBS containing 1 mM CaCl2 
twice for 5 minutes each. The cells were fixed in 200 µl of 4% of PFA for 10 
minutes at room temperature. PFA solution was removed and cells were washed with 
200 µl of PBS twice for 5 minutes each. The cells were treated with 200 µl of 4 M of 
HCl (hydrochloric acid, VWR) for 10 minutes to denature the DNA. HCl solution 
was removed and cells were washed with PBS three times for 5 minutes each. The 
cells were permeabilised with 200 µl of 0.4% of Triton X-100 for 15 minutes. Triton 
X-100 was removed and the cells were washed with PBS twice for 10 minutes each. 
The cells were blocked with 200 µl of 2% of BSA for 1 hour. The blocking solution 
was removed and the cells were incubated with 200 µl of anti-5mC primary antibody 
(mouse monoclonal antibody 33D3, Diagenode) at 1:300 dilution in blocking 
solution for 2 hours at room temperature. The antibody was removed and cells were 
washed with 200 µl of 0.05% of PBST three times for 15 minutes each. The cells 
were incubated with 200 µl of Alexa Fluor 488 donkey anti-mouse secondary 
antibody (Invitrogen Molecular Probes) at 1:200 dilution in blocking solution for 1 




The cells were incubated with 200 µl of 0.3 µM of DAPI for 15 minutes. DAPI 
solution was removed and cells were washed with PBST twice for 15 minutes each. 
The coverslips were mounted onto slides as described before. 
 
ssDNA primary antibody (rabbit polyclonal antibody, Demeditec Diagnostics) 
followed by Alexa Fluor 488 donkey-anti rabbit secondary antibody was used as a 
control immunostaining performed in parallel. 
 
2.4.4 DNA methylation immunostaining in mouse embryonic tissues 
(before optimisation) 
Described below is the standard tissue immunostaining procedure (before 
optimisation), performed at room temperature in a dark humidity chamber unless 
indicated otherwise.  
 
Tissues were fixed by overlaying with 200 µl of 4% of PFA for 50 minutes at room 
temperature within a PAP pen traced area of the slide as described in section 2.4.2. 
PFA solution was removed and tissues were washed with 200 µl of PBS twice for 5 
minutes each. Tissues were treated with 200 µl of 4 M of HCl for 15 minutes to 
denature the DNA. HCl solution was removed and tissues were washed with PBS 
three times for 5 minutes each. The tissues were permeabilised with 200 µl of 0.4% 
of Triton X-100 for 30 minutes. Triton X-100 was removed and tissues were washed 
with PBS twice for 10 minutes each. The tissues were blocked with 200 µl of 2% of 
BSA for 1 hour. This blocking solution was removed and tissues were incubated with 
200 µl of anti-5mC primary antibody for 2 hours at room temperature at 1:300 
dilution in blocking solution. The antibody was removed and tissues were washed 
with 200 µl of 0.05% of PBST three times for 15 minutes each. The tissues were 
incubated with 200 µl of Alexa Fluor 488 donkey anti-mouse secondary antibody for 
1 hour at 1:200 dilution in blocking solution. The antibody was removed and tissues 
were washed with PBST for 15 minutes. The tissues were incubated with 200 µl of 
0.3 µM of DAPI for 15 minutes. DAPI solution was removed and the tissues were 
washed with PBST twice for 15 minutes each. The tissues were mounted with 




Three controls were used in this immunostaining procedure. The first control, for 
DNA denaturation and antibody specificity, used ssDNA primary antibody followed 
by Alexa Fluor 488 donkey anti-rabbit secondary antibody; the second control for 
nonspecific background used Alexa Fluor 488 donkey anti-mouse secondary 
antibody without primary antibody; and the third control for auto-fluorescence was 
without both primary and secondary antibodies. 
 
2.4.5 DNA methylation immunostaining in mouse embryonic tissues 
(after optimisation) 
Described below is the optimised tissue immunostaining procedure, performed at 
room temperature in a dark humidity chamber unless indicated otherwise.  
 
Tissues were fixed by overlaying with 200 µl of 2% of PFA for 50 minutes at room 
temperature within a PAP pen traced area of the slide as described in section 2.4.2. 
PFA solution was removed and tissues were washed with 200 µl of PBS twice for 5 
minutes each. The tissues were permeabilised with 200 µl of 0.5% of Triton X-100 
for 30 minutes. Triton X-100 was removed and tissues were washed with PBS twice 
for 10 minutes each. Tissues were boiled in 10 mM sodium citrate pH 6 either using 
hot plate or microwave techniques (section 2.4.5.1) to denature the DNA. Tissues 
were washed in 250 ml of PBS on a rocking jar for 15 minutes. The tissues were 
blocked with 200 µl of blocking buffer, a mixture of 2% of BSA and 2% of donkey 
serum in PBS for 1 hour. This blocking solution was removed and tissues were 
incubated with 200 µl of anti-5mC primary antibody for 2 hours at room temperature 
at 1:300 dilution in BSA solution. The antibody was removed and tissues were 
washed with 200 µl of PBST three times for 15 minutes each. The tissues were 
incubated with either 200 µl of Alexa Fluor 488 donkey anti-mouse (see Chapter 3) 
or 200 µl of Alexa Fluor 568 donkey anti-mouse (Invitrogen Molecular Probes) (see 
Chapter 4) secondary antibodies for 1 hour at 1:200 dilution in BSA solution. The 
antibody was removed and tissues were washed with PBST for 15 minutes. The 
tissues were incubated with 200 µl of 0.3 µM of DAPI for 15 minutes. DAPI solution 




tissues were mounted with mounting medium and covered with a coverslip as 
described in section 2.4.2.  
 
2.4.5.1 DNA denaturation for immunostaining 
Heat-mediated antigen retrieval was used in this study to replace a problematic acid-
dependent DNA denaturation step in the standard tissue immunostaining procedure. 
Antigen retrieval (also known as epitope retrieval or unmasking) refers to any 
technique in which the masking effects of aldehyde fixation on some antigens are 
reversed and epitope-antibody binding is restored. But, in this case, heat-induced 
antigen retrieval approach also denatured DNA double-strands to make the 
nucleotides accessible to antibody detection, at the same time as it retrieved antigen 
epitopes. Two methods of DNA denaturation were successfully optimised; using a 
hot plate and microwave techniques. But only the microwave technique was taken 
forward in Chapter 4 due to several practical advantages. Described below are the 
two methods of DNA denaturation. 
 
For hot plate technique, a heat resistant beaker containing 0.01 M sodium citrate pH 
6.0 was first preheated on a hot plate to near boiling point. The slides were then 
transferred in a holder to the beaker containing preheated 0.01 M sodium citrate pH 
6.0. The beaker was immediately brought to a boil on the hot plate. Boiling was 
continued for a further 10 minutes to complete DNA denaturation and antigen 
retrieval. The beaker was carefully removed from the hot plate and the heated slides 
were allowed to cool for 10 minutes while submerged in solution. The slides were 
finally rinsed in a rocking jar containing 250 ml of PBS for 15 minutes to remove 
any loose material.  
 
For microwave technique, a wide microwavable dish filled with 2.5 cm of H2O was 
first preheated in a microwave oven for 8 minutes at full power. In parallel, a 
Schieferdecker jar was filled with 0.01 M sodium citrate pH 6.0 and the slides were 
then put in. It was important to ensure that the slides were completely covered with 
the buffer. The jar (without the lid) was placed in the previously preheated dish, 




the microwave oven at full power for 3 minutes. It was very important to ensure that 
the antigen retrieval solution was not evaporated to the point that the tissue sections 
dried. More antigen retrieval solution was added if necessary. The slides were again 
heated for an additional 3 minutes to complete DNA denaturation and antigen 
retrieval. The Schieferdecker jar was carefully removed from the microwave oven 
and the heated slides were allowed to cool for 10 minutes while submerged in 
solution. The slides were finally rinsed in a rocking jar containing 250 ml of PBS for 
15 minutes to remove any loose material. 
 
2.4.6 DNA hydroxymethylation immunostaining in mouse embryonic 
tissues  
The optimised tissue immunostaining protocol used for staining 5mC (section 2.4.5) 
was employed for the staining of 5hmC. Like anti-5mC antibody, anti-5hmC 
antibody also required denatured DNA as the native context of double-stranded DNA 
may sterically hinder the primary antibody from binding to its target. Anti-5hmC 
primary antibody followed by either Alexa Fluor 568 donkey-anti rabbit (see 
Chapter 3) or Alexa Fluor 488 donkey-anti rabbit (see Chapter 4) secondary 
antibodies was used for immunodetection of 5hmC. Tissues were incubated with 
anti-5hmC primary antibody (Active Motif) in the dark for 2 hours at room 
temperature at 1:500 dilution in BSA solution. 
 
2.4.7 GFP immunostaining in MBD-GFP mouse embryonic tissues  
The optimised tissue immunostaining protocol used for staining 5mC (section 2.4.5) 
was employed for the detection of GFP in transgenic mouse embryonic tissues. 
Double staining of GFP and 5mC (see Chapter 3) was initially performed to ensure 
that the MBD-GFP and 5mC results observed in transgenic mouse tissues were well 
correlated before performing single staining of GFP. No denaturation step was 
performed for single staining of GFP in Chapter 6. GFP double immunostaining was 
only successful when using the microwave-heating denaturation method. The 
protocol optimisation for combinatorial applications of the GFP immunostaining 





Anti-GFP primary antibody (Invitrogen) followed by Alexa Fluor 488 donkey-anti 
rabbit was used for immunodetection of GFP to overcome weak fluorescent signals 
of native GFP. GFP-booster Atto488 (Chromotek) was also used in the protocol 
optimisation for the preservation of native GFP proteins. Tissues were incubated 
with anti-GFP primary antibody in the dark for 2 hours at room temperature at 1:200 
dilution in BSA solution. For GFP booster, tissues were incubated with the GFP 
booster primary antibody at 1:200 dilution in BSA solution using the same 
conditions as anti-GFP.  
 
2.4.8 Immunostaining for epigenetic modifier enzymes in mouse 
embryonic tissues  
Enzymes responsible for active DNA demethylation and methylation events were 
also investigated in this study using the indirect immunofluorescence technique. 
These enzymes included Tet1, Tet2, Tet3 and DNMT3A. The standard tissue 
immunostaining procedure used for staining histone modifications (section 2.4.2) 
was used in this study to stain for Tet1, Tet2, Tet3 and DNMT3A. For Tet1 staining, 
Tet1 primary antibody (GeneTex) followed by Alexa Fluor 488 donkey-anti rabbit 
was used. For Tet2 staining, Tet2 primary antibody (Abcam) followed by Alexa 
Fluor 488 donkey-anti rabbit was used. For Tet3 staining, Tet3 primary antibody 
(Millipore) followed by Alexa Fluor 488 donkey-anti rabbit was used and for 
DNMT3A staining, DNMT3A primary antibody (Santa Cruz Biotechnology) 
followed by Alexa Fluor 568 donkey-anti goat (Invitrogen Molecular Probes) was 
used. Tissues were incubated with primary antibodies in the dark at specific dilutions 
in BSA solution (Table 2.1) overnight at 4oC. 
 
2.4.9 Tissue-specific marker immunostaining in wild-type and 
transgenic mouse embryonic tissues 
Tissue-specific markers used in this study were cTnT (cardiac marker), HNF4α 
(hepatic marker), RC2 (nestin marker) and Vasa (DDX4/MVH) (germ cell marker). 
For double staining of cTnT and RC2 with histone modifications in wild-type mouse 
embryonic heart and brain tissues, respectively, the standard tissue immunostaining 




double staining of cTnT, HNF4α and RC2 with GFP in transgenic mouse embryonic 
heart, liver and brain tissues, respectively, the optimised tissue immunostaining 
protocol used for staining 5mC (section 2.4.5) was used, but with the omission of the 
denaturation step. For double staining of Vasa and 5mC in wild-type mouse 
embryonic gonadal tissues, the optimised tissue immunostaining protocol for staining 
5mC was used to observe the genome-wide DNA demethylation proses in mouse 
primordial germ cells. 
 
For cardiac staining, anti-cTnT primary antibody (DHSB) followed by either Alexa 
Fluor 488 donkey-anti mouse or Alexa Fluor 568 donkey-anti mouse was used. For 
hepatic staining, anti-HNF4α primary antibody (Santa Cruz Biotechnology) followed 
by Alexa Fluor 568 donkey-anti goat was used. For nestin staining, RC2 primary 
antibody (DHSB) followed by either Alexa Fluor 488 donkey-anti mouse or Alexa 
Fluor 568 donkey-anti mouse was used. For primordial germ cell staining, anti-
DDX4/MVH primary antibody (Abcam) followed by Alexa Fluor 488 donkey-anti 
rabbit was used. Tissues were incubated with primary antibodies in the dark at 
specific dilutions in BSA solution (Table 2.1) either overnight at 4oC or for 2 hours 
at room temperature.  
 
2.5 Immunofluorescence microscopy 
The immunostained tissues were analysed using advanced microscopic imaging 
techniques. The fluorescent molecules can be visualised either by fluorescence 
widefield microscopy or confocal microscopy. Immunofluorescence microscopy is 
an extremely useful technique for detecting and localising particular antigens within 
tissue sections via fluorescently-labeled antibodies. After staining, the slides were 
viewed using a Nikon Eclipse-Ti inverted fluorescence microscope (Nikon, Tokyo, 
Japan) (see Chapter 3 and Chapter 6) and Zeiss LSM 780 confocal microscope 
with an oil immersion 40X objective (see Chapter 4 and Chapter 5, unless 
indicated otherwise). The slides were examined under a fluorescence microscope 
using DAPI/FITC/tetramethyl rhodamine isothiocyanate (TRITC) triple band-pass 
filter sets, whereas under the confocal microscope, triple band-pass filter sets for 




In Chapter 3, the fluorescence microscope was used to observe the presence and 
distribution pattern of epigenetic markers. In Chapter 4 and Chapter 5, the confocal 
microscope was used to observe the dynamic nuclear changes in DNA methylation 
(5mC and 5hmC) and histone modifications (H3K9me3 and H3K27me3) states 
during embryonic development as well as the enzymes (Tet1, Tet2, Tet3 and 
DNMT3A) that are responsible for the dynamic changes in DNA methylation. For 
dynamic studies, confocal microscopy imaging was performed under controlled 
conditions. A set of images of each tissue type for each epigenetic marker at different 
developmental stages was taken on the same day, using the exact same exposure and 
gain to ensure maximum reliability and informativeness of the imaging data.  
 
Laser scanning confocal microscopy was used for dynamic studies due to several 
advantages it possessed over conventional widefield optical microscopy. One of the 
main advantages of confocal microscopy is the ability to control the depth of field. A 
key advantage of confocal microscopy is the ability to remove out-of-focus noise, 
thus producing sharp and high-resolution images. The confocal microscopy is also 
capable of eliminating or reducing the background information away from the focal 
plane. 
 
2.6 Stage-specific embryonic tissue identification 
For immunofluorescence staining of 5mC and 5hmC, no tissue-specific markers were 
used as immunodetection of 5mC and 5hmC required denaturation of the DNA 
which was totally incompatible with the preservation of most protein epitopes. 
Therefore, tissue identity was determined by morphology. Morphological structures 
of stage-specific embryonic tissues were identified by reference to ‘Kaufman’s 
Atlas’ (Kaufman, 1992) and the web publication of the open access mouse embryo 
eHistology resource (www.emouseatlas.org/emap/eHistology/) (Graham et al., 
2015).   
 
The Atlas of Mouse Development by Matthew H. Kaufman is an essential text and a 
much used reference for understanding mouse developmental anatomy. This atlas 




and comprehensive descriptions of the anatomical attributes relevant to each stage of 
development. 
 
2.7 Image processing and analysis 
The obtained fluorescence images were processed and analysed using the free, open-
source software ImageJ (Schneider et al., 2012). Using ImageJ, the contrast and 
brightness of individual channels in the stack were adjusted. But for confocal images, 
specific for dynamic studies, no adjustments were made. The confocal images with 
raw fluorescence intensities were used to avoid possible misinterpretation of the 
results. 
 
2.8 Semi-quantitative image analysis 
Standard imaging conditions were employed for all whole mount immunostained 
cryosections to allow for semi-quantitative comparative analysis of nuclei from 
different tissues. Zeiss LSM 780 confocal microscope images capturing DAPI, A488 
and A568 signal were saved as three channels in lsm format and imported into 
ImageJ software as a stack. Outlines of multiple isolated nuclei were manually traced 
with the drawing tool (Shift key down) in the DAPI channel and selections were 
saved as filled objects on a mask layer using the ‘Fill’ command. Objects on the 
mask layer were thresholded using the ‘Threshold’ command and the corresponding 
intensities of these nuclei in the green and red channel were measured with the 
‘Analyze Particles’ command. The list of values for each nucleus was exported to 













Table 2.1: Primary antibodies used in the experiments. Optimal dilutions for 
each of the antibodies are shown in the second column. 
Antibody Dilution in BSA solution Supplier 
H3K9me3 1:1000 Millipore 
H3K27me3 1:500 Millipore 
5mC 1:300 Diagenode 
ssDNA 1:500 Demeditec Diagnostics 
5hmC 1:500 Active Motif 
GFP 1:200 Invitrogen 
GFP-booster Atto488 1:200 Chromotek 
Tet1 1:600 GeneTex 
Tet2 1:250 Abcam 








RC2 1:100 DHSB 
Vasa 1:300 Abcam 
 
 
Table 2.2: Secondary antibodies used in the experiments. Optimal dilutions for 
each of the antibodies are shown in the second column. 
Antibody Dilution in BSA solution Supplier 




























Chapter 3 – Optimised immunostaining for 
studying DNA methylation in tissues 
 
3.1 Introduction 
Immunostaining refers to an antibody-based method to identify the presence and 
localisation of a particular protein within individual cells or tissue sections (Maity et 
al., 2013). Detection of a specific protein or antigen within cells is known as 
immunocytochemistry (Burry, 2011), whereas antigen detection within tissues is 
generally known as immunohistochemistry (Shi and Stack, 2015). Visual detection 
of specific target antigens is achieved through the use of antibodies that have been 
chemically conjugated to fluorescent dyes such as fluorescein isothiocyanate (FITC) 
or tetramethyl rhodamine isothiocyanate (TRITC), a technique usually referred to as 
immunofluorescence of IF (Odell and Cook, 2013). Immunofluorescent-stained cells 
or tissue sections can then be visualised using fluorescence widefield or confocal 
microscopy (Wang and Matise, 2013).  
 
There are two main methods of immunofluorescent staining, direct and indirect. For 
direct immunofluorescent staining, the antibody (called the primary antibody) against 
the antigen of interest is directly conjugated to a fluorescent dye (Pástor, 2010). On 
the other hand, for indirect immunofluorescence, the primary antibody is 
unconjugated and an additional fluorescence dye-conjugated antibody (called the 
secondary antibody) directed toward the primary antibody is used for detection of 
target antigen (Barbierato et al., 2012). The latter method, while requiring an 
additional step, results in secondary antibody clustering at the site of the epitope with 
amplification of the signal.  
 
Immunofluorescence staining has been frequently used to study dynamic changes in 
DNA modification states at time points during mammalian development (Rose et al., 
2014; Santos and Dean, 2006). In addition, highly specific antibodies raised against 
5mC, and more recently, its derivatives 5hmC, 5fC and 5caC have been developed 




staining of 5mC and 5hmC, DNA must first be denatured into single strands in order 
to increase the accessibility of the epitopes to the antibodies (Ito et al., 2010; 
Jørgensen et al., 2006; Li and O’Neill, 2013). The most commonly-employed method 
for the denaturation of DNA is acid treatment, but the denaturation method may vary 
depending on the application (Salvaing et al., 2012; Yamaguchi et al., 2013; Zhang et 
al., 2016a). Moreover, in the case of acid treatment, harsh denaturing conditions may 
compromise the integrity of the chromatin structure (Jørgensen et al., 2006). 
 
A number of methodologies were acquired for this study, including DNA 
methylation immunostaining in mouse embryonic tissues. As this methodology is 
regarded as standard in the field, it was very important to have this working reliably 
on mouse embryo cryosections in order to be able to investigate tissues undergoing 
dynamic nuclear changes in DNA methylation and hydroxymethylation states. In 
particular, the study of their possible relationship with histone modifications during 
mouse embryonic development required comparable quality of immunostaining of 
these independent assays. 
 
Therefore, the aims of this chapter were: 
1. To test standard histone immunocytochemistry protocols specific for mouse 
E13.5 fibroblasts and cryosections, respectively. 
 
2. To test standard DNA methylation immunocytochemistry protocols specific for 
mouse E13.5 fibroblasts and cryosections, respectively. 
 
3. To optimise standard DNA methylation immunohistochemistry protocol on 
mouse E13.5 thin cryosections, and to perform this optimised protocol for DNA 
hydroxymethylation immunostaining. 
 
4. To test optimised DNA methylation immunohistochemistry protocol on MBD-






3.2 Histone immunostaining in mouse embryonic 
fibroblasts 
Immunostaining was performed on fixed mouse E13.5 fibroblasts using a standard 
histone immunocytochemistry protocol, as outlined in Chapter 2 Section 2.4.1. 
 
 
Figure 3.1: Histone immunostaining in E13.5 mouse embryonic fibroblasts. 
Representative staining of mouse embryonic fibroblasts is shown. Left panel: cell 
nuclear DNA counterstained with DAPI (blue). Middle panel: cell stained with anti-
H3K9me3 primary antibody (green). Right panel: merged image. Antibody-specific 
histone immunostaining of cultured cells is confirmed by colocalisation of H3K9me3 
in DNA dense heterochromatin foci. 
 
 
Histone H3K9me3 immunostaining demonstrated colocalisation with DAPI-stained 
dense DNA regions representing heterochromatin (DAPI bright dots) (Figure 3.1), 
where this epitope is expected. This shows that the method used for staining 















3.3 Histone immunostaining in mouse embryonic 
tissues 
Immunostaining was performed on mouse E13.5 fixed cryosections using a standard 
histone immunohistochemistry protocol as outlined in Chapter 2 Section 2.4.2.  
 
 
Figure 3.2: Histone immunostaining in E13.5 mouse embryonic brain tissues. 
Representative staining of mouse embryonic brain tissue sections is shown. Left 
panel: tissues nuclear DNA counterstained with DAPI (blue). Middle panel: tissues 
stained with anti-H3K9me3 primary antibody (green). Right panel: merged image. 
Antibody-specific histone immunostaining of cryosections is apparent by 




Figure 3.3: Histone immunostaining in E13.5 mouse embryonic liver tissues. 
Representative staining of mouse embryonic liver tissue sections is shown. Left 
panel: tissues nuclear DNA counterstained with DAPI (blue). Middle panel: tissues 
stained with anti-H3K9me3 primary antibody (green). Right panel: merged image. 
Antibody-specific histone immunostaining of cryosections is confirmed by 






Histone H3K9me3 immunostaining showed colocalisation with DAPI-stained foci of 
high DNA density (Figure 3.2 and 3.3), as expected. This demonstrates that the 
method used for immunostaining for H3K9me3 in mouse embryonic tissues was 
successful. 
 
3.4 DNA methylation immunostaining in mouse 
embryonic fibroblasts 
Immunostaining was performed on mouse E13.5 cultured fibroblasts following the 





Figure 3.4: DNA methylation immunostaining in E13.5 mouse embryonic 
fibroblasts. Representative staining of mouse embryonic fibroblasts is shown. Left 
panel: cell nuclear DNA counterstained with DAPI (blue). Middle panel: cell stained 
with primary antibodies against, 5mC (green) and ssDNA (green), respectively. 
Right panel: merged images. Antibody-specific DNA immunostaining in cultured 
cells is apparent using the standard protocol. 
 
 
Immunostaining for 5mC and ssDNA demonstrated colocalisation with DAPI-
stained DNA (Figure 3.4). DNA dense foci stained preferentially for 5mC, whereas 




standard method used for staining 5mC in mouse embryonic fibroblasts was 
successful. 
 
3.5 DNA methylation immunostaining in mouse 
embryonic tissues 
Immunostaining was performed on mouse E13.5 thin cryosections following the 








Figure 3.5: DNA methylation immunostaining in E13.5 mouse embryonic brain 
tissues. Representative stainings of mouse embryonic brain tissue sections are 
shown. Left panels: tissue nuclear DNA counterstained with DAPI (blue). Middle 
panels: from top to bottom, tissues stained with primary antibodies against 5mC 
(green), ssDNA (green), control without the primary antibody (green) and control 
without both primary and secondary antibodies (green). Right panels: merged 
images. Cryosection DNA immunostaining using the standard protocol resulted in 
non-specific signal, as no colocalisation was observed between antibody staining 




Figure 3.6: DNA methylation immunostaining in E13.5 mouse embryonic liver 
tissues. Representative staining of mouse embryonic liver tissue sections is shown. 
Left panel: tissue nuclear DNA counterstained with DAPI (blue). Middle panel: 
tissues stained with primary antibody against 5mC (green). Right panel: merged 
image. Non-specific DNA immunostaining using the standard protocol is confirmed 




No significant colocalisation of 5mC and DAPI signal was detected following 
standard DNA methylation immunostaining protocol (Figure 3.5 and 3.6). In 
addition, 5mC staining results show a too strong DAPI signal for DNA to be 
denatured. High background was also detected in 5mC staining. This might be due to 
a very strong non-specific staining, which despite poor colocalisation with DAPI 
sometimes appeared to be nuclear. Similar non-specific staining (strong DAPI 
signals and high background) was observed in ssDNA staining (Figure 3.5). An 
antibody staining control was performed in this experiment. Omission of the primary 
or secondary antibody in the staining procedure resulted in complete absence of 
immunofluorescence staining (Figure 3.5). The controls seemed fine, and the strong 




3.5 and 3.6, brain and liver location could be determined from whole embryo 
cryosection anatomy. 
 
3.6 DNA methylation immunostaining in mouse 
embryonic tissues: protocol optimisation 
Initially, the standard protocol of DNA methylation immunostaining was applied as 
described in Chapter 2 Section 2.4.4. The standard protocol was primarily developed 
for immunocytochemistry of cells. It was initially assumed to work on tissue sections 
adhered on microslides, on the basis of a few immunostained images in the literature 
(Hahn et al., 2013; Jin et al., 2011). However, the existing methodology was found 
not to work for mouse embryo tissue cryosections. Therefore, several tests were 
subsequently undertaken to optimise the protocol. These tests are described in the 
following sections. 
 
3.6.1 pH test 
In this test, pH was monitored at four different stages throughout the procedure: 
fixation, denaturation, permeabilisation and blocking (Table 3.1). The pH was 
checked with a pH paper. This test was performed to determine whether the HCl step 

















Table 3.1: pH test for DNA methylation immunostaining in mouse embryonic 
tissues. pH was monitored at four different stages throughout the standard staining 
procedure, including after second wash of PFA, after third wash of HCl, after second 
wash of Triton X-100 and after blocking with BSA.  
 
 
        
 
Figure 3.7: pH test. (A) pH after second wash of PFA. (B) pH after third wash of 
HCl. (C) pH after second wash of Triton X-100. (D) pH after blocking with BSA. The 





One possibility was that the HCl step for DNA denaturation was not sufficiently 
neutralised when the antibody was added, causing the antibody to precipitate. As 
evident from A, B, C and D (Figure 3.7), however, all stages show a pH near 7.0. 
This shows that the pH was maintained at pH 7.0 throughout the procedure. It was 
found that the pH was restored to neutral pH after only three PBS washes on the 
slide. This suggested that the antibody was not denatured or precipitated by any 
remaining acid.   
 
3.6.2 Washing step test 
In this test, the slide was washed thoroughly in a large volume of PBS on a rocking 
jar after the HCl step (Table 3.2). This test was performed to determine whether the 
acid denatured proteins or aggregates introduced by HCl step were completely 
removed. Acid denatured proteins might cause high background. 
 
Table 3.2: Washing step test for DNA methylation immunostaining in mouse 









Figure 3.8: DNA methylation immunostaining in E13.5 mouse embryonic brain 
tissues. Representative stainings of mouse embryonic brain tissue sections are 
shown. Left panels: tissue nuclear DNA counterstained with DAPI (blue). Middle 
panels: tissues stained with 5mC (green) and ssDNA (green), respectively. Right 





Figure 3.9: DNA methylation immunostaining in E13.5 mouse embryonic liver 
tissues. Representative stainings of mouse embryonic liver tissue sections are 
shown. Left panels: tissues counterstained with DAPI (blue). Middle panels: tissues 
stained with 5mC (green) and ssDNA (green), respectively. Right panels: merged 
images. Non-specific immunostaining is not removed by intensive washing in either 




Since the histone protocol did not show these immunostaining issues, another 
possibility was that the HCl step introduced background from acid denatured or 
extracted protein. After including an intensive washing step often used in standard 
histochemistry protocols, still no colocalisation of 5mC and DAPI was detected in 
brain or in liver tissue sections (Figure 3.8 and 3.9). 5mC staining results showed 
too strong DAPI signals for DNA to be denatured. However, less background was 
detected in 5mC staining. Similar conditions (strong DAPI signals and less 
background) were observed in ssDNA staining (Figure 3.8 and 3.9). Washing in a 
rocking jar might remove acid denatured proteins trapped inside the tissue. These 
denatured proteins might cause high background as they would expose numerous 
epitopes normally engaged in protein-protein interactions. Unlike with nuclear 
protein immunostaining, washes can be more vigorous when staining the DNA. This 
test suggested that the two different primary antibodies bound non-specifically to 
nuclear surfaces after intensive washes, but showed more general debris after gentle 
washes. The strong signal did not look like an ordinary background but more like an 
incompatibility between protocol steps causing precipitation. The strong non-specific 
staining on tissues was seen regardless of washing. Washing in a rocking jar step was 
continually used in the subsequent test as background was seen to reduce using this 
step. 
 
3.6.3 Inverted step and neutralisation test 
In this test, the permeabilisation step was performed before the HCl step and HCl 
step was immediately neutralised with 100 mM Tris-HCl pH 8.5 (Table 3.3). For 
tissues, the cell protocol might need specific adaptation of denaturation together with 











Table 3.3: Inverted step and neutralisation test for DNA methylation 
immunostaining in mouse embryonic tissues. Permeabilisation step was 
performed before the HCl step and HCl step was immediately neutralised with 100 





Figure 3.10: DNA methylation immunostaining in E13.5 mouse embryonic 
brain tissues. Representative staining of mouse embryonic brain tissue sections is 
shown. Left panel: tissue nuclear DNA counterstained with DAPI (blue). Middle 
panel: tissues stained with primary antibody against 5mC (green). Right panel: 
merged image. The protocol variation of performing the permeabilisation before the 







Figure 3.11: DNA methylation immunostaining in E13.5 mouse embryonic liver 
tissues. Representative staining of mouse embryonic liver tissue sections is shown. 
Left panel: tissue nuclear DNA counterstained with DAPI (blue). Middle panel: 
tissues stained with primary antibody against 5mC (green). Right panel: merged 
image. Performing the permeabilisation before the HCl denaturation did not result in 
less non-specific signal. 
 
 
To further reduce the impact of possible acid-induced background signal, the HCl 
step was conducted after permeabilisation followed by immediate pH neutralisation, 
a variation based on some protocols. Yet, no colocalisation of 5mC and DAPI was 
detected in brain or in liver tissue sections (Figure 3.10 and 3.11). 5mC staining 
results showed too strong DAPI signals for DNA to be denatured. Permeabilisation 
was performed before the HCl step in order for the denatured proteins to be washed 
out more effectively. Following permeabilisation and DNA denaturation by HCl, 
histones are expected to be released and other denatured proteins to be precipitated. 
Neutralisation was performed immediately to diminish precipitation while HCl 
debris was washed out using a rocking jar. This test was based on a suggestion that 
the standard protocol may work well in cells as flat cultured cells washed out HCl 
debris better and have less extracellular matrix. Inverted permeabilisation and 
neutralisation steps were continually used in the subsequent tests as background was 
seen to reduce using these steps. 
 
3.6.4 Duration of 5mC antibody incubation test 
Previously, 5mC was incubated for 2 hours at room temperature in the dark. In this 
test, 5mC antibody was incubated overnight at 4C. The standard protocol was also 
slightly changed where the concentration of Triton X-100 was increased to 0.5% and 




changes were to verify possible antibody accessibility issues. The blocking solution 
might have to be adapted to mixed background types, therefore blocking were with a 
mix of BSA and donkey serum. 
 
Table 3.4: Duration of 5mC antibody incubation test for DNA methylation 
immunostaining in mouse embryonic tissues. 5mC antibody incubation was 
performed overnight 4C. In addition to overnight 5mC antibody incubation, the 
concentration of Triton X-100 was increased to 0.5% and an additional blocking 










Figure 3.12: DNA methylation immunostaining in E13.5 mouse embryonic 
brain tissues. Representative staining of mouse embryonic brain tissue sections is 
shown. Left panel: tissue nuclear DNA counterstained with DAPI (blue). Middle 
panel: tissues stained with primary antibody against 5mC (green). Right panel: 
merged image. Partial colocalisation (arrows) between 5mC and DAPI dense foci 




Figure 3.13: DNA methylation immunostaining in E13.5 mouse embryonic liver 
tissues. Representative staining of mouse embryonic liver tissue sections is shown. 
Left panel: tissue nuclear DNA counterstained with DAPI (blue). Middle panel: 
tissues stained with primary antibody against 5mC (green). Right panel: merged 




The overnight 4C incubation resulted in approximately 15% of nuclear regions 
demonstrating colocalisation of 5mC and DAPI in brain as well as in liver tissue 
sections (Figure 3.12 and 3.13). Longer duration of 5mC antibody incubation 
therefore improved the antibody signal. The adhesive elements that caused non-
specific staining were better covered by using additional blocking with donkey 
serum. The nature of the problem was still being reconsidered at the HCl step, as the 




overnight 5mC antibody incubation was not used in the subsequent test until optimal 
condition for HCl step was found. However, 0.5% Triton X-100 and 2% donkey 
serum were continually used in the subsequent test as both conditions seemed to aid 
in the reduction of the background and non-specific staining, respectively. 
 
3.6.5 Duration of HCl treatment test 
In this test, the tissues were treated with HCl for 30 minutes (Table 3.5). Longer 
duration of HCl treatment gives a higher possibility of DNA in each nucleus to be 
denatured. 
 
Table 3.5: Duration of HCl treatment test for DNA methylation immunostaining 








Figure 3.14: DNA methylation immunostaining in E13.5 mouse embryonic 
brain tissues. Representative staining of mouse embryonic brain tissue sections is 
shown. Left panel: tissue nuclear DNA counterstained with DAPI (blue). Middle 
panel: tissues stained with primary antibody for 5mC (green). Right panel: merged 
image. Partial colocalisation (arrows) between 5mC and DAPI dense foci was 




Figure 3.15: DNA methylation immunostaining in E13.5 mouse embryonic liver 
tissues. Representative staining of mouse embryonic liver tissue sections is shown. 
Left panel: tissue nuclear DNA counterstained with DAPI (blue). Middle panel: 
tissues stained with primary antibody against 5mC (green). Right panel: merged 
image. Partial colocalisation (arrows) by longer HCl treatment was confirmed. 
 
 
In view of the persistence of strong DAPI staining despite the HCl denaturation step, 
it was possible that DNA denaturation was not complete. HCl treatment for 30 
minutes resulted in approximately 15% of nuclear regions colocalising for 5mC and 
DAPI in brain as well as in liver tissue sections (Figure 3.14 and 3.15). Longer 
duration of HCl treatment was employed to increase the possibility for DNA in each 
nucleus to be denatured. The denaturation time often needs to be recalibrated, as cells 
will denature quicker than tissues, and various tissues will also show differences. 





3.6.6 Duration of HCl treatment test (2) 
In this test, the duration of HCl treatment was further increased to 45 minutes (Table 
3.6). Longer duration of HCl treatment gives higher possibility of DNA in each 
nucleus to be denatured if tissue morphology is not affected.  
 
Table 3.6: Duration of HCl treatment test for DNA methylation immunostaining 











Figure 3.16: DNA methylation immunostaining in E13.5 mouse embryonic 
brain tissues. Representative staining of mouse embryonic brain tissue sections is 
shown. Left panel: tissue nuclear DNA counterstained with DAPI (blue). Middle 
panel: tissues stained with primary antbody against 5mC (green). Right panel: 
merged image. Partial colocalisation (arrows) between 5mC and DAPI dense foci 




Figure 3.17: DNA methylation immunostaining in E13.5 mouse embryonic liver 
tissues. Representative staining of mouse embryonic liver tissue sections is shown. 
Left panel: tissue nuclear DNA counterstained with DAPI (blue). Middle panel: 
tissues stained with primary antibody against 5mC (green). Right panel: merged 
image. Partial colocalisation (arrows) by longer HCl treatment was confirmed. 
 
 
HCl treatment for 45 minutes resulted in approximately 15% of nuclear regions 
colocalising for 5mC and DAPI in brain as well as in liver tissue sections (Figure 
3.16 and 3.17). Longer duration of HCl treatment was employed to increase the 
possibility for DNA in each nucleus to be denatured, but no further enhancement was 
seen at the expense of likely acid damage to the tissues. 45 minutes of HCl treatment 
was considered to be optimal denaturation condition for HCl step and was therefore 





3.6.7 Duration of HCl treatment and 5mC antibody incubation test  
In this test, two conditions were combined: 45 minutes of HCl treatment and 
overnight incubation of 5mC antibody (Table 3.7). Longer duration of HCl treatment 
gives higher possibility for DNA in each cell to be denatured and longer duration of 
antibody incubation gives higher possibility of antibody access and binding. 
 
Table 3.7: Duration of HCl treatment and 5mC antibody incubation test for 
DNA methylation immunostaining in mouse embryonic tissues. 45 minutes of 









Figure 3.18: DNA methylation immunostaining in E13.5 mouse embryonic 
brain tissues. Representative staining of mouse embryonic brain tissue sections is 
shown. Left panel: tissue nuclear DNA counterstained with DAPI (blue). Middle 
panel: tissues stained with primary antibody against 5mC (green). Right panel: 
merged image. Partial colocalisation (arrows) between 5mC and DAPI dense foci 




Figure 3.19: DNA methylation immunostaining in E13.5 mouse embryonic liver 
tissues. Representative staining of mouse embryonic liver tissue sections is shown. 
Left panel: tissue nuclear DNA counterstained with DAPI (blue). Middle panel: 
tissues stained with primary antibody against 5mC (green). Right panel: merged 
image. Partial colocalisation (arrows) between 5mC and DAPI dense foci was 
achieved by combining longer incubations. 
 
 
Partial success with longer HCl treatment and longer primary antibody incubation 
suggested combining both conditions could produce further gains. Yet still 
approximately 15% of nuclear regions demonstrated colocalisation of 5mC and 
DAPI in brain as well as in liver tissue sections (Figure 3.18 and 3.19). No further 
increase in colocalisation between 5mC and DAPI was observed. DNA denaturation 
is a critical step in this method as longer treatment of HCl might lead to tissue 




antibody specificity problems in tissues but not in cultured cells. Further optimisation 
of the DNA denaturation step using HCl could not be considered. Although a further 
37C HCl treatment protocol variation was tested, this did not result in further gains 
(not shown). Therefore, an alternative denaturation step was employed to improve 
the antibody signals. 
 
3.6.8 DNA denaturation by boiling test 
In this test, after the permeabilisation step the slide was boiled for 10 minutes in 10 
mM sodium citrate pH 6 (Table 3.8). This alternative denaturation step was 
employed to denature the DNA as it is similar to an antigen retrieval step, which is 
recommended whenever antibody signals need to be improved (at the expense of 
some heat damage to the tissues). It is also related to the DNA denaturation step in in 
situ hybridisation experiments and had been used by some protocols using wax 
embedded tissue sections. 
 
Table 3.8: DNA denaturation by boiling test for DNA methylation 
immunostaining in mouse embryonic tissues. DNA denaturation step was 






Figure 3.20: DNA methylation immunostaining in E13.5 mouse embryonic 
brain tissues. Representative stainings of mouse embryonic brain tissue sections 
are shown. Top left panel: tissue nuclear DNA counterstained with DAPI (blue). Top 
right panel: tissues stained with primary antibody against 5mC (green). Bottom left 
panel: tissues stained antibody against with ssDNA (red). Bottom right panel: 
merged image. Colocalisation between 5mC, ssDNA and DAPI is apparent after 







Figure 3.21: DNA methylation immunostaining in E13.5 mouse embryonic liver 
tissues. Representative staining of mouse embryonic liver tissue sections are 
shown. Top left panel: tissue nuclear DNA counterstained with DAPI (blue). Top 
right panel: tissues stained with primary antibody against 5mC (green). Bottom left 
panel: tissues stained with antibody against ssDNA (red). Bottom right panel: 
merged image. Colocalisation between 5mC, ssDNA and DAPI is confirmed after 
DNA denaturation by boiling in sodium citrate. 
 
 
Figure 3.20 and 3.21 show that the change in method used for DNA denaturation in 
mouse embryonic tissues was successful in brain tissues as well as in liver tissues, as 
demonstrated by 5mC colocalisation with DAPI. Boiling in 10 mM of sodium citrate 
for denaturation of DNA was demonstrated to be much more effective in tissues than 
HCl treatment. Similar improvement was observed for 5mC and ssDNA staining. 




observed colocalisation with 5mC and DAPI. Patterns of observed signal were 
consistent with the partially immunostained images from HCl denatured cultured 
cells. The boiling step was derived from protocols for sodium citrate Southern 
hybridisation, fluorescent in situ hybridisation (FISH) and histochemistry staining of 
dehydrated paraffin sections. The method is also used for antigen retrieval; this 
generally retrieves protein epitopes but in this case included denaturation of DNA to 
expose DNA bases. The boiling step therefore retrieves antigen epitopes as well as 
denaturing DNA. Formalin or other aldehyde fixation may form protein cross-links 
that mask the antigenic sites in tissue specimens, thereby showing poor or false 
negative staining for immunohistochemical detection of certain proteins. The citrate 
based solution is designed to break the protein cross-links, thus unmask the antigens 
and epitopes in formalin-fixed and paraffin embedded tissue sections, therefore 
enhancing staining intensity of antibodies. Of further relevance is that DNA 
denaturation by sodium citrate boiling, as used in Southern hybridisation, FISH and 
paraffin section histochemistry may be better at dealing with dehydrated DNA on a 
substrate, including DNA adhered onto glass. 
 
3.7 DNA hydroxymethylation immunostaining in 
mouse embryonic tissues 
5hmC has been proposed to be an intermediate in an active DNA demethylation 
pathway. Thus, immunohistochemical detection of 5hmC was crucial in order to 
investigate tissues undergoing dynamic nuclear changes in DNA hydroxymethylation 
state during development. Therefore, the optimised immunohistochemistry method 





Figure 3.22: DNA hydroxymethylation immunostaining in E13.5 mouse embryonic brain tissues. Representative stainings of 
mouse embryonic brain tissue sections are shown. First panel: tissue nuclear DNA counterstained with DAPI (blue). Second panel: 
tissues stained with primary antibody against 5mC (green). Third panel: tissues stained with antibody against 5hmC (red). Fourth panel: 




Figure 3.23: DNA hydroxymethylation immunostaining in E13.5 mouse embryonic liver tissues. Representative stainings of mouse 
embryonic liver tissue sections are shown. First panel: tissue nuclear DNA counterstained with DAPI (blue). Second panel: tissues stained 
with primary antibody against 5mC (green). Third panel: tissues stained with antibody against 5hmC (red). Fourth panel: merged image of 




It is shown that the method used for staining 5mC successfully stained for 5hmC. 
5hmC and 5mC were expected to show overlap if 5hmC is a derivative, yet 5hmC 
signals were mainly enriched in euchromatic regions and excluded from DAPI-dense 
foci in brain tissues as well as in liver tissues (Figure 3.22 and 3.23). This result has 
confirmed what the lab has observed for primary mouse embryonic fibroblast 
cultures (Nestor et al., 2015). 
 
3.8 DNA methylation immunostaining in MBD-GFP 
mouse embryonic tissues 
A transgenic mouse GFP reporter was under characterisation in the lab as an 
approach to visualise DNA methylation in tissues. Tissues carrying a GFP fusion 
with a CpG methyl-binding domain (human MBD1) were used in this study. In order 
to assess the effectiveness of this marker, it was very important to have the optimised 
protocol for 5mC detection working reliably on these MBD-GFP mouse embryo 
cryosections. This was because, for any GFP signals observed in transgenic mouse 
tissues, 5mC results were used as a necessary control for comparison. Thus, it was 
crucial for the working protocol to detect both markers together on the same 
cryosection in order to observe how well these two marks correlate. 
 
 
Figure 3.24: DNA methylation immunostaining in E11.5 MBD-GFP mouse 
embryonic brain tissues. Representative stainings of MBD-GFP mouse embryonic 
brain tissue sections are shown. First panel: GFP-expressing cells (green) were 
detected in PFA-fixed cryosection before the staining procedure. Second panel: 
tissue nuclear DNA counterstained with DAPI (blue). Third panel: tissues stained 
with anti-GFP antibody (green). Fourth panel: tissues stained with anti-5mC 
antibody (red). Fifth panel: merged image. The working protocol for 5mC detection 
did not preserve the native GFP fluorescent pattern present before the staining 








Figure 3.25: DNA methylation immunostaining in E11.5 MBD-GFP mouse 
embryonic liver tissues. Representative stainings of MBD-GFP mouse embryonic 
liver tissue sections are shown. First panel: GFP-expressing cells (green) were 
detected in PFA-fixed cryosection before the staining procedure. Second panel: 
tissue nuclear DNA counterstained with DAPI (blue). Third panel: tissues stained 
with anti-GFP antibody (green). Fourth panel: tissues stained with anti-5mC 
antibody (red). Fifth panel: merged image. The working protocol for 5mC detection 
did not preserve the native GFP fluorescence in either brain tissue (Figure 3.24) or 
liver tissue (compare first and third panel).  
 
 
Figure 3.24 and 3.25 show that the working protocol for immunodetection of 5mC 
did not preserve the native GFP or its detection by anti-GFP antibody in either brain 
or liver tissue. As a control, the presence of GFP signal in PFA-fixed tissue 
cryosections was recorded prior to staining, showing that the GFP signals were 
detected in heterochromatic foci before the procedure. Another control, GFP 
immunostaining without denaturation step, also was performed (data not shown). 
Omission of this critical denaturation step in the staining procedure resulted in the 
detection of GFP signals. Anti-GFP antibody was incorporated into the 5mC staining 
protocol in order to overcome dim and degraded signals. However, anti-GFP 
immunostaining did not rescue detectable GFP signals apart from non-nuclear 
background. 
 
It is shown that the method used for staining 5mC was successful but unfortunately it 
did not preserve the native GFP. The problem was considered at the denaturation 
step as heat denaturation leads to disruption of GFP signal. Therefore, an alternative 
refinement of the denaturation method was employed to preserve native GFP signals 





3.9 DNA methylation immunostaining in MBD-GFP 
mouse embryonic tissues: preservation of native 
GFP proteins 
GFP immunostaining using optimised 5mC immunodetection was unsuccessful. An 
alternative denaturation method was employed to preserve the native GFP signals 
whilst at the same time working reliably for 5mC immunodetection. 
 
3.9.1 Formamide-based denaturation method 
Heating is not the only way to denature DNA, an organic solvent such as formamide 
also has the ability to break the hydrogen bonds that hold the double helix together. 
Formamide is a well-known and the most frequently used denaturing agent for DNA. 
Therefore, an alternative denaturation method using 70% formamide, 2X saline 
sodium citrate (SSC) adapted from Shi et al. (2004a) was employed. 
 
 
Figure 3.26: DNA methylation immunostaining in E11.5 MBD-GFP mouse 
embryonic brain tissues. Representative staining of MBD-GFP mouse embryonic 
brain tissue sections is shown. First panel: GFP-expressing cells (green) were 
detected in PFA-fixed cryosection before the staining procedure. Second panel: 
tissues counterstained with DAPI (blue). Third panel: same tissues stained with anti-
GFP (green). Fourth panel: tissues stained with 5mC (red). Fifth panel: merged 
image. Formamide-based denaturation method did not detect 5mC as a nuclear 










Figure 3.27: DNA methylation immunostaining in E11.5 MBD-GFP mouse 
embryonic liver tissues. Representative staining of MBD-GFP mouse embryonic 
liver tissue sections is shown. First panel: GFP-expressing cells (green) were 
detected in PFA-fixed cryosection before the staining procedure. Second panel: 
tissues counterstained with DAPI (blue). Third panel: same tissues stained with anti-
GFP (green). Fourth panel: tissues stained with 5mC (red). Fifth panel: merged 
image. Formamide-based denaturation method did not detect 5mC as a nuclear 
signal, and neither did it preserve the native GFP in either tissue.  
 
 
Figure 3.26 and 3.27 show that the alternative denaturation method using formamide 
did not work for either 5mC or as GFP detection. Positive GFP signals were detected 
in PFA-fixed tissue cryosections, indicating that the GFP was present before the 
staining procedure. The formamide-denatured DNA method showed no 
improvement; in fact, this method worked even worse than heat-denatured DNA. 
Therefore, no subsequent actions were taken to optimise it. For that reason, another 
method for DNA denaturation was sought in order to detect both markers. 
 
3.9.2 Microwave-heating denaturation method 
A further refinement of the denaturation method using the same heat treatment as 
previously was employed. The denaturation method was adapted from Piyathilake et 
al. (2004). But instead of boiling the slides in a sodium citrate-containing beaker on a 
hot plate, the alternative heating method employed a microwave, in which the slides 
were boiled in a sodium citrate-containing Schieferdecker jar in the microwave. 
Microwaving is commonly used as a heating method for heat-induced epitope 
retrieval in immunohistochemistry, but in this case, it also includes denaturation of 






Figure 3.28: DNA methylation immunostaining in E11.5 MBD-GFP mouse 
embryonic brain tissues. Representative staining of MBD-GFP mouse embryonic 
brain tissue sections is shown. First panel: GFP-expressing cells (green) were 
detected in PFA-fixed cryosection before the staining procedure. Second panel: 
tissues counterstained with DAPI (blue). Third panel: same tissues stained with anti-
GFP antibody (green). Fourth panel: tissues stained with 5mC (red). Fifth panel: 
merged image. 5mC immunostaining worked after microwave treatment with 
approximately 10% of GFP signals detectable by antibody after heat-mediated 




Figure 3.29: DNA methylation immunostaining in E11.5 MBD-GFP mouse 
embryonic liver tissues. Representative staining of MBD-GFP mouse embryonic 
liver tissue sections is shown. First panel: GFP-expressing cells (green) were 
detected in PFA-fixed cryosection before the staining procedure. Second panel: 
tissues counterstained with DAPI (blue). Third panel: same tissues stained with anti-
GFP antibody (green). Fourth panel: tissues stained with 5mC (red). Fifth panel: 
merged image. 5mC immunostaining worked after microwave treatment with 
approximately 10% of GFP signals detectable by antibody after heat-mediated 
antigen retrieval (marked by arrows). Observations in brain (Figure 3.28) were 
confirmed in liver. 
 
 
Figure 3.28 and 3.29 show that the change in heating method for DNA denaturation 
was partially successful. The microwave heating method allowed successful staining 
of 5mC and enabled the preservation of immunodetectable native GFP signals. 
However, only approximately 10% of GFP signals survived after heat-mediated 
antigen retrieval. Positive GFP signals were detected in PFA-fixed tissue 
cryosections, indicating that the GFP was present before the staining procedure. 




microwave treatment where it appeared to rescue detection of the natural fluorophore 
of GFP. 
 
5mC and GFP signals demonstrated colocalisation with DAPI staining. A good 
overlap between 5mC and GFP signals was also observed, particularly in 
heterochromatic areas where both marks were highly enriched. It is shown that 5 
minutes of microwave treatment resulted in detection of 5mC and preservation of 
approximately 10% of GFP signals. Suitable conditions for heat denaturation were 
further investigated to avoid potential risk of overheating. In particular, overheating 
may fully denature the GFP protein and destroy its ability to fluoresce.  
 
3.9.2.1 Optimisation of microwave boiling duration 
To improve the GFP retention, microwave boiling duration was optimised.  
 
3.9.2.1.1 Duration of microwave boiling test (4 minutes) 
In this test, the duration of microwave boiling was shortened from 5 minutes to 4 
minutes. A short boiling time may preserve more GFP signals. 
 
 
Figure 3.30: DNA methylation immunostaining in E11.5 MBD-GFP mouse 
embryonic brain tissues. Representative staining of MBD-GFP mouse embryonic 
brain tissue sections is shown. First panel: GFP-expressing cells (green) were 
detected in PFA-fixed cryosection before the staining procedure. Second panel: 
tissues counterstained with DAPI (blue). Third panel: same tissues stained with anti-
GFP (green). Fourth panel: tissues stained with 5mC (red). Fifth panel: merged 
image. Four minutes of microwave treatment resulted in an increase of GFP signals 











Figure 3.31: DNA methylation immunostaining in E11.5 MBD-GFP mouse 
embryonic liver tissues. Representative staining of MBD-GFP mouse embryonic 
liver tissue sections is shown. First panel: GFP-expressing cells (green) were 
detected in PFA-fixed cryosection before the staining procedure. Second panel: 
tissues counterstained with DAPI (blue). Third panel: same tissues stained with anti-
GFP (green). Fourth panel: tissues stained with 5mC (red). Fifth panel: merged 
image. 4 minutes of microwave treatment resulted in an increase in GFP signals to 
an estimated 20%, yet 5mC immunodetection was still effective (marked by arrows). 
Observations in brain were confirmed in liver. 
 
 
Figure 3.30 and 3.31 show that the 4 minutes of microwave treatment resulted in 
increased GFP signals to approximately 20%. This treatment was also compatible 
with 5mC immunodetection. Positive GFP signals were detected in PFA-fixed tissue 
cryosections, indicating that the GFP was present before the staining procedure. 5mC 
and GFP signals demonstrated colocalisation with DAPI staining. A good overlap 
between 5mC and GFP signals was also observed. Indeed, a shorter boiling time 
preserved more GFP signals. 
 
3.9.2.1.2 Duration of microwave boiling test (3 minutes) 
To further improve the GFP retention, the duration of microwave boiling was 











Figure 3.32: DNA methylation immunostaining in E11.5 MBD-GFP mouse 
embryonic brain tissues. Representative staining of MBD-GFP mouse embryonic 
brain tissue sections is shown. First panel: GFP-expressing cells (green) were 
detected in PFA-fixed cryosection before the staining procedure. Second panel: 
tissues counterstained with DAPI (blue). Third panel: same tissues stained with anti-
GFP (green). Fourth panel: tissues stained with 5mC (red). Fifth panel: merged 
image. Three minutes of microwave treatment resulted in an increase in GFP 





Figure 3.33: DNA methylation immunostaining in E11.5 MBD-GFP mouse 
embryonic liver tissues. Representative staining of MBD-GFP mouse embryonic 
liver tissue sections is shown. First panel: GFP-expressing cells (green) were 
detected in PFA-fixed cryosection before the staining procedure. Second panel: 
tissues counterstained with DAPI (blue). Third panel: same tissues stained with anti-
GFP (green). Fourth panel: tissues stained with 5mC (red). Fifth panel: merged 
image. Three minutes of microwave treatment resulted in an increase in GFP 
signals to an estimated 45%, yet 5mC immunodetection was still effective (marked 
by arrows). Observations in brain were confirmed in liver. 
 
 
Figure 3.32 and 3.33 show that the 3 minutes of microwave treatment resulted in a 
further increase in GFP signals to approximately 45%. This treatment was still 
compatible with 5mC immunodetection. Positive GFP signals were detected in PFA-
fixed tissue cryosections, indicating that the GFP was present before the staining 
procedure. 5mC and GFP signals demonstrated colocalisation with DAPI staining. A 
good overlap between 5mC and GFP signals was also detected. Indeed, a further 






3.9.2.1.3 Duration of microwave boiling test (2 minutes) 
To determine the condition boundaries of the boiling duration, 2 minutes of 
microwave treatment was performed. 
 
 
Figure 3.34: DNA methylation immunostaining in E11.5 MBD-GFP mouse 
embryonic brain tissues. Representative staining of MBD-GFP mouse embryonic 
brain tissue sections is shown. First panel: GFP-expressing cells (green) were 
detected in PFA-fixed cryosection before the staining procedure. Second panel: 
tissues counterstained with DAPI (blue). Third panel: same tissues stained with anti-
GFP (green). Fourth panel: tissues stained with 5mC (red). Fifth panel: merged 
image. Two minutes of microwave treatment resulted in a decrease in GFP signals 
to an estimated 20% yet 5mC immunodetection was still effective (marked by 




Figure 3.35: DNA methylation immunostaining in E11.5 MBD-GFP mouse 
embryonic liver tissues. Representative staining of MBD-GFP mouse embryonic 
liver tissue sections is shown. First panel: GFP-expressing cells (green) were 
detected in PFA-fixed cryosection before the staining procedure. Second panel: 
tissues counterstained with DAPI (blue). Third panel: same tissues stained with anti-
GFP (green). Fourth panel: tissues stained with 5mC (red). Fifth panel: merged 
image. Two  minutes of microwave treatment resulted in a decrease in GFP signals 
to an estimated 20% yet 5mC immunodetection was still effective (marked by 
arrows) but some areas started to show non-specific staining. Observations in brain 
(Figure 3.34) were confirmed in liver. 
 
 
Figure 3.34 and 3.35 show that the 2 minutes of microwave treatment resulted in 
decreased GFP signals to approximately 20%. This treatment was still compatible 
with 5mC immunodetection, however some areas started to show non-specific 




indicating that the GFP was present before the staining procedure. 5mC and GFP 
signals demonstrated colocalisation with DAPI staining. A good overlap between 
5mC and GFP signals was also detected. It is shown that reducing the boiling time 
did not result in further gains.  
 
Therefore, 3 minutes of microwave boiling was considered an optimal condition and 
was used for subsequent experiment. 
 
3.9.2.2 GFP antibody test 
Detection of native GFP signals may be improved by using another GFP antibody. 
For that reason, the use of anti-GFP antibody was changed to GFP booster detection 
agent. GFP booster might give better results in detecting heat-denatured GFP as it is 
a single chain nanobody, claimed to have some advantages. Compared to indirect 
immunofluorescence, this GFP fusion nanobody has the potential to provide a more 
direct and dense staining, mainly due to its nanoscale size (2-3 nm). Furthermore, 
GFP nanobody is shown to react in mouse (manufacturer’s datasheet) and there are 
numerous published studies using it (Ridzuan et al., 2012; Rothbauer et al., 2006; 
Szymanska et al., 2016). 
 
 
Figure 3.36: DNA methylation immunostaining in E11.5 MBD-GFP mouse 
embryonic brain tissues. Representative staining of MBD-GFP mouse embryonic 
brain tissue sections is shown. First panel: GFP-expressing cells (green) were 
detected in PFA-fixed cryosection before the staining procedure. Second panel: 
tissues counterstained with DAPI (blue). Third panel: same tissues stained with anti-
GFP (green). Fourth panel: tissues stained with 5mC (red). Fifth panel: merged 








Figure 3.37: DNA methylation immunostaining in E11.5 MBD-GFP mouse 
embryonic liver tissues. Representative staining of MBD-GFP mouse embryonic 
liver tissue sections is shown. First panel: GFP-expressing cells (green) were 
detected in PFA-fixed cryosection before the staining procedure. Second panel: 
tissues counterstained with DAPI (blue). Third panel: same tissues stained with anti-
GFP (green). Fourth panel: tissues stained with 5mC (red). Fifth panel: merged 
image. GFP booster did not preserve the native GFP in either brain or liver tissue. 
 
 
Figure 3.36 and 3.37 show that the change in GFP antibody did not result in more 
rescue of native GFP signals. GFP signal detection using alternative GFP booster 
antibody showed weak nuclear staining but was unsuccessful in staining the native 
GFP pattern. Positive GFP signals were observed in PFA-fixed tissue cryosections, 
indicating that the GFP was present before the staining procedure. Therefore, anti-
GFP was used for subsequent experiment. 
 
3.9.2.3 Duration of PFA fixation test 
PFA tends to quench fluorescence of the GFP fusion protein. Mild fixation may 
prevent the quenching of GFP fluorescence, thereby increasing its visibility. 









Figure 3.38: DNA methylation immunostaining in E11.5 MBD-GFP mouse 
embryonic brain tissues. Representative stainings of MBD-GFP mouse embryonic 
brain tissue sections are shown. First panel: GFP-expressing cells (green) after 50 
minutes of PFA fixation. Second panel: GFP-expressing cells (green) after 30 




Figure 3.39: DNA methylation immunostaining in E11.5 MBD-GFP mouse 
embryonic liver tissues. Representative stainings of MBD-GFP mouse embryonic 
liver tissue sections are shown. First panel: GFP-expressing cells (green) after 50 
minutes of PFA fixation. Second panel: GFP-expressing cells (green) after 30 




Figure 3.38 and 3.39 show that the mild fixation did not result in increased GFP 
signals, indicating that PFA did not quench the fluorescence of GFP. There was no 
significant difference in fluorescence intensity of GFP signals between 50 minutes 
and 30 minutes of PFA fixation. Therefore, a standard 50 minutes of PFA fixation 




3.9.2.4 ssDNA immunostaining using microwave-based denaturation 
method 
As a control and to further confirm the denaturation of DNA, ssDNA 




Figure 3.40: DNA methylation immunostaining in E11.5 MBD-GFP mouse 
embryonic brain tissues. Representative staining of MBD-GFP mouse embryonic 
brain tissue sections is shown. First panel: tissues counterstained with DAPI (blue). 
Second panel: same tissues stained with 5mC (green). Third panel: tissues stained 
with ssDNA (red). Fourth panel: merged image. ssDNA staining was observed using 




Figure 3.41: DNA methylation immunostaining in E11.5 MBD-GFP mouse 
embryonic liver tissues. Representative staining of MBD-GFP mouse embryonic 
liver tissue sections is shown. First panel: tissues counterstained with DAPI (blue). 
Second panel: same tissues stained with 5mC (green). Third panel: tissues stained 
with ssDNA (red). Fourth panel: merged image. ssDNA staining was confirmed in 
brain (Figure 3.40) and liver. 
 
 
Figure 3.40 and 3.41 show that the presence of ssDNA was detected. ssDNA 
demonstrated colocalisation with 5mC and DAPI. The denaturation of DNA was 





3.9.2.5 DNA hydroxymethylation immunostaining using microwave-
based denaturation method 
As 5hmC detection was crucial for this study, it was important to have the alternative 




Figure 3.42: DNA methylation immunostaining in E11.5 MBD-GFP mouse 
embryonic brain tissues. Representative staining of MBD-GFP mouse embryonic 
brain tissue sections are shown. First panel: tissues counterstained with DAPI 
(blue). Second panel: same tissues stained with 5mC (green). Third panel: tissues 
stained with 5hmC (red). Fourth panel: merged image. 5hmC staining was observed 




Figure 3.43: DNA methylation immunostaining in E11.5 MBD-GFP mouse 
embryonic liver tissues. Representative staining of MBD-GFP mouse embryonic 
liver tissue sections is shown. First panel: tissues counterstained with DAPI (blue). 
Second panel: same tissues stained with 5mC (green). Third panel: tissues stained 
with 5hmC (red). Fourth panel: merged image. 5hmC staining was confirmed in 
brain (Figure 3.42) and liver. 
 
 
Figure 3.42 and 3.43 show that the alternative microwave-heating denaturation 
method used for staining 5mC successfully stained for 5hmC. It is shown that the 





3.10  Discussion 
This PhD study aims to investigate the changing nuclear distributions and levels of 
DNA methylation during development, to discover dynamic variations amongst 
developing mouse tissues, a topic which is currently under-investigated. In this study 
of DNA methylation dynamics, immunohistochemical technique has been employed 
as an investigative tool. Optimal immunohistochemistry protocols are fundamental to 
minimise the possibility of false negative results, whilst at the same time not 
introducing a false positive result. Furthermore, reliable immunohistochemical 
studies may represent an important source of information for accurately 
understanding the nuclear epigenetic dynamics during development with relevance 
to cell reprogramming for regenerative medicine. Therefore, this chapter focuses on 
the optimisation of DNA methylation immunohistochemistry protocol aiming to 
achieve the optimal conditions for the detection of DNA methylation and reports 
significant improvements on methods published in the literature. 
 
3.10.1 DNA methylation immunostaining: protocol optimisation 
The existing standard methodology for DNA methylation immunostaining using HCl 
DNA denaturation works for cultured cells, preimplantation embryos (mouse, rat and 
sheep) and embryos to larvae (zebrafish). These examples have shown that 5mC 
stains heterochromatin, 5hmC stains throughout nucleus except nucleoli and ssDNA 
staining copies the DAPI pattern. However, the existing methodology was found not 
to work for mouse embryo tissue cryosections, on which all antibodies for 5mC, 
5hmC and ssDNA stain preferentially nuclei but without reference to the DAPI 
pattern. Therefore, all these antibodies have a similar non-specific nuclear 
appearance on cryosections, which could be potentially misleading when viewed at 
low magnification. 
 
Examples of working protocols for DNA methylation immunostaining of 
cryosections in the literature were examined but not many tissues have been 
characterised for DNA methylation. Only a few images in the literature demonstrated 
a working technique and some images found for paraffin sections suffered from 




The standard protocol was assumed to work on tissues as it worked on cells but 
methodology changes and optimisation were required. The standard denaturation 
protocol uses HCl and rapid neutralisation with buffer, for example Ruzov et al. 
(2011). Somehow this causes 5mC antibody specificity problems in tissues but not in 
cultured cells or small whole embryos. Further optimisation of the DNA denaturation 
step using HCl needs to be considered. Overall, the existing protocol was found not 
to be a very reproducible method, yet it is a standard methodology and widely used. 
 
Therefore, an alternative denaturation step was employed to improve the antibody 
detection. It is shown that this alternative method used for DNA denaturation in 
mouse embryonic tissues by boiling in 10 mM of sodium citrate was successful. 
During the process of heat-induced antigen unmasking, heat causes the cross-linked 
proteins to unfold in a manner similar to DNA denaturation (Fowler et al., 2011), 
whereas the citrate solution used during this heating may help to further unfold the 
proteins, resulting in the recovery of antigen reactivity (Hussaini et al., 2013). 
However, the precise mechanism of antigen retrieval is not properly understood 
(Vollert et al., 2015).  
 
In this case, the antigen retrieval heating technique was successfully applied to 
denature the DNA, making it single-stranded and accessible for antibody binding. 
Using this method, it is shown in nuclei throughout the cryosection that 5mC stains 
heterochromatin, 5hmC stains nuclear euchromatin except for nucleoli and ssDNA 
staining copies the DAPI pattern. 
 
To further confirm the results, three important controls had been performed to verify 
the specificity of both 5mC and 5hmC antibodies. The first control was 
5mCimmunostaining in both cells and tissues, which showed immunofluorescence 
evidence for the presence of 5mC, suggesting that this monoclonal antibody worked 
perfectly specific in capturing methylated DNA in cells, as well as in tissues. The 
second control was 5mC immunostaining in hypomethylated mouse embryonic 
primordial germ cells, which demonstrated no apparent evidence of 5mC staining as 




control was single staining of 5mC and 5hmC, which displayed 5mC was mainly 
located in heterochromatic regions, whereas 5hmC enrichment was found in 
euchromatic regions, indicating that both antibodies were highly specific for their 
respective epitopes and did not cross-react with one another. Second and third 
controls are discussed in greater detail in Chapter 4. 
 
5hmC immunostaining, however, was not particularly performed in cells and 
hypohydroxymethylated cells/tissues, therefore these controls should be carried out 
in order to further confirm the specificity of the 5hmC antibody. Nonetheless, anti-
5hmC, as well as anti-5mC antibodies, are well-characterised antibodies whose 
antigenic specificity is well known and there are several published studies using the 
same antibodies (Diotel et al., 2017; Franco et al., 2017; Jafarpour et al., 2017; Lee et 
al., 2017). In addition, according to the manufacturer’s datasheet, dotblot assay 
demonstrates no cross-reactivity of the 5mC antibody with 5hmC and cytosine. 
Similarly, for the 5hmC antibody, dotblot assay shows no cross-reactivity of this 
antibody with 5mC and cytosine (manufacturer’s datasheet). Furthermore, both 
antibodies are shown to react in mouse (manufacturer’s datasheet). 
 
3.10.2 DNA methylation immunostaining: preservation of native GFP 
proteins 
GFP is frequently used in molecular biology to generate fluorescent tagged/fusion 
proteins in order to visualise the subcellular localisation of specific proteins (Chalfie 
et al., 1994; Yamagata et al., 2007; Yamazaki et al., 2007). Nonetheless, being 
genetically encoded and not chemically engineered, there are a number of technical 
limitations of GFP as a subcellular marker. These limitations include the following: 
low expression level, photosensitive, weak signal intensity, insolubility, and 
instability at high temperature (Vela and Buja, 2016).  
 
In the case of immunohistochemical staining, preservation of tissue morphology with 
chemical fixatives such as formaldehyde is necessary (Howat and Wilson, 2014). 
However, one shortcoming of fixation of GFP-expressing tissues is that it may lose 




DNA methylation immunostaining protocol used in this study to visualise GFP 
involves heat treatment. This approach has its limitations as GFP tends to lose its 
fluorescence in heat-treated tissue sections (Nakamura et al., 2008). It seems that 
treatment involving heat irreversibly denatures GFP, thus destroying its ability to 
emit fluorescence (Nakamura et al., 2008). To counter these limitations, 
immunostaining with commercially available antibodies is normally used to detect 
GFP (Jensen, 2012). Low fluorescence signals can be recovered using an anti-GFP 
antibody (Choudhury et al., 2016; Kohl et al., 2014). 
 
Despite these limitations, this study has found that GFP immunostaining worked 
after optimising protocols for microwave treatment, with 45% of signals surviving 
after heat-mediated antigen retrieval. This opens up the possibility for combinatorial 
applications of the GFP immunodetection method with procedures requiring heat 
treatment. 
 
3.10.3 Comparison between two methods of DNA denaturation 
DNA methylation immunostaining of cryosections was found to require DNA 
denaturation by heat treatment (hot plate or microwave) (Figure 3.44) instead of HCl 
DNA denaturation. Most importantly, GFP immunostaining offered good 







Figure 3.44: DNA methylation immunohistochemistry protocol. DNA 
methylation immunostaining of cryosections requires heat-mediated DNA 
denaturation either using (A) hot plate or (B) microwave techniques. Both methods 
are reported in Beaujean et al. (2017) (in press). 
 
 
Immunohistochemistry has become the most valuable tool in many medical research 
laboratories as it permits visualisation of specific antigens in tissues (Goto et al., 
2015). Therefore, ensuring the accuracy and reliability of the results obtained 
through visual inspection of stained tissues is critical. Based on this study, both 
methods that were optimised have proven to be very accurate and reliable in 
detecting DNA methylation in tissue cryosections. Furthermore, the ultimate aim 
when optimising immunohistochemistry protocols is to ensure consistent and 
reproducible results. Based on obtained results, both optimised methods were shown 
to be capable of producing high-quality, uniform staining, with a degree of 




across experiments. In addition, the use of heat in the immunostaining procedure was 
generally considered too harsh and likely to destroy tissue morphology. Remarkably, 
both heat-mediated DNA denaturation methods did not show any apparent 
detrimental effects to nuclear detail and morphology of the tissue sections.  
 
However, in subsequent experimental works, microwave heating became the method 
of choice due to several practical advantages. It has been shown that the application 
of microwave heating during the immunohistochemical staining process can 
significantly reduce the amount of time needed to perform the denaturation step, thus 
speeding up the entire staining process. Furthermore, the microwave oven has the 
potential to provide heat instantly, thus a significantly higher temperature can be 
reached more quickly. Moreover, with this method, the amount of heat delivered and 
time required can be manually set with the push of a button, which makes it easy to 
operate and convenient to use. Most importantly, microwave heating is safer than an 
external hot plate heating. 
 
Nonetheless, the application of a domestic microwave is not ideal due to the presence 
of hot and cold spots in the oven, leading to uneven distribution of heat (Vinod et al., 
2016). In order to overcome this problem, the built-in rotating platform has been 
employed to ensure substantially uniform heat distribution. Indeed, it has been 
demonstrated in this study that the microwave-assisted staining protocol uniformly 
stained DNA methylation throughout the tissue section.  
 
Considering the advantages offered by microwave heating, this method was therefore 
employed in the next chapter to investigate tissues undergoing dynamic nuclear 
changes in DNA methylation and hydroxymethylation states during development 




Chapter 4 - 5mC and 5hmC DNA methylation 




Cytosine DNA methylation was historically viewed as a relatively stable gene-
silencing epigenetic modification throughout the life cycle (Hackett et al., 2012). 
Nonetheless, compelling evidence suggests that DNA methylation patterns undergo a 
genome-wide dramatic change during mammalian development (Zhou et al., 2016). 
Such change involves both passive and active mechanisms of DNA demethylation 
(Seisenberger et al., 2013b). Well known examples of developmental DNA 
demethylation processes occur in the primordial germ cells (PGCs) and in zygotes 
(Messerschmidt et al., 2014). However, little is known about the DNA methylation 
dynamics of other tissues in mammalian development. With this rationale, the 
changing nuclear distributions and levels of DNA methylation during development 
were experimentally investigated in the present chapter in order to discover dynamic 
variations amongst developing mouse tissues. I hypothesised that variations in DNA 
methylation localisation and nuclear organisation were associated with 
differentiation to many tissues. 
 
Several promising, and a few controversial, model pathways of active DNA 
demethylation have been proposed (Tammen et al., 2013). One of the potential 
candidate mechanisms that has gained acceptance in recent years involves iterative 
oxidation of 5mC by Tet proteins, which produces three oxidised cytosine bases 
(5hmC/5fC/5caC) (Neri et al., 2015). This finding indicates that 5hmC may act as an 
intermediate in the removal of 5mC (Zhong et al., 2017). Since 5mC is needed as a 
substrate for the oxidation reaction, a significant reduction in 5mC levels could 
possibly be explained by the generation of 5hmC (Hu et al., 2013). Together, these 
data are consistent with a model in which the gain of 5hmC may coincide with a 




suggested model of active oxidative demethylation through 5hmC formation is also 
in keeping with a recent study done by Amouroux et al. (2016) which demonstrated 
that the accumulation of 5hmC is dependent on the de novo DNA methylation 
activity. Using this separate de novo pathway, 5hmC is generated from 5mC and 
serves as a DNA demethylation intermediate, but 5hmC could also function as a 
stable epigenetic mark with its own regulatory role without apparently triggering 
active cytosine demethylation (Heras et al., 2017; Li et al., 2016). 
 
Thus, it was of considerable interest to address the question about the origin of 5hmC 
during development. In an attempt to answer this important research question raised 
by the findings described above, confocal immunofluorescence experiments were 
performed in order to investigate the dynamics of DNA methylation of both 5mC and 
5hmC. Furthermore, imaging mouse embryonic tissues from stages E9.5 to E14.5 
also allowed accurate characterisation of 5mC and 5hmC changes across different 
tissues, which had not been systematically investigated previously. In addition, 
strong 5mC changes in the early PGCs of the embryo were investigated as well. 
 
Therefore, the aims of this chapter were: 
1. To investigate tissues undergoing dynamic nuclear changes in DNA methylation 
(5mC) state during development from E9.5 to E14.5 mouse whole embryonic 
stages using our optimised immunohistochemistry protocol.  
 
2. To investigate tissues undergoing dynamic nuclear changes in DNA 
hydroxymethylation (5hmC) state during development from E9.5 to E14.5 mouse 
embryonic stages using our same standardised immunohistochemistry protocol.  
 
3. To investigate the colocalisation and possible correlation between the levels of 
5mC and 5hmC during mouse fetal development in brain neorcortex, surface 
ectoderm, liver, red blood cells, diaphragm and heart. 
 





5. To detect the presence of Tet1, Tet2, Tet3 enzymes and DNA methyltransferase 
DNMT3A in cryosections of E12.5 mouse embryonic neocortex, liver, red blood 
cells, diaphragm and heart. 
 
4.2 Results 
DNA methylation dynamics at 5mC and 5hmC were observed in whole embryo 
cryosections taken during mouse fetal development with results reported in brain 
neocortex surface ectoderm, liver, red blood cells, diaphragm and heart. 
 
4.2.1 5mC and 5hmC DNA methylation dynamics in developing 
mouse embryonic neocortex 
The dynamics of 5mC and 5hmC during development of the embryonic mouse 
neocortex, examined by confocal microscopy at a magnification of 40X, are shown 
in Figure 4.1. The resulting dynamics are also shown at a higher image resolution 
using zoomed observations in Figure 4.2. The neocortex is part of the cerebral cortex 
and is the hallmark of the mammalian brain. The exact location of the neocortex in 
the brain is shown in Figure 4.3. 5mC and 5hmC display interesting dynamic 
patterns in the developing cerebral neocortex. Immunofluorescence experiments 
showed that the levels of both 5mC and 5hmC are low at E9.5. 5mC levels begin to 
increase between E10.5 and E12.3, peak at E13.5 and remain high until E14.5 
(Figure 4.1 and 4.2 – 5mC). Remarkably, 5hmC exhibits the same pattern of 
dynamic changes in signal intensity as 5mC from E10.5 to E13.5, but at E14.5, in 
contrast to 5mC, the level of 5hmC appears to decline substantially (Figure 4.1 and 
4.2 – 5hmC). These results suggested that the dynamic nuclear changes in DNA 
methylation and hydroxymethylation states observed in neocortex were in good 
agreement with a model where the 5hmC may be an epigenetic modification in its 
own right. There was clearly no significant correlation between the loss of 5mC and 
the generation of 5hmC at the global nuclear level. 
 
Analysis of immunofluorescence images also showed that the 5mC signals are 
mainly localised in the heterochromatic regions correlating with DAPI density 




regions. In brain, they are excluded from DAPI-dense areas of the nuclei (Figure 4.2 
– 5hmC). The observed staining patterns of 5hmC and 5mC are in agreement with 
the results obtained in Chapter 3, indicating that the optimised 5mC and 5hmC 
immunostaining protocols demonstrate good reproducibility of results between 





Figure 4.1: 5mC and 5hmC double immunostaining in E9.5 to E14.5 mouse embryonic brain neocortical tissues. First row: 
cryosectioned tissues showing nuclear DNA counterstained with DAPI (blue). Second row: primary antibody against 5hmC (green). Third 
row:  antibody against 5mC (red). Fourth row: merged images of DAPI, 5hmC and 5mC. Columns 1 to 6: representative mouse embryonic 
brain neocortical tissue sections at stages from E9.5 to E14.5. Areas within the dashed lines represent a neocortical zone of interest. 




are embryonic neural stem cells. The brighter cells continue through development until E13.5 when the preplate is formed. Specific 
markers that can be used to identify the regions of interest are Pax6/Sox2 (which serve as markers for radial glia cells), Tbr2 (which 
serves as a marker for basal progenitor cells in the neocortex), and Tbr1/Tuj1 (which serve as markers for neurons). Images were 






Figure 4.2: 5mC and 5hmC double immunostaining in E9.5 to E14.5 mouse embryonic brain neocortical cell nuclei. First row: 
cryosectioned tissues showing nuclear DNA counterstained with DAPI (blue). Second row: primary antibody against 5hmC (green). Third 
row: antibody against 5mC (red). Fourth row: merged images of DAPI, 5hmC and 5mC. Columns 1 to 6: representative mouse embryonic 
brain neocortical cell nuclei at stages from E9.5 to E14.5. The confocal images were obtained by zooming into areas within the dashed 





Figure 4.3: Sagittal view of an E14.5 mouse embryonic brain. The dashed line 
inset highlights the neocortex (green) and its location in the brain. At developmental 
stage of E14.5, the neocortex is divided into several functionally distinct layers: the 
ventricular and sub-ventricular zones (VZ/SVZ), which lie adjacent to the lateral 
walls of the lateral ventricles (blue), comprise the neural stem and intermediate 
progenitor cells; the intermediate zone (IZ), which is located above the VZ/SVZ, 
comprises migrating cells and axons; and the cortical plate (CP), which lies between 
the IZ and the superficial marginal zone (MZ), contains post-mitotic neurons 
(Barazzuol et al., 2015). 
 
 
To identify these 5hmC- and 5mC-rich cell populations, immunohistochemical 
detection of nestin with RC2 antibody was performed on cryosections of E12.5 
mouse embryo. Nestin is an intermediate filament protein that is widely used as a 
molecular marker for neural progenitor and stem cells. Adjacent serial sections were 
used for either nestin or 5hmC or 5mC staining, as immunodetection of 5hmC and 
5mC required heat denaturation treatment which was incompatible with the 
preservation of most protein epitopes. 
 
At E12.5, neocortex possesses relatively high abundance of 5hmC as well as 5mC 




expressing cells, as shown in Figure 4.4. The location of these epigenetic marks was 
in the outer region, external to the neocortex rather than the ventricular zones where 
neural progenitors reside.  
 
 
Figure 4.4: 5mC and 5hmC double immunostaining in E12.5 mouse embryonic 
brain neocortical tissues. Mouse embryonic neocortical tissue cryosection as 
shown in Fig 4.1 with a non-denatured cryosection immunostained for nestin. First 
column: nuclear DNA counterstained with DAPI (blue). Second column: from top to 
bottom, primary antibodies against 5hmC (green), 5mC (red) and nestin, RC2 
(green). Third column: merged images. Areas within the dashed lines represent 
neocortical zones of interest. Images were obtained using a confocal microscope 
with a 40X oil-immersion objective lens. Intense staining of nestin is closely 
correlated with high levels of 5hmC and 5mC. Some non-specific nestin staining 






4.2.2 5mC and 5hmC DNA methylation dynamics in developing 
mouse embryonic surface ectoderm 
The dynamics of 5mC and 5hmC during development of the embryonic mouse 
surface ectoderm, examined at a magnification of 40X, are shown in Figure 4.5. The 
resulting dynamics are also shown at a higher image resolution using zoomed 
observations in Figure 4.6. Surface ectodermal tissues were identified using 
Kaufman’s atlas of mouse development. The surface ectoderm, which is derived 
from ectoderm, is a single-layered epithelium that gives rise to tissues on the outer 
surface of the embryo, for instance, epidermis, hair, nails and lens of the eye (Rao P 
and Kumar D, 2016). The images of surface ectoderm were only taken at E9.5, E10.5 
and E11.5, as at the early stages of development the tissues were thicker and became 
noticeably thinner and indistinguishable at the later stages (E12.5, E13.5 and E14.5). 
This was evidently due to a formation of other tissues. 5mC and 5hmC display 
interesting dynamic patterns in developing surface ectoderm. Immunofluorescence 
experiments showed very low levels of staining for 5mC from E9.5 to E11.5 (Figure 
4.5 and 4.6 – 5mC), whereas for 5hmC, the levels of staining at the same stages of 
embryonic development are moderate (Figure 4.5 and 4.6 – 5hmC). These results 
suggested that the dynamic nuclear changes in DNA methylation and 
hydroxymethylation states observed in surface ectoderm were in good agreement 
with a model where the generation of 5hmC may correlate with the loss of old 5mC, 
but the observations were also consistent with an involvement of de novo 
methylation in the generation of 5hmC. 
  
Closer inspection of immunofluorescence images also showed that the 5mC signals, 
where detectable, are mainly localised in the heterochromatic regions (Figure 4.6 – 
5mC), whereas 5hmC signals are predominantly localised in the euchromatic regions 
and are excluded from DAPI-dense foci (Figure 4.6 – 5hmC). The observed staining 
patterns of 5hmC and 5mC are in agreement with the results obtained in Chapter 3, 
suggesting that the optimised immunofluorescence staining protocols for 5mC and 
5hmC immunostaining protocols display high repeatability and reproducibility of 






Figure 4.5: 5mC and 5hmC double immunostaining in E9.5 to E11.5 mouse 
embryonic surface ectodermal tissues. First row: cryosectioned tissues showing 
nuclear DNA counterstained with DAPI (blue). Second row: primary antibody against 
5hmC (green). Third row: antibody against 5mC (red). Fourth row: merged images 
of DAPI, 5hmC and 5mC. Columns 1 to 3: representative mouse embryonic surface 
ectodermal tissue sections at stages from E9.5 to E11.5. Areas within the dashed 
boxes represent surface ectodermal tissues. Images were obtained using a confocal 






Figure 4.6: 5mC and 5hmC double immunostaining in E9.5 to E11.5 mouse 
embryonic surface ectodermal cell nuclei. First row: cryosectioned tissues 
showing nuclear DNA counterstained with DAPI (blue). Second row: primary 
antibody against 5hmC (green). Third row: antibody against 5mC (red). Fourth row: 
merged images of DAPI, 5hmC and 5mC. Columns 1 to 3: representative mouse 
embryonic surface ectodermal cell nuclei at stages from E9.5 to E11.5. The confocal 
images were obtained by zooming into areas within the dashed boxes shown in 
Figure 4.5. Scale bar indicates 10 µm. 
 
 
4.2.3 5mC and 5hmC DNA methylation dynamics in developing 
mouse embryonic liver 
The dynamics of 5mC and 5hmC during development of the embryonic mouse liver, 
examined at a magnification of 40X, are shown in Figure 4.7. The zoomed 




and 5hmC display interesting dynamic patterns in developing liver. 5mC exhibits 
consistently low levels of staining throughout liver development (from E9.5 to 
E14.5) (Figure 4.7 and 4.8 – 5mC). On the contrary, immunofluorescence 
experiments showed that the levels of 5hmC are low at E9.5. 5hmC levels become 
markedly increased at E10.5, reaching their maximum at E11.5. After reaching the 
maximum, 5hmC appears to remain constant at a relatively high level until E14.5 
(Figure 4.7 and 4.8 – 5hmC). The pattern of high 5hmC at later stages (from E12.5 
to E14.5) apparently becomes much more scattered as at these stages of embryonic 
development, fetal liver becomes the main hematopoietic organ and is full of blood 
cells. Erythrocytes (red blood cells), the most numerous blood cells, are the easiest to 
identify as they generally have a rounded shape and are relatively uniform in size, 
making it easy to distinguish between the liver cells and red blood cells without 
using tissue-specific markers. Leukocytes (white blood cells), on the other hand, 
which are slightly larger than erythrocytes can be identified histologically by the 
complex shape of their nuclei. Several types of leukocytes have segmented nuclei, 
meaning that the nucleus is pinched off into two or more smaller segments that are 
still connected to each other. These results suggested that the dynamic nuclear 
changes in DNA methylation and hydroxymethylation states observed in liver were 
in good agreement with the model where the generation of 5hmC may correlate with 
the loss of old 5mC, but the observations were also found to be consistent with an 
involvement of de novo methylation in the generation of 5hmC. 
 
As in other tissues, the liver immunofluorescence images showed that the 5mC 
signals are mainly localised in the heterochromatic regions but also at the nuclear 
periphery (Figure 4.8 – 5mC), whereas 5hmC signals are mostly found in the 
euchromatic regions and are excluded from DAPI-dense foci (Figure 4.8 – 5hmC). 
The observed staining patterns of 5hmC and 5mC are in agreement with the results 
obtained in Chapter 3, suggesting good reproducibility of 5mC and 5hmC when the 








Figure 4.7: 5mC and 5hmC double immunostaining in E9.5 to E14.5 mouse embryonic liver tissue. First row: cryosectioned tissues 
showing nuclear DNA counterstained with DAPI (blue). Second row: primary antibody against 5hmC (green). Third row: with antibody 
against 5mC (red). Fourth row: merged images of DAPI, 5hmC and 5mC. Columns 1 to 6: representative mouse embryonic liver 
cryosections at stages from E9.5 to E14.5. Images were obtained using a confocal microscope with a 40X oil-immersion objective lens.  





Figure 4.8: 5mC and 5hmC double immunostaining in E9.5 to E14.5 mouse embryonic liver cell nuclei. First row: cryosectioned 
tissues showing nuclear DNA counterstained with DAPI (blue). Second row: primary antibody against 5hmC (green). Third row: antibody 
against 5mC (red). Fourth row: merged images of DAPI, 5hmC and 5mC. Columns 1 to 6: representative mouse embryonic liver tissue 
sections at stages from E9.5 to E14.5. The confocal images were obtained by zooming into the images shown in Figure 4.7. The dashed 




4.2.4 5mC and 5hmC DNA methylation dynamics in developing 
mouse embryonic red blood cells 
The dynamics of 5mC and 5hmC during development of the embryonic mouse red 
blood cells, examined at a magnification of 40X, are shown in Figure 4.9. 
Immunofluorescent staining of 5hmC and 5mC in red blood cells was performed as 
published genomic studies reported that whole blood has the lowest 5hmC content 
(Nestor et al., 2012; Stewart et al., 2015). The past reports are consistent with the 
immunostaining results obtained in the present study. 5mC and 5hmC display 
interesting dynamic patterns in the developing red blood cells. Immunofluorescence 
experiments showed high levels of staining for 5mC from E12.5 to E14.5 (Figure 
4.9 – 5mC), whereas for 5hmC, the levels of staining at the same stages of 
embryonic development are very low (Figure 4.9 – 5hmC). The images of red blood 
cells in liver were only taken at E12.5, E13.5 and E14.5 as at the early stages of 
development, the progenitors of these cells were morphologically unrecognisable and 
indistinguishable. Definitive erythrocytes, which began to emerge from the fetal liver 
at E12.5, were easily identified because of their small, round nuclei and because they 
often presented in small clusters. These results suggested that the dynamic nuclear 
changes in DNA methylation and hydroxymethylation states observed in red blood 
cells were in good agreement with the model where the generation of 5hmC may 
correlate with the loss of old 5mC. Indeed, the opposite 5hmC/5mC levels observed 
in this study provide strong support for the hypothesis. 
 
Blood cell immunofluorescence images also showed that the 5mC signals are to 
partly be localised in the DNA-dense heterochromatic regions (Figure 4.9 – 5mC), 
whereas the low level 5hmC signals are predominantly located in the euchromatic 
regions and excluded from DAPI-dense foci (Figure 4.9 – 5hmC). Moreover, the 
images also show that the intense immunofluorescence signals of 5mC are arranged 
predominantly at the nuclear periphery. The observed staining patterns of 5mC and 
5hmC are in agreement with the results obtained in Chapter 3 suggesting that the 
optimised protocols for the detection of both 5mC and 5hmC are robust and highly 






Figure 4.9: 5mC and 5hmC double immunostaining in E12.5 to E14.5 mouse 
embryonic red blood cells. First row: nuclear DNA counterstained with DAPI 
(blue). Second row: primary antibody against 5hmC (green). Third row: antibody 
against 5mC (red). Fourth row: merged images of DAPI, 5hmC and 5mC. Columns 
1 to 3: representative mouse embryonic red blood cells in whole embryo 
cryosections at stages from E12.5 to E14.5. Images were obtained using a confocal 











4.2.5 5mC and 5hmC DNA methylation dynamics in developing 
mouse embryonic diaphragm 
The dynamics of 5mC and 5hmC during development of the embryonic mouse 
diaphragm, examined at a magnification of 40X, are shown in Figure 4.10. The 
resulting dynamics are also shown at a higher image resolution using zoomed 
observations in Figure 4.11. 5mC and 5hmC display interesting dynamic patterns in 
the developing diaphragm. Immunofluorescence experiments showed that 5mC 
exhibits consistently low levels of staining throughout diaphragm development (from 
E9.5 to E14.5) (Figure 4.10 and 4.11 – 5mC). 5hmC, on the other hand, shows low 
levels of staining at E9.5. Subsequently, at E10.5, 5hmC levels become markedly 
elevated. Following elevation, 5hmC appears to remain constant at a relatively high 
level until E14.5 (Figure 4.10 and 4.11 – 5hmC). These results suggested that the 
dynamic nuclear changes in DNA methylation and hydroxymethylation states 
observed in diaphragm were in good agreement with the model where the generation 
of 5hmC may correlate with the loss of old 5mC, but these observations were also 
found to be consistent with an involvement of de novo methylation in the generation 
of 5hmC. 
 
Analysis of diaphragm tissue immunofluorescence images also showed that the 5mC 
signals are partly localised in the heterochromatic regions (Figure 4.10 and 4.11 – 
5mC), whereas 5hmC signals are mainly detected in the euchromatic regions and 
excluded from DAPI-dense foci (Figure 4.10 and 4.11 – 5hmC). Moreover, the 
images also show nuclei in which 5mC is arranged predominantly at the nuclear 
periphery. The observed staining patterns of 5mC and 5hmC are in line with the 
results obtained in Chapter 3 suggesting that the optimised protocols for the detection 
of both 5mC and 5hmC demonstrate high reproducibility and consistency of results 





Figure 4.10: 5mC and 5hmC double immunostaining in E9.5 to E14.5 mouse embryonic diaphragm tissues. First row: 
cryosectioned tissues showing nuclear DNA counterstained with DAPI (blue). Second row: primary antibody against 5hmC (green). Third 
row: antibody against 5mC (red). Fourth row: merged images of DAPI, 5hmC and 5mC. Columns 1 to 6: representative mouse embryonic 
diaphragm tissue in whole embryo cryosections at stages from E9.5 to E14.5. Areas within the dashed lines represent diaphragm tissues. 





Figure 4.11: 5mC and 5hmC double immunostaining in E9.5 to E14.5 mouse embryonic diaphragm cell nuclei. First row: 
cryosectioned tissues showing nuclear DNA counterstained with DAPI (blue). Second row: primary antibody against 5hmC (green). Third 
row: antibody against 5mC (red). Fourth row: merged images of DAPI, 5hmC and 5mC. Columns 1 to 6: representative mouse embryonic 
diaphragm tissue cryosections at stages from E9.5 to E14.5. The confocal images were obtained by zooming into areas within the dashed 




4.2.6 5mC and 5hmC DNA methylation dynamics in developing 
mouse embryonic heart 
The dynamics of 5mC and 5hmC during development of the embryonic mouse heart, 
examined at a magnification of 40X, are shown in Figure 4.12. The resulting 
dynamics are also shown at a higher image resolution using zoomed observations in 
Figure 4.13 and 4.14. 5mC and 5hmC display interesting dynamic patterns in the 
developing heart. Immunofluorescence experiments showed that the levels of 5mC 
are high at E9.5 and E10.5. At E11.5, 5mC levels begin to decrease and reach their 
minimum at E12.5. After reaching the minimum, 5mC appears to remain constant in 
both regions (trabecular [Figure 4.13] and compact myocardium [Figure 4.14]) at a 
relatively low level until E14.5 (Figure 4.12 – 5mC). 5hmC, on the other hand, 
shows low levels of staining at E9.5 and E10.5. At E11.5, 5hmC levels begin to 
increase and reach their maximum at E12.5, coincident with the loss of 5mC. After 
reaching the maximum, 5hmC appears to remain constant in the trabecular 
compartment (Figure 4.13) at a relatively high level until E14.5, whereas in the 
compact myocardium (Figure 4.14), 5hmC levels begin to decline shortly after 
E12.5 and reach their minimum at E13.5. 5hmC then stays constant at a relatively 
low level until E14.5 (Figure 4.12 – 5hmC). These results suggested that the 
dynamic nuclear changes in DNA methylation and hydroxymethylation states 
observed in trabecular region were in good agreement with the model where the 
generation of 5hmC may correlate with the loss of old 5mC, but the observations 
were also found to be consistent with an involvement of de novo methylation in the 
generation of 5hmC. On the contrary, the dynamic nuclear changes in DNA 
methylation and hydroxymethylation states observed in compact myocardium were 
in line with the model where the 5hmC levels are controlled independently. There 
was clearly no significant correlation between the loss of 5mC and the generation of 
5hmC at the global nuclear level. 
 
Nuclear analysis of heart development immunofluorescence images also showed that 
the 5mC signals are largely distributed in the heterochromatic regions in addition to 
the nuclear periphery (Figure 4.13 and 4.14 – 5mC), whereas 5hmC signals are 




foci (Figure 4.13 and 4.14 – 5hmC). The observed staining patterns of 5mC and 
5hmC are in agreement with the results obtained in Chapter 3 indicating that this 
good level of reproducibility is achieved using the optimised protocols for detecting 





Figure 4.12: 5mC and 5hmC double immunostaining in E9.5 to E14.5 mouse embryonic heart tissues. First row: cryosectioned 
tissues showing nuclear DNA counterstained with DAPI (blue). Second row: primary antibody against 5hmC (green). Third row: antibody 
against 5mC (red). Fourth row: merged images of DAPI, 5hmC and 5mC. Columns 1 to 6: representative mouse embryonic heart tissue 
cryosections at stages from E9.5 to E14.5. The dashed lines highlight the boundary between the trabecular region (Trab) and the compact 





Figure 4.13: 5mC and 5hmC double immunostaining in E9.5 to E14.5 mouse embryonic heart cell nuclei. First row: cryosectioned 
tissues showing nuclear DNA counterstained with DAPI (blue). Second row: primary antibody against 5hmC (green). Third row: antibody 
against 5mC (red). Fourth row: merged images of DAPI, 5hmC and 5mC. Columns 1 to 6: representative mouse embryonic heart tissue 
cryosections at stages from E9.5 to E14.5. The confocal images at stages from E9.5 to E12.5 were obtained by zooming into the images 
shown in Figure 4.12, whereas the confocal images at stages E13.5 and E14.5 were obtained by zooming into the trabecular regions 





Figure 4.14: 5mC and 5hmC double immunostaining in E9.5 to E14.5 mouse embryonic heart cell nuclei. First row: cryosectioned 
tissues showing nuclear DNA counterstained with DAPI (blue). Second row: primary antibody against 5hmC (green). Third row: antibody 
against 5mC (red). Fourth row: merged images of DAPI, 5hmC and 5mC. Columns 1 to 6: representative mouse embryonic heart tissue 
cryosections at stages from E9.5 to E14.5. The confocal images at stages from E9.5 to E12.5 were obtained by zooming into the images 
shown in Figure 4.12, whereas the confocal images at stages E13.5 and E14.5 were obtained by zooming into the compact myocardium 




4.2.7 Quantification of 5mC and 5hmC staining patterns 
Figure 4.15 and 4.16 show quantification of the 5mC and 5hmC signals in individual 
nuclei in E9.5 and E14.5 mouse embryonic diaphragm, liver, liver red blood cells, 
heart trabecular, heart compact myocardium and heart red blood cells. The levels of 
5hmC in E14.5 red blood cells contained in liver and heart tissue are indeed lowest in 
this group. For diaphragm and liver, between E9.5 and E14.5, the levels of 5hmC are 
remarkably increased, for few cells in liver but spreading out over a wide range for 
diaphragm nuclei, whereas the levels of 5mC appear consistently lower. For heart 
trabecular nuclei, the levels of 5mC also show an apparent decrease between E9.5 
and E14.5, whereas the levels of 5hmC nuclei are spread out and markedly higher at 
E14.5. For heart compact myocardium, the levels of 5mC are high at E9.5 and then 
become lower at E14.5, whereas for 5hmC, the levels between E9.5 and E14.5 show 
a modest increase compared to the trabeculae, which contain cells originating in the 
compact myocardium. 
 





















Figure 4.15: Quantification of the 5mC and 5hmC staining patterns in E9.5 and E14.5 mouse embryonic diaphragm, liver and 
blood cell nuclei. (A) Mask image of nuclei of E14.5 mouse embryonic diaphragm (blue), liver (red) and red blood cells (green) created 
using ImageJ (see Chapter 2, section 2.8) (B) A schematic showing of the results of quantification of 5mC and 5hmC signals in mouse 












Figure 4.16: Quantification of the 5mC and 5hmC staining patterns in E9.5 and E14.5 mouse embryonic heart trabecular, heart 
compact myocardium and heart blood cell nuclei. (A) Mask image of nuclei of E14.5 mouse embryonic heart trabecular (blue), heart 
compact myocardium (red) and heart red blood cells (green) created using ImageJ (see Chapter 2, section 2.8) (B) A schematic showing 
of the results of quantification of 5mC and 5hmC signals in mouse embryonic heart trabecular (blue), heart compact myocardium (red) 






4.2.8 5mC immunostaining in E12.5 mouse embryonic primordial 
germ cells (PGCs) 
Based on the finding that the genome-wide epigenetic states in PGCs undergo 
dramatic waves of reprogramming to remove DNA methylation, 
immunofluorescence double staining for 5mC in PGCs was subsequently performed 
as a necessary control to see whether the optimised protocol used for staining 5mC 
was capable of accurately detecting the hypomethylated state of PGCs in 
cryosections of E12.5 whole embryo mouse gonad. Moreover, the fluorescent signal 
results of 5mC erasure in PGCs were essentially required to help ensure the 
reliability and accuracy of 5mC results obtained in neocortex, surface ectoderm, 
liver, red blood cells, diaphragm and heart.  
 
Mouse embryonic gonad at stage E12.5 was chosen for this experiment because at 
this stage of development the PGCs have migrated and reached their target tissue and 
settled in the fetal gonad. Furthermore, it has also been reported that, at E12.5, PGCs 
are in a hypomethylated state, suggesting that this embryonic stage is suitable for 
visualising DNA methylation changes (Yamaguchi et al., 2013). In addition, anti-











Figure 4.17: 5mC immunostaining in E12.5 mouse embryonic PGCs. First column: nuclear DNA counterstained with DAPI (blue). 
Second column: primary antibody against Vasa (green) highlighting PGC cells. Third column: primary antibody against 5mC (red). Fourth 
column: merged image of Vasa and 5mC. Fifth column: merged image of DAPI, Vasa and 5mC. Top row: Representative images of PGCs 
taken under 10X objective lens. Bottom row: zoomed-in portion of PGCs images in the top row. Vasa-positive PGCs were at 






Figure 4.17 shows that the optimised protocol for 5mC immunostaining successfully 
detects a hypomethylated state in E12.5 PGCs. Representative immunofluorescence 
images show that cells that demonstrate direct association with Vasa-positive PGCs 
have indeed significantly lower 5mC staining levels. Consistent with other 
experimental findings, the result of the present experiment showed loss of DNA 
methylation in E12.5 PGCs. Furthermore, this experimental result also provided 
assurance that the hypomethylated DNA detected by our optimised 5mC 
immunostaining protocol in other mouse embryonic tissues was in fact reliable and 
accurate, and not due to local variations of in immunofluorescent staining. 
 
Moreover, it is also shown that successful double immunostaining for 5mC and 
PGCs was achieved using the optimised protocol for immunodetection of 5mC, 
indicating that even under harsh DNA-denaturing conditions required by this 
procedure, anti-Vasa antibody was still found to stain positively for the germ cell-
specific protein Vasa in the gonadal region (Figure 4.15 – Vasa). This result was 
therefore possible due to the compatibility of the PGCs immunostaining protocol 
with procedures requiring heat treatment. Tissue marker colocalisation on heat-
denatured 5mC or 5hmC cryosections proved more problematic with other 
antibodies. 
 
4.2.9 5mC and 5hmC single immunostainings in E14.5 mouse 
embryonic brain tissue: primary antibody specificity control 
Since the dynamic study was performed by double staining with anti-5mC and anti-
5hmC antibodies, there was a potential concern raised regarding the potential for 
cross-reactivity of the antibodies, as the 5mC and 5hmC modifications have very 
similar chemical structures. In addition, potential steric hindrance or antibody 
competition for closely located sites was a potential concern. Therefore, 5mC and 
5hmC single immunostainings were performed as an additional control in order to 








Figure 4.18: 5mC and 5hmC single immunostainings in E14.5 mouse 
embryonic brain cell nuclei. Left column: nuclear DNA counterstained with DAPI 
(blue). Middle column: primary antibodies against 5mC (red) and 5hmC (green). Top 
row, right column: merged image of DAPI and 5mC. Bottom row, right column: 
merged image of DAPI and 5hmC. Images were obtained using a confocal 
microscope with a 40X oil-immersion objective lens. 5mC signals mainly localise in 
DAPI-intense heterochromatic regions (top row, marked by arrows), whereas 5hmC 
signals primarily localise in euchromatic regions and exclude from the DAPI-bright 
granules (bottom row, marked by arrows). Scale bar indicates 20 µm. 
 
 
Representative confocal immunofluorescence images show that the 5mC signals are 
robustly accumulated in DAPI-dense heterochromatic chromatin regions, while 
5hmC signals are contrastingly distributed in DAPI-sparse euchromatic regions 
avoiding the DAPI-dense aggregates (Figure 4.18). These results suggested that both 










4.2.10 Enzyme immunostaining in E12.5 mouse embryonic tissues 
The three enzymes of the mammalian Tet family (Tet1, Tet2 and Tet3) are 
responsible for the loss of 5mC and the production of 5hmC. Moreover, a recent 
study demonstrates that de novo DNA methylation could play a key role in the 
formation of 5hmC. Therefore, it was crucial to investigate the presence of these 
enzymes in order to discover the origin of 5hmC. Cryosections of E12.5 mouse 
tissues were immunostained with antibodies against Tet1, Tet2, Tet3 and DNMT3A. 
Day E12.5 embryo was chosen for this experiment because at this stage the dynamic 
range of high and low levels of 5mC and 5hmC was most apparent. 
 
Detectable signals of Tet1, Tet2, Tet3 and DNMT3A are observed in neocortex 
(Figure 4.19), liver (Figure 4.20), diaphragm (Figure 4.22) and heart (Figure 4.23). 
However, in red blood cells, no apparent signals of Tet1, Tet2, Tet3 and DNMT3A 
are detected (Figure 4.21). The observation in the red blood cells was theoretically 
expected in view of the very low levels of 5hmC and high levels of 5mC staining in 
red blood cells. Immunofluorescent images of 5mC and 5hmC staining are shown in 
each of the figures (Figure 4.19, 4.20, 4.21, 4.22, 4.23 – 5mC and 5hmC) as 
comparative references of their staining levels. No results for surface ectoderm were 
obtained as at E12.5, this tissue was barely visible. 
 
The confocal images further show interesting distribution patterns of Tet1, Tet2, Tet3 
and DNMT3A. In neocortex, Tet1 signals are localised mainly in euchromatin 
regions, Tet2 signals are found mostly in heterochromatin regions, Tet3 distribution 
patterns are indistinguishable, and DNMT3A signals are enriched strongly in 
euchromatin regions (Figure 4.19). In liver, all enzymes seem to be distributed 
preferentially in euchromatin regions (Figure 4.20). Diaphragm appears to have 
distribution patterns of Tet1, Tet2, Tet3 and DNMT3A that are identical to enzymes 
distribution patterns in neocortex (Figure 4.22). In heart, Tet1 signals are unclear, 
Tet2 signals are localised predominantly in heterochromatin regions, Tet3 and also 





Overall, these observations were in agreement with the model where the loss of 5mC 
may trigger the formation of 5hmC, but the results were also consistent with an 
involvement of DNMT3A-driven de novo methylation in the production of 5hmC 
(Amouroux et al., 2016). In line with the previous studies, these findings also 
confirmed the important role of Tet1, Tet2, Tet3 and DNMT3A in mediating the 
accumulation of 5hmC. Their intranuclear distributions were in support of 
euchromatin-colocalised de novo 5mC methylation and 5hmC hydroxylation, in 
addition to heterochromatin-localised hydroxylation of old 5mC. However, it would 
be of great interest to see the dynamic patterns of these enzymes throughout 
embryonic development and investigate their correlation with 5mC and 5hmC 





Figure 4.19: Tet1, Tet2, Tet3 and DNMT3A immunostainings in E12.5 mouse embryonic brain neocortical cell nuclei in whole 
embryo cryosections. Representative stainings of mouse embryonic brain neocortical cell nuclei in whole embryo cryosections are 
shown. First row: nuclear DNA counterstained with DAPI (blue). Second row, first panel: primary antibody against 5hmC (green). Second 
row, second panel: antibody against 5mC (red). Second row, third panel: antibody against Tet1 (green). Second row, fourth panel: 
antibody against Tet2 (green). Second row, fifth panel: antibody against Tet3 (green). Second row, sixth panel: antibody against DNMT3A 
(red). Third row: merged images. Images were obtained using a confocal microscope with a 40X oil-immersion objective lens. Indirect 





Figure 4.20: Tet1, Tet2, Tet3 and DNMT3A immunostainings in E12.5 mouse embryonic liver cell nuclei in whole embryo 
cryosections. Representative stainings of mouse embryonic liver cell nuclei are shown. First row: nuclear DNA counterstained with DAPI 
(blue). Second row, first panel: primary antibody against 5hmC (green). Second row, second panel: antibody against 5mC (red). Second 
row, third panel: antibody against Tet1 (green). Second row, fourth panel: antibody against Tet2 (green). Second row, fifth panel: antibody 
against Tet3 (green). Second row, sixth panel: antibody against DNMT3A (red). Third row: merged images. Images were obtained using a 






Figure 4.21: Tet1, Tet2, Tet3 and DNMT3A immunostainings in E12.5 mouse embryonic red blood cell nuclei in whole embryo 
cryosections. Representative stainings of mouse embryonic red blood cell nuclei are shown. First row: nuclear DNA counterstained with 
DAPI (blue). Second row, first panel: primary antibody against 5hmC (green). Second row, second panel: antibody against 5mC (red). 
Second row, third panel: antibody against Tet1 (green). Second row, fourth panel: antibody against Tet2 (green). Second row, fifth panel: 
antibody against Tet3 (green). Second row, sixth panel: antibody against DNMT3A (red). Third row: merged images. Images were 
obtained using a confocal microscope with a 40X oil-immersion objective lens. No apparent signals of Tet1, Tet2, Tet3 and DNMT3A were 





Figure 4.22: Tet1, Tet2, Tet3 and DNMT3A immunostainings in E12.5 mouse embryonic diaphragm cell nuclei in whole embryo 
cryosections. Representative stainings of mouse embryonic diaphragm cell nuclei are shown. First row: nuclear DNA counterstained with 
DAPI (blue). Second row, first panel: primary antibody against 5hmC (green). Second row, second panel: antibody against 5mC (red). 
Second row, third panel: antibody against Tet1 (green). Second row, fourth panel: antibody against Tet2 (green). Second row, fifth panel: 
antibody against Tet3 (green). Second row, sixth panel: antibody against DNMT3A (red). Third row: merged images. Images were 
obtained using a confocal microscope with a 40X oil-immersion objective lens. Detectable Tet1, Tet2, Tet3 and DNMT3A signals were 





Figure 4.23: Tet1, Tet2, Tet3 and DNMT3A immunostainings in E12.5 mouse embryonic heart cell nuclei in whole embryo 
cryosections. Representative stainings of mouse embryonic heart cell nuclei are shown. First row: nuclear DNA counterstained with 
DAPI (blue). Second row, first panel: primary antibody against 5hmC (green). Second row, second panel: antibody against 5mC (red). 
Second row, third panel: antibody against Tet1 (green). Second row, fourth panel: antibody against Tet2 (green). Second row, fifth panel: 
antibody against Tet3 (green). Second row, sixth panel: antibody against DNMT3A (red). Third row: merged images. Images were 
obtained using a confocal microscope with a 40X oil-immersion objective lens. Tet1, Tet2, Tet3 and DNMT3A were present at detectable 





This chapter sought to explore DNA methylation states in terms of the cell type 
variations and the temporal changes of 5mC amongst developing mouse embryonic 
tissues and investigate their relationship with the formation and dynamics of 5hmC.  
 
4.3.1 5mC and 5hmC dynamics in developing mouse embryonic 
tissues 
Immunofluorescence observations revealed developmental tissue variations of 5mC, 
together with 5hmC, in brain neocortex, surface ectoderm, liver, red blood cells, 
diaphragm and heart. The optimised protocols used for 5mC and 5hmC detection in 
standardised conditions were able to display interesting dynamics across 
developmental stages. All tissues examined demonstrated distinct dynamic changes 
in 5mC and 5hmC patterns, except for liver and diaphragm, which showed some 
distribution-based similarity. Moreover, the dynamics of 5mC and 5hmC seemed to 
be tissue-specific, but again except for liver and diaphragm as they both appeared to 
share some features of similarity. Furthermore, both liver and diaphragm might also 
possess similarity in nuclear organisation of transcription for cellular differentiation. 
Apparently, heart showed much more dynamic changes in 5mC as well as 5hmC 
compared to other tissues, suggesting that nuclear organisation and DNA methylation 
state changes may be important for normal development of heart. On the contrary, 
5mC in conjunction with 5hmC existed at highly elevated levels at certain 
developmental stages of neocortex, indicating that strong transcriptional silencing 
and activation states may be necessary for the development of neocortical zones. 
 
Importantly, a recent study has reported significant levels of 5hmC in the cerebral 
cortex of the adult rat and its crucial role in the brain (Zheng et al., 2015). Another 
study also found significant enrichment of 5hmC in the adult mouse brain (Li and 
Liu, 2011). These results are consistent with Kriaucionis and Heintz who first 
reported discovery of 5hmC abundance in the adult mouse cortex  and found that 
5hmC was roughly 40% as abundant as 5mC in Purkinje cells (Kriaucionis and 
Heintz, 2009). Our findings likely explain the enrichment of 5hmC and 5mC as well 




(Li and Liu, 2011) also found high distribution of 5hmC in human liver. The high 
levels of 5hmC observed in this study at later stages of liver development are found 
to be consistent with the published data describing 5hmC distribution in human 
tissues, suggesting that 5hmC may be necessary for the expression of hepatic genes. 
On the other hand, research studies on 5hmC in blood indicate that blood cells are 
strongly depleted of 5hmC (Gross et al., 2016; Nestor et al., 2012; Stewart et al., 
2015). Consistent with the previous reports, confocal microscopy experiments also 
showed extremely low 5hmC levels in blood cells. For other tissue types, including 
surface ectoderm and diaphragm, less experimental literature on 5mC and 5hmC 
distributions is available. Thus, the data obtained from this study could provide new 
insights into the dynamics and distributions of both DNA modifications in these less-
studied tissues. The same goes for heart, due to 5mC and 5hmC varying distribution 
levels throughout heart development, as an appropriate comparison with the literature 
could not be made. 
 
However, a possible alternative explanation that could be made for high levels of 
5hmC in neocortex and heart trabeculae is they both are the zones with low 
proliferative activity (Barazzuol et al., 2015; Luxán et al., 2013), indicating that both 
tissues are enriched with post-mitotic cells. These observations are in accordance 
with a previous study that suggests high 5hmC is associated with non-proliferating 
post-mitotic cells (Ruzov et al., 2011). Nevertheless, its function is not yet clear. 
 
4.3.2 The origin of 5hmC during development 
In order to investigate the relationship between 5mC and 5hmC, three proposed 
models to explain the formation of 5hmC were utilised. These included loss of 5mC, 
gain of 5hmC by Tet proteins (Figure 4.24A), loss of 5mC, gain of 5hmC by Tet 
enzymes requiring DNMT3A (Figure 4.24B), and 5hmC acting on its own without 
concerted active DNA demethylation. Immunofluorescence analysis of the possible 
correlation between the levels of 5mC and 5hmC discovered that the dynamic 
changes of 5mC and 5hmC during neocortical and compact myocardial development 
supported the model where the 5hmC may be an independent epigenetic mark with 




ectoderm, liver, red blood cells, diaphragm and cardiac trabeculae, dynamic changes 
in 5mC and 5hmC levels agreed closely with the model where the accumulation of 
5hmC may be associated with the loss of old 5mC, but the observations were also 
consistent with an involvement of de novo DNA methyltransferase DNMT3A in the 
formation of 5hmC. 
 
 
Figure 4.24: Model for 5hmC as de novo epigenetic mark. (A) Tet proteins 
catalyse the oxidation of old 5mC (red) to produce 5hmC (green). (B) Tet enzymes 
oxidise de novo 5mC (red), produced by de novo DNA methyltransferase DNMT3A, 
and yield 5hmC (green). Dashed red lines represent the possible levels of 5mC. 
Figure created from the model proposed by Amouroux et al. (2016). 
 
 
Furthermore, the confocal image data describing the presence of all enzymes (Tet1, 
Tet2, Tet3, and DNMT3A) that are responsible for the production of 5hmC further 
confirmed the dynamic observed. A close inspection of the distribution patterns of 
enzymes suggests that DNMT3A 5mC may methylate euchromatin and euchromatic 
Tet1 (or Tet3, but less so Tet2) may render it into 5hmC in the euchromatin. Perhaps, 
these observations could therefore be taken in support of the de novo model, while 
more heterochromatin-localised Tet3 enzymes could hydroxylate old 5mC. However, 




those enzymes in the developing mouse tissues, not only at one stage of 
development, to further support the dynamic changes in 5mC and 5hmC. 
 
Taken together, this study suggests two possible developmental roles of 5hmC, 
including its role as a transient intermediate product of Tet-mediated active cytosine 
demethylation which can be oxidised further to form another two oxidised cytosine 
bases and its role as a new, stable and independent epigenetic mark that could recruit 
its own protein readers. However, further investigation may be necessary in order to 




Chapter 5 - H3K9me3 and H3K27me3 histone 




It has become increasingly apparent that DNA methylation does not act 
independently, but instead there is a close teamwork between DNA methylation and 
histone modifications (Patel, 2016). Great interest has been placed in the relationship 
between DNA methylation and histone lysine methylation, as the two systems appear 
to be highly correlated with one another (Du et al., 2015a). DNA and histone 
methylation systems interact closely in the regulation of transcription and chromatin 
organisation (Cedar and Bergman, 2009). Both epigenetic marks are likely to work in 
concert in establishing patterns of gene silencing during normal development 
(Cheng, 2014). Interestingly, the epigenetic interplay can occur in two-way 
interactions, in which DNA methylation can either be influenced by histone lysine 
methylation or vice versa (Rose and Klose, 2014). Accumulating evidence suggests 
that this crosstalk may be achieved through an intricate network of interactions 
between DNA and histone lysine methyltransferases (Zhang et al., 2015). 
 
Two histone marks, trimethylation of K9 and K27 on histone H3 (H3K9me3 and 
H3K27me3), are well known to be associated with constitutive and facultative 
heterochromatin formation, respectively, and gene repression (Boros et al., 2014). 
The epigenetic crosstalk between H3K9me and DNA methylation was first 
discovered several years ago by Tamaru and Selker (2001), demonstrating that DNA 
methylation is dependent on histone lysine methylation. Furthermore, trimethylation 
of H3K9 in particular has been shown to be very closely linked to cytosine 
methylation (Kim and Kim, 2012; Liu et al., 2013; Saksouk et al., 2015; Stewart et 
al., 2016). However, this crosstalk is not in agreement with the most recent study in 
mice (Zhao et al., 2016), which suggests that DNA maintenance methylation does 




Another important crosstalk between H3K27me3 and DNA methylation in directing 
transcriptional repression has also been reported (Reddington et al., 2013b). DNA 
methylation is necessary for the appropriate placement of H3K27me3, indicating that 
dysregulation of these two repressive mechanisms might be implicated in the 
development of many different types of cancer (Reddington et al., 2014). 
Interestingly, the relationship between H3K27me3 and DNA methylation is genomic 
region dependent, as these two epigenetic marks are found to be mutually exclusive 
in CpG dinucleotide-rich regions, whereas in other regions of H3K27me3 genomic 
enrichment, extensive overlap between these two mechanisms is apparent. 
Furthermore, the mutual exclusivity of H3K27me3 and DNA methylation may occur 
due to inhibition of PRC2 activity at DNA-methylated CpG-rich areas. Such 
inhibitory mechanism can be explained by epigenetic switching as reported in a 
previous study for prostate cancer cells (Gal-Yam et al., 2008). This study suggests 
that genes which are repressed by Polycomb complexes in normal prostate cells 
acquire CpG methylation and lose their H3K27me3 marks in the PC3 cancer cells. 
(Brinkman et al., 2012; de la Calle Mustienes et al., 2015; Yan et al., 2015). 
 
Therefore, it was of considerable interest to explore the correlation between DNA 
methylation and histone lysine methylation particularly focusing on trimethylation at 
both H3K9 and H3K27 in order to gain an accurate and deeper understanding of this 
interesting relationship during development. Immunofluorescent staining technique 
was again employed in the experiments reported here. Dynamic nuclear changes in 
H3K9me3 and H3K27me3 states were identified in the developing brain neocortex 
and heart. The dynamic patterns of both histone markers were subsequently 
compared with the dynamics of 5mC demonstrated in Chapter 4. Neocortex and heart 
were selected for a comparative study because both tissues showed distinct dynamic 









Therefore, the aims of this chapter were: 
1. To observe dynamic nuclear changes in H3K9me3 state during neocortex and 
heart development from E8.5 to E14.5 mouse whole embryonic stages. 
 
2. To observe dynamic nuclear changes in H3K27me3 state during neocortex and 
heart development from E8.5 to E14.5 mouse whole embryonic stages. 
 
3. To investigate the relationship between DNA methylation and histone lysine 
methylation in the developing neocortex and heart.  
 
5.2 Results 
Histone trimethylation dynamics at H3K9 and H3K27 were observed in whole 
embryo cryosections taken during mouse fetal development with results reported in 
brain neocortex and heart.  
 
5.2.1 Dynamics of H3K9me3 during embryonic neocortical 
development in mouse 
Figure 5.1 shows antibody staining patterns for H3K9me3 during embryonic 
neocortical development. Histone H3K9me3 displays consistently strong 
immunostaining in brain throughout development (embryonic days 8.5 to 14.5). 
Images of brain neocortical cell nuclei are shown in Figure 5.2 – H3K9me3. 
Confocal microscopy reveals that H3K9me3 immunostaining colocalises 
predominantly with DAPI brightly stained regions of high DNA density.  
 
Furthermore, monoclonal RC2 antibody staining was used in this experiment to 
observe for intermediate filament nestin. RC2 staining is detected in the neocortical 
regions of E9.5 to E14.5 cryosections, but at E8.5, significantly less intense signal of 
RC2 is observed (Figure 5.2 – RC2). H3K9me3 exhibits a high degree of 
colocalisation with nestin-expressing cells. This result suggested that high levels of 





It seemed that the patterns of H3K9me3 staining were similar to the patterns of 5mC 
staining described in Chapter 4. Fluorescence signals of these two epigenetic marks 
were found to be intense in the regions of neocortical tissue. These observations thus 
supported the research model which proposes that trimethylation of H3K9 works in 






Figure 5.1: H3K9me3 immunostaining in E8.5 to E14.5 mouse embryonic brain neocortical tissues in whole embryo 
cryosections. First row: nuclear DNA counterstained with DAPI (blue). Second row: primary RC2 antibody against nestin (green). Third 
row: primary antibody against H3K9me3 (red). Fourth row: merged images of DAPI, nestin and H3K9me3. Columns 1 to 7: representative 
mouse embryonic brain neocortical tissue cryosections at stages from E8.5 to E14.5. Areas within the dashed lines represent neocortical 





Figure 5.2: H3K9me3 immunostaining in E8.5 to E14.5 mouse embryonic brain neocortical cell nuclei. First row: nuclear DNA 
counterstained with DAPI (blue). Second row: primary RC2 antibody against nestin (green). Third row: primary antibody against H3K9me3 
(red). Fourth row: merged images of DAPI, nestin and H3K9me3. Columns 1 to 7: representative mouse embryonic brain neocortical cell 
nuclei at stages from E8.5 to E14.5. The confocal images were obtained by zooming into areas within the dashed lines shown in Figure 




5.2.2 Dynamics of H3K27me3 during embryonic neocortical 
development in mouse 
The dynamic changes of another classic repressive histone marker, trimethylation on 
H3K27, were also investigated in this study. H3K27me3 is a characteristic marker 
for facultative heterochromatin including X chromosome inactivation (Xi), whereas 
H3K9me3 is associated with constitutive heterochromatin typical for pericentromeric 
regions. Remarkably, H3K27me3 demonstrates a staining pattern similar to that of 
H3K9me3 in the developing mouse neocortex (Figure 5.3). Immunofluorescence 
images show that H3K27me3 is maintained at consistently high levels throughout 
embryonic brain development (from E8.5 to E14.5) (Figure 5.4 – H3K27me3). 
Moreover, inside each of the female cell nuclei, one large patch of Xi associated-
H3K27me3 is detected.  
 
Monoclonal RC2 antibody staining detects positive nestin signal in all stages of 
development except for E8.5, which demonstrates significantly weaker fluorescence 
signals (Figure 5.4 – RC2). Like the H3K9me3 signal, this repressive histone 
modification also showing colocalisation with RC2-positive cells, providing a direct 
link between H3K27me3 and neural progenitor cells. 
 
Interestingly, immunofluorescence microscopy for H3K27me3 revealed similar 
distribution patterns to H3K9me3 and 5mC, indicating that these three epigenetic 
marks were highly and mutually interconnected. Together, these findings suggest the 














Figure 5.3: H3K27me3 immunostaining in E8.5 to E14.5 mouse embryonic brain neocortical tissues in whole embryo 
cryosections. First row: nuclear DNA counterstained with DAPI (blue). Second row: primary RC2 antibody against nestin (green). Third 
row: primary antibody against H3K27me3 (red). Fourth row: merged images of DAPI, nestin and H3K27me3. Columns 1 to 7: 
representative mouse embryonic brain neocortical tissue cryosections at stages from E8.5 to E14.5. Areas within the dashed lines 
represent neocortical tissues. Images were obtained using a confocal microscope with a 40X oil-immersion objective lens. Scale bar 





Figure 5.4: H3K27me3 immunostaining in E8.5 to E14.5 mouse embryonic brain neocortical cell nuclei. First row: nuclear DNA 
counterstained with DAPI (blue). Second row: primary RC2 antibody against nestin (green). Third row: primary antibody against 
H3K27me3 (red). Fourth row: merged images of DAPI, nestin and H3K27me3. Columns 1 to 7: representative mouse embryonic brain 
neocortical cell nuclei at stages from E8.5 to E14.5. The confocal images were obtained by zooming into areas within the dashed lines 




5.2.3 Dynamics of H3K9me3 during embryonic heart development in 
mouse 
To further elucidate the relationship between H3K9me3 and 5mC, 
immunofluorescence detection of H3K9me3 was performed on cryosections of 
mouse embryonic heart. The dynamic nuclear organisation of H3K9me3 in the 
developing heart is shown in Figure 5.5. H3K9me3 is found at extremely high levels 
at E8.5. The levels of H3K9me3 then begin to decrease gradually between E9.5 to 
E11.5, reaching their lowest at E12.5. H3K9me3 is subsequently found to remain 
stable at very low levels until E14.5 (Figure 5.6 - H3K9me3). These observations 
suggested that H3K9me3 during early heart development exhibited much more 
dynamics than in embryonic brain neocortex. Furthermore, confocal microscopy 
images also show significant enrichment of H3K9me3 signals in transcriptionally 
inactive heterochromatic regions. 
 
Anti-cTnT antibody was used in this immunofluorescence experiment as a cardiac-
specific marker. All embryonic stages show detectable fluorescence signals of cTnT 
except for E8.5 and E9.5, no apparent cTnT signals were observed (Figure 5.6 - 
cTnT). The dynamic change pattern of H3K9me3 was examined closely at regions 
with high levels of cTnT staining. 
 
The dynamic nuclear changes in H3K9 trimethylation during embryonic heart 
development correlated the best with the dynamics of 5mC observed in Chapter 4. 














Figure 5.5: H3K9me3 immunostaining in E8.5 to E14.5 mouse embryonic heart tissues in whole embryo cryosections. First row: 
nuclear DNA counterstained with DAPI (blue). Second row: primary antibody against cTnT (green). Third row: primary antibody against 
H3K9me3 (red). Fourth row: merged images of DAPI, cTnT and H3K9me3. Columns 1 to 7: representative mouse embryonic heart tissue 
cryosections at stages from E8.5 to E14.5. Images were obtained using a confocal microscope with a 40X oil-immersion objective lens. 





Figure 5.6: H3K9me3 immunostaining in E8.5 to E14.5 mouse embryonic heart cell nuclei. First row: nuclear DNA counterstained 
with DAPI (blue). Second row: primary antibody against cTnT (green). Third row: primary antibody against H3K9me3 (red). Fourth row: 
merged images of DAPI, cTnT and H3K9me3. Columns 1 to 7: representative mouse embryonic heart cell nuclei at stages from E8.5 to 




5.2.4 Dynamics of H3K27me3 during embryonic heart development in 
mouse 
The connection between H3K27me3 and 5mC was further explored in other mouse 
embryonic tissue in order to confirm the existence of crosstalk among different 
epigenetic pathways. As shown in Figure 5.7, the dynamic changes of H3K27me3 
status in the developing heart follow the same pattern as H3K9me3. Representative 
confocal images show that at E8.5, H3K27me3 displays very high levels of 
detection. The subsequent decline in H3K27me3 levels was observed between E9.5 
to E12.5. Following the decrease, H3K27me3 then stays constant at its lowest level 
until E14.5 (Figure 5.8 - H3K27me3). These results clearly suggested that 
H3K27me3 in cardiomyocytes showed more dynamic behavior than neocortex 
during early embryonic brain development. The images also show the presence of an 
inactive X-associated H3K27me3-rich patch inside each of the female nuclei.  
 
For cTnT staining, the signals are detected at all stages of embryonic development, 
except for E8.5 and E9.5, no detectable fluorescence signals were observed (Figure 
5.8 - cTnT). Changes in H3K27me3 distribution were observed within regions of 
cTnT-positive cardiomyocytes. 
 
Again, a remarkable correlation was found among dynamic changes of H3K27me3, 
H3K9me3 and 5mC, pointing to a potential functional link between these three 














Figure 5.7: H3K27me3 immunostaining in E8.5 to E14.5 mouse embryonic heart tissues in whole embryo cryosections. First row: 
nuclear DNA counterstained with DAPI (blue). Second row: primary antibody against cTnT (green). Third row: primary antibody against 
H3K27me3 (red). Fourth row: merged images of DAPI, cTnT and H3K27me3. Columns 1 to 7: representative mouse embryonic heart 
tissue cryosections at stages from E8.5 to E14.5. Images were obtained using a confocal microscope with a 40X oil-immersion objective 





Figure 5.8: H3K27me3 immunostaining in E8.5 to E14.5 mouse embryonic heart cell nuclei. First row: nuclear DNA counterstained 
with DAPI (blue). Second row: primary antibody against cTnT (green). Third row: primary antibody against H3K27me3 (red). Fourth row: 
merged images of DAPI, cTnT and H3K27me3. Columns 1 to 7: representative mouse embryonic heart cell nuclei at stages from E8.5 to 




5.2.5 Quantification of H3K9me3 staining patterns in heart 
Figure 5.9 shows the quantification of H3K9me3 signals in individual nuclei in E9.5 
mouse embryonic whole heart, and E14.5 heart where trabecular and compact 
myocardium have differentiated. For heart trabecular nuclei, the levels of H3K9me3 
show an apparent decrease between E9.5 and E14.5. For heart compact myocardium, 
the levels between E9.5 and E14.5 show a stronger decrease compared to the 
trabeculae, which contain cells originating in the compact myocardium. 
 
Overall, semi-quantificative analysis of H3K9me3 displayed good consistency with 
immunostaining results but additionally revealed a relative difference in H3K9me3 
loss, which appears more marked in compact myocardium than in the trabeculae. 
 
 
Figure 5.9: Quantification of the H3K9me3 staining patterns in E9.5 and E14.5 
mouse embryonic heart cell nuclei. (A) E14.5 nuclei traced for trabecular (blue), 
compact (pink) myocardium (B) A notched boxplot showing the results of 
quantification of H3K9me3 signals in mouse embryonic whole heart at E9.5 and 
compact and trabecular myocardium at E14.5. Box plots represent medians (thick 
horizontal lines within boxes), interquartile ranges (IQRs), and ranges (excluding 
only values greater than ±1.58 times the IQR; outliers beyond this range are shown 
by individual open circles). The notches in the boxes are calculated as ±1.58 times 










This chapter aimed to observe dynamic nuclear changes in H3K9me3 and 
H3K27me3 states during brain neocortical and heart development. The obtained data 
were subsequently used for comparative analysis with 5mC results in order to 
explore the correlation between these three epigenetic marks. H3K9me3 and 
H3K27me3 are markers for constitutive and facultative heterochromatin, 
respectively, and could report on the developmental dynamics of these 
heterochromatin compartments more specifically than 5mC alone. Standard histone 
immunohistochemistry protocol was used for detecting those histone markers. 
 
5.3.1 H3K9me3 and H3K27me3 histone methylation dynamics in 
developing mouse embryonic tissues 
The standardized staining procedure used for detecting H3K9me3 and H3K27me3 
revealed interesting dynamic observations relating to both markers in the developing 
neocortex and heart. This analysis of the distribution patterns of H3K9me3 and 
H3K27me3 during neocortical development potentially discovered the existence of 
an interplay between these two marks. A similar result was obtained in the 
developing heart, where the levels of H3K9me3 and H3K27me3 displayed almost 
identical trends, further supporting this relationship. These observations clearly 
suggested a correlation that could signify possible mechanistic crosstalk between 
these two heterochromatin-related histone marks. For instance, H3K9me3 and 
H3K27me3 may function as a team to establish higher order chromatin structure 
across the nucleus. The obtained data are in excellent agreement with the growing 
body of histone literature reporting the complex connections between these two 
histone marks (Mozzetta et al., 2014; Sabbattini et al., 2014; Zhang et al., 2015). 
 
Furthermore, the distribution patterns of H3K9me3 and H3K27me3 in the 
developing neocortex were far less dynamic than in the developing heart. Possible 
functional interplay between H3K9me3 and H3K27me3 mechanisms could be to 
ensure maintenance of heterochromatin and epigenetic gene silencing during early 
neocortical development. These findings are in line with previous research 




neural progenitor cells (Pereira et al., 2010). The pattern of H3K9me3 distribution in 
the developing neocortex was found to be in good agreement with Western blot 
analysis that demonstrated stable level of H3K9me3 in the developing mouse brain, 
although the analysis was not done particularly in neocortex (Bártová et al., 2016). 
On the contrary, heart showed more dynamic behaviour of H3K9me3 and 
H3K27me3 than neocortex during early mouse development. The nuclear 
organisation in heart as revealed by the dynamic distributions of H3K9me3 and 
H3K27me3 raises the question whether it is crucial for proper heart function and 
formation. Moreover, chromatin organisation could also be necessary for cell 
differentiation and cell proliferation. 
 
Constitutive heterochromatin, which is found predominantly at the pericentromeric 
regions of chromosomes is marked by H3K9me3 (Jamieson et al., 2016). Consistent 
with previous observations, detailed confocal microscopic analysis showed that 
H3K9me3 was highly enriched at the chromatin-dense chromocenters. Facultative 
heterochromatin, on the other hand, which is represented by X chromosome 
inactivation, is marked by H3K27me3 (Degl’Innocenti and D’Errico, 2017; Saksouk 
et al., 2014). In keeping with previous reports, H3K27me3 was indeed enriched on 
this facultative heterochromatin in female cells. 
 
5.3.2 The relationship between DNA methylation and histone lysine 
methylation 
Comparisons between DNA methylation and histone lysine methylation (H3K9me3 
and H3K27me3) based on their distribution patterns in the developing neocortex and 
heart revealed a remarkably close relationship between these three epigenetic marks. 
This present study observed clear correlations in support of a functional crosstalk 
between the three major epigenetic repressive machineries. These three 
representatives of hetero- or inaccessible chromatin may establish cooperation to 






HP1 proteins, which preferentially bind H3K9me3, play a key role in promoting the 
formation of highly condensed heterochromatin structures (Muramatsu et al., 2016). 
Interestingly, these proteins have been shown to interact and recruit DNMTs, 
providing a direct link to the interplay between H3K9me3 and DNA methylation 
(Hirabayashi and Gotoh, 2010; Lehnertz et al., 2003; Saksouk et al., 2015). In a 
similar fashion, PRC2 complex, which catalyses trimethylation of H3K27, has also 
been demonstrated to interact with all three DNMTs (Mohammad et al., 2009; Viré 
et al., 2006; Zhang et al., 2016b). Remarkably, another recent study has revealed the 
existence of a cooperation between HP1 and PRC2 complex, further confirming the 
tight correlation between the three repressive epigenetic markers (Boros et al., 2014). 
Taken together, the results we have newly observed in developing embryonic tissues 
indicate that repressive epigenetic systems may indeed be working together as part of 




Chapter 6 – Visualisation of DNA methylation 
using transgenic MBD-GFP mice 
 
6.1 Introduction 
Genetic engineering, also known as genetic modification or GM, involves taking a 
specific gene from one organism and incorporating it into a completely unrelated 
organism (Sadelain et al., 2012). Such inserted gene is called a transgene and the 
organism that is created by genetic manipulation techniques is referred to as a 
transgenic or genetically modified organism (GMO) (Scharfenberger et al., 2014). 
Researchers have employed the application of transgenes to study the development 
and function of proteins in organisms (Rongvaux et al., 2014). Furthermore, the 
introduction of foreign DNA, a process known as transgenesis, could potentially 
result in a phenotypic change in an individual organism (Kim et al., 2016). 
 
A wide range of transgenic animals has been successfully generated for a variety of 
purposes. Examples of animal species include mice (Maeda et al., 2016), zebrafish 
(Kawakami et al., 2016), frogs (Takagi et al., 2013) and rabbits (Lang et al., 2016). 
Nevertheless, genetically modified mice are by far the most routinely used to study 
gene transfer (Doyle et al., 2012). This is because they are relatively inexpensive, 
easily housed and maintained, breed well and are convenient due to their small size 
(Kumar et al., 2009). Importantly, the mouse genome was sequenced early on and 
proves to be easily manipulated by transgenic technology (Haruyama et al., 2009). 
The application of this technique of gene transfer to early developing embryos has 
allowed researchers to produce more appropriate and reliable animal models for 
studying human development, diseases, and disorders (Cho et al., 2009). 
 
A reporter or marker gene is a gene that is commonly used as an indicator to 
elucidate transgenic events. For instance, the reporter gene can be employed to 
visually detect the activity of a specific gene in tissues (Vacaru et al., 2014). One of 
the most frequently used reporter gene for transgenic research is Green Fluorescent 




expressing fluorescent proteins have become ideal tools for monitoring protein 
distribution and expression as well as dynamic cellular events by microscopy (Besser 
et al., 2015; Ueda et al., 2014).  
 
One of the main current techniques available for studying DNA methylation is 
immunohistochemistry. However, in the case of immunohistochemistry, the intact 
structure of chromatin is destroyed by the heat treatment that is required in the 
optimised protocol for the successful binding of anti-5mC antibody to methylated 
DNA. Apart from immunohistochemistry technique, there is no appropriate method 
to visualise the dynamics of DNA methylation status in living cells or, particularly, 
in organisms.  
 
Thus, to track and detect the dynamic changes in 5mC during development, part of 
this study’s design relied on transgenic MBD-GFP mice to visualise DNA 
methylation in live cells and tissues. Embryos carrying a GFP fusion with a CpG 
methyl-binding domain (Human MBD1) were derived from transgenic mice 
generated by the lab and the collaborating lab prior to this study. MBD1 
preferentially binds to methylated DNA at CpG sites. This transgenic line expresses a 
GFP-MBD fusion protein driven by a ubiquitous promoter of the CAG type. In this 
model, the injected transgene was integrated randomly into the genome. In addition, 
GFP reporter system used in this study allowed direct GFP fluorescence visualisation 
without the need to add exogenous substrates or cofactors for detection. Thus, the 
dynamic expression patterns of proteins can be followed in live embryos as well as 
whole organisms. Transgenic primary fibroblasts and cardiomyocytes from E13.5 – 
E14.5 embryos had been characterised in vitro in the lab, but the reporter fusion had 
not been characterised as a marker for MBD1 and its binding to 5mC during 
development, and therefore transgenic embryos were used in this experiment. 
 
Therefore, the aims of this chapter were: 
1. To investigate tissues undergoing dynamic nuclear changes in the state of 5mC 






2. To investigate the correlation between the MBD-GFP results observed in 
transgenic mice and the 5mC results obtained in wild-type. 
 
3. To characterise the transgenic MBD-GFP mouse. 
 
6.2 Results 
Native MBD-GFP protein signal was visible in primary cell cultures but was 
sensitive to the cryosection protocol. The signal was therefore amplified by 
immunostaining for GFP in order to characterise its expression during development. 
Immunostaining of whole mouse embryo cryosections at stages from E10.5 to E14.5 
for MBD-GFP protein expression revealed the distribution of MBD-GFP (Figure 
6.1, 6.2, 6.3, 6.4 and 6.5). The highest levels of GFP expression were detected in 
heart, liver, brain and neural tube. However, no apparent developmental dynamics of 
GFP were observed. All four tissues displayed uniform levels of high GFP 
throughout embryonic development (Figure 6.6, 6.7, 6.8, 6.9 - GFP). 
 
Furthermore, the fluorescence images also show that in cell nuclei, the GFP signals 
are predominantly concentrated in the areas of intense DAPI which represent 
transcriptionally inactive heterochromatin. MBD-GFP nuclear distribution pattern 
was well correlated with patterns of 5mC nuclear distribution discussed in Chapter 4. 
The correlation between MBD-GFP and 5mC marks was also investigated at great 
length in Chapter 3, which showed detectable overlapping of intense GFP and 5mC 
signals in heterochromatin regions. However, developmental changes between 
MBD-GFP levels and the levels of 5mC states were not in agreement. These 
observations therefore throw doubt on whether the transgenic MBD-GFP mouse can 
prove to be a beneficial tool for visualisation of comparative DNA methylation levels 
in live tissues during development. 
 
In addition, bright fluorescent signals of GFP in brain and neural tube demonstrated 
colocalisation with nestin-expressing cells (Figure 6.8, 6.9 – RC2), suggesting that 





Figure 6.1: Immunostaining of whole mouse embryo cryosections at E10.5 for MBD-GFP protein expression. The representative 
mosaic fluorescent images of whole embryo cryosections are shown. Left image: nuclear DNA counterstained with DAPI (blue). Right 
image: antibody against GFP (green). Images were obtained using a fluorescence microscope with a 4X objective lens. High GFP 





Figure 6.2: Immunostaining of whole mouse embryo cryosections at E11.5 for MBD-GFP protein expression. The representative 
mosaic fluorescent images of whole embryo cryosections are shown. Left image: nuclear DNA counterstained with DAPI (blue). Right 
image: antibody against GFP (green). Images were obtained using a fluorescence microscope with a 4X objective lens. High GFP signals 





Figure 6.3: Immunostaining of whole mouse embryo cryosections at E12.5 for MBD-GFP protein expression. The representative 
mosaic fluorescent images of whole embryo cryosections are shown. Left image: nuclear DNA counterstained with DAPI (blue). Right 
image: antibody against GFP (green). Images were obtained using a fluorescence microscope with a 4X objective lens. Heart, liver, brain 





Figure 6.4: Immunostaining of whole mouse embryo cryosections at E13.5 for MBD-GFP protein expression. The representative 
mosaic fluorescent images of whole embryo cryosections are shown. Left image: nuclear DNA counterstained with DAPI (blue). Right 
image: antibody against GFP (green). Images were obtained using a fluorescence microscope with a 4X objective lens. Strong GFP 





Figure 6.5: Immunostaining of whole mouse embryo cryosections at E14.5 for MBD-GFP protein expression. The representative 
mosaic fluorescent images of whole embryo cryosections are shown. Left image: nuclear DNA counterstained with DAPI (blue). Right 
image: antibody against GFP (green). Images were obtained using a fluorescence microscope with a 4X objective lens. GFP is expressed 





Figure 6.6: GFP immunostaining in E10.5 to E14.5 mouse embryonic heart cell nuclei. First row: nuclear DNA counterstained with 
DAPI (blue). Second row: primary antibody against GFP (green). Third row: antibody against cTnT (red). Fourth row: merged images of 
DAPI, GFP and cTnT. Columns 1 to 5: representative mouse embryonic heart cell nuclei at stages from E10.5 to E14.5. Images were 





Figure 6.7: GFP immunostaining in E10.5 to E14.5 mouse embryonic liver cell nuclei. First row: nuclear DNA counterstained with 
DAPI (blue). Second row: primary antibody against GFP (green). Third row: antibody against HNF4α (red). Fourth row: merged images of 
DAPI, GFP and HNF4α. Columns 1 to 5: representative mouse embryonic liver cell nuclei at stages from E10.5 to E14.5. Images were 





Figure 6.8: GFP immunostaining in E10.5 to E14.5 mouse embryonic brain cell nuclei. First row: nuclear DNA counterstained with 
DAPI (blue). Second row: primary antibody against GFP (green). Third row: antibody against RC2 (red). Fourth row: merged images of 
DAPI, GFP and RC2. Columns 1 to 5: representative mouse embryonic brain cell nuclei at stages from E10.5 to E14.5. Images were 





Figure 6.9: GFP immunostaining in E10.5 to E14.5 mouse embryonic neural tube cell nuclei. First row: nuclear DNA counterstained 
with DAPI (blue). Second row: primary antibody against GFP (green). Third row: antibody against RC2 (red). Fourth row: merged images 
of DAPI, GFP and RC2. Columns 1 to 5: representative mouse embryonic neural cell nuclei at stages from E10.5 to E14.5. Images were 





This chapter aimed to identify tissues undergoing dynamic nuclear changes in 5mC 
in developing MBD-GFP mouse embryos. Immunostaining of whole mouse embryo 
cryosections for MBD-GFP protein expression revealed that no dynamic changes in 
levels comparable to those seen in 5mC levels were observed in the developing heart, 
liver, brain and neural tube. Moreover, MBD-GFP results also showed that the 5mC 
was found to be stable at high level throughout the development of these four tissues. 
MBD-GFP protein seemed therefore to be expressed in a tissue-specific pattern. The 
reason for this preferential expression in certain organs is unclear. This could be due 
to a combination of higher protein expression and lower protein turnover, while cell 
division rate could additionally influence protein levels. Therefore, the signals 
observed may not be comparable between tissues. 
 
The localisation of MBD-GFP was also revealed by immunostaining with anti-GFP 
antibody. In the cell nuclei, GFP signals were found to be mainly located in the dense 
regions of heterochromatin, proving that the MBD-GFP probe can accurately 
recognise heterochromatin that contains hypermethylated DNA. Furthermore, the 
experimental results also suggested that the MBD-GFP probe successfully captured 
global status of 5mC in living conditions.  
 
The distribution patterns of 5mC observed in transgenic mouse embryos were in 
keeping with the 5mC distribution patterns observed in Chapter 4. However, the 
dynamics of 5mC reported through MBD1-GFP binding in transgenic mouse 
embryos were in contradiction with the 5mC dynamics discovered in Chapter 4. The 
dynamics of 5mC in the developing heart and liver were compared between wild 
type and transgenic embryos. As for the brain, the 5mC dynamic result cannot be 
practically compared because the initial observation of 5mC dynamics in transgenic 
embryos was not specifically done in neocortex. Overall, this experiment yielded 
some unexpected results.  
 
In addition, high fluorescence signals of both 5mC and GFP demonstrated 




confirmed that the high genomic content of 5mC was associated with neural 
progenitors. 
 
Nevertheless, further investigation is required to provide a clear picture about how 
DNA methylation status is reported in transgenic MBD-GFP mouse. Moreover, 
additional experiments can be undertaken in order to characterise the transgenic 
mouse in more detail. One of the critical experiments that need to be performed is 
GFP detection in PGCs to investigate how this well-characterised global DNA 
demethylation event is represented. Furthermore, instead of using a fluorescence 
widefield microscope, the utilisation of confocal microscopy technique would offer 
high-contrast and extremely high-quality images that can attribute signal more 
specifically to individual cell nuclei. The results obtained for MBD-GFP, therefore, 







Chapter 7 - General discussion, conclusions 
and future works 
 
Epigenetics, the study of non-DNA sequence-encoded heritable traits propagated 
through modifications in the genomic DNA and chromatin proteins, is of increasing 
importance in biomedicine. Epigenetic mechanisms are implicated in the regulation 
of gene expression patterns that are at the basis of cell type specification during 
development and are necessary for maintenance of healthy life (Moffat et al., 2012; 
Reddington et al., 2013a). Their malfunction contributes to common complex 
inflammatory, cardiovascular and oncogenic disease, as well as being implicated in 
the lifetime programming effects from foetal and environmental exposures (Rose et 
al., 2013; Sproul and Meehan, 2013). 
 
This PhD study aimed to advance scientific understanding of the nuclear epigenetic 
dynamics during mammalian development. A few prominent examples of 
developmental DNA methylation changes have been characterised in zygotes and 
germ cells. However, DNA methylation dynamics of other tissues in mammalian 
development are currently under-investigated. This knowledge has relevance to 
understanding epigenetic maintenance of cell types in adult life and diseases such as 
cancer, and can contribute to cell reprogramming for regenerative medicine, as the 
early observations of zygotic programming led the way to the first cell 
reprogramming by nuclear transfer experiments (Campbell et al., 1996; Gurdon, 
2006). Therefore, the first aim of this study was to discover tissues undergoing 
dynamic nuclear changes in DNA methylation during mouse development. These 
changes were then characterised in order to report on developmental tissue-specific 
differences in DNA methylation and associated histone marks. This study utilised 
comparative immunocytochemistry by immunofluorescence staining analysis as a 






7.1 Optimised immunostaining for studying DNA methylation states in 
tissues 
The standard protocol for immunodetection of 5mC was initially thought to work on 
tissues as it worked on cells but certain steps required adaptation and rigorous 
optimisation (see Chapter 3). The problem was attributed to the acid denaturation 
step as it appeared to be ineffective at denaturing nuclear DNA in cryosectioned 
tissues. Acid can also lead to a destruction of DNA, potentially resulting in non-
representative binding of 5mC antibody. Thus, the acid-dependent DNA denaturation 
step was replaced with heat-mediated DNA denaturation and antigen retrieval, which 
was indeed able to successfully improve the detection of methylated DNA by 
properly denaturing the DNA and simultaneously reversing the formaldehyde 
crosslinking. Heat treatment seemed to aptly disassociate in every nucleus a double-
stranded DNA into single strands without apparent DNA damage. 
 
Nonetheless, the requirement of using heat to induce denaturation of DNA lowers the 
possibility of combining the optimised 5mC immunodetection protocol with tissue 
specific markers. The heat treatment conditions were found to be incompatible with 
the preservation of most protein epitopes. The use of tissue-specific markers in 
parallel could allow more precise attribution of nuclear signal to specific cell types 
than on the basis of anatomy alone. Therefore, further optimisation would be 
important particularly at the DNA denaturation step in order to be able to perform 
double immunostaining with tissue-specific markers and accurately detect 5mC in 
the tissue of interest.  
 
7.2 5mC and 5hmC DNA methylation dynamics in developing mouse 
embryonic tissues 
The successful 5mC immunodetection protocol was employed to examine 
developing mouse tissues across the embryo for variations in involvement and 
dynamics of DNA methylation states (see Chapter 4). Immunofluorescence data of 
5mC were subsequently used for comparative analysis with 5hmC dynamic 
observations. Thus, the second aim of this study is to investigate the origin of 5hmC 




Detailed immunofluorescence analysis suggests novel possible DNA demethylation 
events in the developing tissues studied. The molecular events of 5mC loss and 
concomitant 5hmC gain coupled with the existence of enzymatic activities are 
consistent with previous DNA demethylation studies in zygotes and PGCs 
(Amouroux et al., 2016; Ruzov et al., 2011; Yamaguchi et al., 2013; Zhang et al., 
2012a). This study also reveals the importance of nuclear organisation during early 
development of certain tissues. Chromatin may become more compacted or diffuse 
in response to developmental changes in gene expression. On the other hand, in some 
other tissues, particularly surface ectoderm and red blood cells, it seems like there is 
a need for switching genes respectively on or off throughout development, although 
the precise reason is still unclear, it is notable that erythrocytes undergo globin gene 
switching and eventually become enucleated (Chao et al., 2015). The findings, 
however, require further experimental investigation at the genomic level in order to 
seek the best explanation of the observations. Contrastingly, some tissues did not 
follow the classic events of CpG demethylation, but in fact confocal analysis of 
distribution levels were indicative that 5hmC appeared to work by itself without 
depending on other mechanisms. The apparent dynamic range observed for 5hmC 
levels was also greater than for 5mC levels, although this may be due to higher 
antibody affinity for the less abundant 5hmC epitope. A unique role of 5hmC has 
been reported in several studies (Hahn et al., 2013; Heras et al., 2017; Iurlaro et al., 
2013; Li and O’Neill, 2013; Salvaing et al., 2012). However, the exact molecular 
mechanism of 5hmC is still under extensive investigation.  
 
One possible explanation for elevated levels of 5hmC in certain stages of developing 
tissues could be due to higher oxygen conditions (Wenger et al., 2015). In support, a 
recent study suggests high oxygen levels trigger the enzymatic activity of Tet 
proteins (Chia et al., 2011). Tet enzymes utilise α-ketoglutarate (α-KG) and 
molecular oxygen to oxidise 5mC and yield 5hmC, indicating that high levels of 
oxygen may be associated with increase in Tet activity and generation of 5hmC. 
Furthermore, another recent study discovered that tumour hypoxia (i.e. oxygen-
deficient tumour cells) induces hypermethylation of DNA by reducing the activity of 




important of oxygen in the production of 5hmC. In this study, high 5hmC levels were 
observed in the later stages of trabeculae development. It is conceivable that 
ventricular blood can diffuse into the trabecula and trigger the localised formation of 
5hmC. This observation is further supported by very low levels of 5hmC in fetal red 
blood cells. These progenitor cells have not yet committed to oxygen transfer, 
therefore contain no oxygen (O’Connell et al., 2013). The enrichment of 5hmC in 
neocortex remains unsure although this study could speculate an involvement of 
cortical vascularisation.  
 
An alternative mechanism relating to cell turnover may be based on DNA replication 
and mitotic index of the tissues, which could potentially enhance 5mC maintenance 
over 5hmC hydroxylation activities. It is notable that the heart trabecular tissues and 
the outer neocortex zones in which higher 5hmC levels were observed contain less 
mitotic cells that migrate from more proliferative zones.  
 
These and other testable models will be investigated in future studies. In addition, 
more developing mouse embryonic tissues should be further explored for the 
dynamics of 5mC and 5hmC in order to better understand their precise role and 
mechanism.  
 
7.3 H3K9me3 and H3K27me3 histone methylation dynamics in 
developing mouse embryonic tissues 
The third aim of this study is to investigate relevant connections between DNA 
methylation and histone lysine methylation (see Chapter 5). The overall levels and 
distribution patterns of H3K9me3 and H3K27me3 revealed tight correlations with 
5mC distribution patterns. Furthermore, these three epigenetic marks were found to 
be enriched at their respective constitutive and facultative heterochromatic foci. This 
study suggests the existence of a possible mechanistic interplay between DNA 
methylation and histone lysine methylation. They may work in combination to 
establish higher order structures of heterochromatin across nuclear compartments and 





Fascinatingly, the interplay between these three systems appears to work in a tissue-
specific manner. In neocortex, a silenced state of heterochromatin may need to be 
maintained throughout development, whereas in heart, nuclear organisation may be 
necessary for normal development. Nevertheless, their mechanistic interplay in a 
tissue-specific manner is still not well understood. Importantly, these observations 
are worthy of attention but these exploratory findings need further investigation 
specifically at a genomic level.  
 
Similar to 5mC, it would also be interesting to explore the existence of crosstalk 
between DNA hydroxymethylation and specific histone modifications that are 
marked for open chromatin, for instance H3K4me3. 5hmC was found to be 
correlated negatively with repressive histone marks H3K9me3 and H3K27me3 (Wen 
et al., 2014). Thus, it is worth carrying out this experiment in order to be able to 
reveal and better understand the complex crosstalk among different types of 
epigenetic modification. 
 
7.4 Visualisation of DNA methylation using transgenic MBD-GFP mice 
The last aim of this study was to visualise DNA methylation in tissues using a 
transgenic MBD-GFP mouse (see Chapter 6). Immunofluorescence analysis 
revealed that the MBD-GFP probe can recognise correctly heterochromatin 
containing hypermethylated DNA. This study also provided strong evidence that the 
MBD-GFP signals were positively correlated with 5mC signals observed in wild-
type tissue, suggesting that MBD-GFP results were in good agreement with the 
experimental control. MBD-GFP levels and dynamics observed in the developing 
neocortex seemed to follow the dynamics of 5mC in wild type. In contrast, MBD-
GFP levels and dynamics observed in the developing heart and liver did not quite 
correlate with wild-type results. The stronger MBD-GFP signal in heart indicated 
that transgene expression in these particular tissues may not report on comparative 
5mC levels between these tissues, despite correctly reporting on DNA methylation 
within each cell type. This transgenic MBD-GFP mouse warrants deeper 





7.5 Future improvements 
A major advance in the field during the past few years has been the identification of 
5hmC as the sixth base in the mammalian genome. 5hmC has since been the subject 
of extensive investigation providing a better understanding of its biological function. 
Furthermore, a commercial antibody targeting 5hmC has also become available since 
then. The available 5hmC antibody has therefore allowed us to unravel the presence 
and distribution of 5hmC in the developing mouse embryonic tissues. However, the 
present study focused mainly on one technique and thus able to report only on 
immunostaining data. Therefore, genomic data, which are currently lacking in this 
study, should be included to provide further support for the immunostaining 
technique. The recent development of 5hmC-specific antibodies has led to the 
development and application of an antibody-based enrichment technique known as 
hydroxymethylated DNA immunoprecipitation (hMeDIP), a technique analogous to 
methylated DNA immunoprecipitation (MeDIP). hMeDIP appears to provide an 
invaluable tool to evaluate locus-specific and genome-wide maps of 5hmC in 
mammalian DNA. Therefore, this technique should be employed alongside MeDIP 
and chromatin immunoprecipitation (ChIP) experiments, followed by next-
generation sequencing (NGS) and bioinformatics analysis in order to obtain 
epigenetic information at the whole genome level. 
 
7.6 Conclusions 
In conclusion, the findings in this study have contributed more scientific 
understanding of DNA methylation dynamics and nuclear heterochromatin 
organisation during mammalian development, and its biological function in the 
specification and maintenance of cell lineages forming tissues and organs. This 
current knowledge may provide important insights into current barriers to cell fate 
reprogramming, which will be of benefit to cell regenerative biomedical technologies 








7.7 Future works 
It would be of great interest to further identify 5hmC-rich cell populations. 
Therefore, for the next experiments, fluorescence activated cell sorting (FACS) will 
be performed to isolate cells that contain high levels of 5hmC. Genomic mapping 
will then be performed using methylated and hydroxymethylated DNA 
immunoprecipitation methods (MeDIP and hMeDIP, respectively) followed by next-
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